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Chapter 1 
In traduction 

Introduction I 
W hite matter lesions are frequently found on cerebral magnetic reso-nance imaging scans of elderly non-demented and demented peo-
ple.l-4 The pathogenesis of white matter lesions is largely unknown. How-
ever age and high diastolic and systolic blood pressure levels and indica-
tors of atherosclerosis have consistently been reported as risk factors for 
white matter lesions, regardless of their location.2-s Many other, especially 
vascular, risk factors have been associated with white matter lesions, but 
these relations were mostly not consistent throughout studies. 
There is growing evidence that white matter lesions play an impor-
tant role in the development of cognitive decline and dementia. 4 .6 -8 The 
white matter can be distinguished into two separate anatomical regions, 
namely the peri ventricular white matter (a strip of white matter adjacent 
to the lateral ventricles) and the subcortical white matter (the white mat-
tcr just underneath the gray matter). Only a few studies have distin-
guished between these two locations and have reported on their determi-
nants separately.9,10 Yet it may be that different risk factors underlie white 
matter lesions at different locations, or that lesions in different locations 
may have different cognitive consequences. 
To date, the reported associations came almost exclusively from 
cross-sectional MRI studies among elderly people. However, the well-es-
tablished risk factors hypertension and atherosclerosis already occur 
much earlier in life, when the prevalence of white matter lesions is still 
low. In order to gain more insight in the pathogenesis of white matter le-
sions a follow-up study starting at mid-life age would be very informative. 
In addition to this, many risk factors are more discriminative at younger 
age (when the prevalence ofthe risk factor is still low) than at higher ages. 
The aim of this thesis is to report on the frequency distribution of 
white matter lesions in the periventricular and subcortical region in eld-
erly people. Secondly, it addresses the association between vascular de-
terminants (assessed during mid-life and late-life) and cerebral white 
matter lesions. The studies presented in this thesis are based on the Rot-
terdam Scan Study, alongitudinal population-based study among 1084 
subjects, aged 60-90 years. The study was carried out in 1995-1996. 
About one half of them (516 subjects) originated from the Zoetermeer 
Study, which is a prospective population-based study with baseline data-
collection in 1975-1978, and a mean follow-up of 20 years. The remaining 
568 subjects came from the Rotterdam Study, which is also a prospective 
population based cohort study with a baseline data-collection in 1990-
1993 (mean follow-up 5 years). 
In chapter 2.1. the literature is reviewed on the frequency and risk 
factors of white matter lesions. Chapter 2.2. describes the region-specific 
frequency distribution of white matter lesions as observed in the Rotter-
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dam Scan Study. The association between blood pressure level, its 
changes over a longer and a shorter period, and white matter lesions is 
reported in chapter 3.1. Chapter 3.2. deals with the relation between 
white matter lesions and hypertension, including its duration and man-
agement. Chapter 4 is devoted to the association between indicators of 
atherosclerosis (chapters 4.1. and 4.2.) and atherosclerosis-related disor-
ders (chapter 4.3. and 4.4.) Chapter 5.1. describes the association be-
tween the APOE genotype and the presence of white matter lesions. In 
chapter 6 the methodological strengths and weaknesses of the study are 
discussed. In addition a pathophysiological model for the emergence of 
white matter lesions is proposed. 
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Epidemiology of 
white matter lesions 

2.1 
Abstract 
Cerebral white matter lesions: 
frequency and risk factors 
Cerebral white matter lesions are a common feature on magnetic resonance 
imaging (MRI) scans of elderly non-demented people. Prevalence ranges from 
5% to 100 % in different studies. The pathogenesis of white mailer lesions re-
mains unclear although age, hypertension and the presence of cardiovascular 
disease have been identified as potential risk factors. 
In this review methodological issues and known risk factors are reviewed The 
focus is on data obtained from large population based MRI studies. It is con-
cluded that the prevalence of white mailer lesions increases with age. Hyper-
tension is an established risk factor for the presence of white mailer lesions. In 
addition there is some evidence for associations with other vascular risk factors~ 
including indicators of atherosclerosis, cardiovascular disease, nutrients and 
ApoE. 
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Introduction 
With the introduction of the computer tomography (CT) scan and the 
magnetic resonance imaging (MRI) scan it became possible to investigate 
the living brain and this revealed a number of unexpected phenomena in 
the cerebral white matter. Both CT and MRI very frequently show white 
matter lesions in elderly non-demented subjects. 1-6 There is evidence that 
these subjects suffer from mild cognitive impairment. 4 ,7,8 In addition, on 
MRI scans of brains of patients with Alzheimer's disease or vascular de-
mentia white matter lesions are manifold. 6 ,g-IS It has been suggested that 
white matter degeneration may play an important role in the pathogenesis 
of Alzheimer's disease. 16 
White matter lesions on MRI scans are hyper intense on both T2 and 
PD (proton density) weighted images with no corresponding lesion at a Tl 
weighted image. On CT scan they are hypo dense. According to their loca-
tion they are usually distinguished in periventricular and deep subcortical 
changes. Most rating scales categorize white matter lesions with respect 
to size. 
Mild to moderate periventricular white matter lesions correlate with peri-
vascular demyelinization, gliosis,17-19 increased extracellular fluid and 
both smaller and fewer axons.20.21 The anatomical substrate of the small, 
punctate deep subcortical white matter lesions observed on MRI scans is 
mild gliosis,22 demyelinization23 ,24 and dilated perivascular spaces. 22 These 
punctate changes are not seen at CT scan and are considered by some 
authors as a different entity than the large white matter lesions2o ,22,25 and 
not important with regard to functional outcome. 26 However, this has 
never been confirmed in large population based MRI studies. The larger 
white matter lesions correspond with lacunar infarctions, white matter 
rarefaction and infarctions21.23.27 and thickening of arteriolar walls. 21 The 
etiology of white matter lesions is not yet fully understood, but findings 
from epidemiologic,4.7,8.28 anatomic29 and neuropathologic 18,21,3o studies 
suggest underlying small vessel disease. 
Today data regarding frequency and risk factors of white matter le-
sions are available from studies on patient series, selected (volunteer) 
sample and large cross sectional population based samples. Large popu-
lation based follow up studies are currently planned. This review will 
mainly discuss results from large population based studies with randomly 
selected subjects from the general population aged 55 years or over, 
namely the Cardiovascular Health Study (CHS),8 the Atherosclerosis Risk 
in Communities Study (ARIq,s the Helsinki Aging Study3l and the Rotter-
dam Study 4.? 
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Methodologic considerations 
Introduction 
The comparability of studies on frequency and risk factors of white matter 
lesions is limited by substantial differences between studies. These differ-
ences concern the selection of the study population, the assessment and 
operationalization of the outcome variable and the assessment of the pu-
tative risk factors. 
Study Population 
Differences in the size of the study population and selection of subjects 
contribute to the varying results on frequency of white matter lesions and 
the strength of associations found between white matter lesions and its 
determinants. Many studies are small and therefore not able to identify 
weak, or strong but rare risk factors. Furthermore, they can not approxi-
mately adjust for confounding, e.g. by age. Other studies only comprise of 
highly selected patients or exclude subjects with risk factors known from 
other studies to be associated with white matter lesions. This selection 
may strongly bias the results regarding etiologic relations. In studies that 
sampled their participants randomly from the general population low re-
sponse may likewise have introduced selection bias. 
MRI specifications 
An issue which has drawn little attention till now is the difference in field 
strength and pulse sequences with relation to prevalence. It is suggested 
that variations in prevalence of white matter lesions are partly explained 
by the variations of field strength and pulse sequences among the several 
studies. 26 Until now this has not been formally investigated. 
White matter lesions rating scale 
In order to interpret and compare results from various studies on the eti-
ology of white matter lesions comparable grading of white matter lesions 
is important. Until now almost every investigator created an own rating 
scale. There are three important considerations with respect to white 
matter lesion scoring: location, size and number. 
Location 
An important characteristic of white matter lesions is their location. Usu-
ally two locations are distinguished, namely peri ventricular and deep 
I Chapter 2. 1 
subcortical. Since it is suggested that both types of white matter lesions 
may have a different etiology29 it is essential not to grade them in one and 
the same category. Still, many studies do not distinguish different loca-
tions and score presence, regardless of location, in a more3 -S,7,8,31-33 or 
less9 .34 detailed way. In addition, deep subcortical and periventricular 
white matter lesions can be scored per brain region in order to identify 
possible region-specific risk factors or region specific functional outcome. 
None of the population based MRI studies that have been published to 
date distinguished between deep subcortical and pcriventricular white 
matter lesions or did a region specific scoring within these areas. 
Size 
The importance of punctate deep subcortical and pencil thin pcrivcn-
tricular white matter lesions is debated and several authors score them in 
the group without white matter lesions.9 ,34,35 Also, presence of white mat-
ter lesions is often dichotomized as absent or present,l,25,34 regardless of 
size or location. Others do count white matter lesions per size category 
and per region, however without using this detailed score in their analy-
ses.36 It is obvious that these considerations directly affect the prevalence 
of white matter lesions. As for etiologic studies, the definition of the out-
come largely influences the power to identify specific determinants and if 
punctate or pencil thin white matter lesions are not scored it is even im-
possible to identify risk factors for these types of lesions. When too crude 
a scale is used, increases in number or extent of white matter lesions may 
not be detected, The power to study determinants of white matter lesions 
will therefore be limited. 
Number 
Another important feature of a white matter lesions rating scale is how it 
deals with the number of the deep subcortical white matter lesions. Most 
currently used scales cluster different amounts of white matter lesions 
above an arbitrarily cut-off number into one, most severe, category.4,21,36 
To date there are no studies that determine risk factors of white matter 
lesions in linear regression models or in trend analyses. Scoring the 
amount of white matter lesions would enable the study of a possible dose-
response relation or a threshold in the relation between determinant and 
number of white matter lesions. 
Risk factor assessment 
A major problem in reviewing risk factors is that they are not uniformly 
defined across studies, except for age and gender. For many risk factors 
different criteria are used, e.g. hypertension. Due to limited sample size or 
10 
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low exposure other risk factors may be grau ped in one exposure category, 
e.g. vascular diseases. By including different risk factors into one expo-
sure category it is not possible to assess the role of a specific risk factor 
on white matter lesions. In addition this makes it difficult to compare as-
sociations found with these risk factors vvith results from other studies. 
All studies thus far are cross sectional in nature. Having the advan-
tage of being carried out relatively quickly, their potential to investigate 
causality is limited. Usually it can not be assured that the risk factors 
preceded the occurrence of white matter lesions. Furthermore, risk factors 
identified in cross sectional studies may be associated -with the white 
matter lesions themselves or -with survival of the subjects -with the white 
matter lesions. 
Frequency 
Prevalence 
The reported prevalence of white matter lesions varies considerably 
among several MRI studies for reasons as discussed above. 
Estimates vary from as low as 10%4 up to 100%.1-3,5,8,32,33,37,38 Table 1 
presents prevalence of white matter lesions in several studies -with ran-
domly selected participants from the general popUlation or healthy vol-
unteers. 
All authors found a highly significantly increasing prevalence of white 
matter lesions -with increasing age. The Cardiovascular Health Study re-
ported a prevalence of any white matter lesions of about 90% in subjects 
between 65 and 69 years increasing up to 98% in persons above 80 years 
of age.8 The ARIC study showed a prevalence of any white matter lesions 
of 85% among subjects -with a mean age of 62 years. 5 They do not report 
prevalence per age category. The Rotterdam Study reported a substantial 
lower prevalence but only considered moderate to severe lesions. They 
found moderate to severe white matter lesions present in 11 % of subjects 
between 65 and 69 years and in 54% of subjects between 80 and 84 
years. These variations are mainly explained by the use of incomparable 
rating scales and differences in frequency of risk factors for white matter 
lesions among the participants. 
A few studies pointed out sex differences in prevalence and severity of 
white matter lesions. The Cardiovascular Health Study showed no large 
differences in prevalence between men and women, but a significantly 
increased white matter severity among women in all ages, except for sub-
jects between 65 and 69 years. Similarly, in the Rotterdam Study an in-
11 I 
Table 1 
Prevalence and rating scales of cerebral white matter lesions in population based studies and among healthy volunteers from the general 
population. Prevalence was defined as the proportion of subjects with white matter lesions present on MRI scan, regardless of severity. 
Author/Study 
Breteler (4) 
The Rotterdam Study 
Christiansen (33) 
The Copenhagen City 
Heart Study 
Lindgren (35) 
Ylikoski (31) 
The He/sinki Aging 
Study 
Longs1reth (8) 
Cardiovascular 
Health Study 
Llao (5) 
ARICstudy 
Subjects 
population based study 
(n=111) 
healthy volunteers 
(n=142) 
population based study 
(n=77) 
population based study 
(n=128) 
population based study 
(n=3301 ) 
population based study 
(n= 1920) 
WhHe matter rating scale 
Combined score deep subcortical white 
matter lesions and periventricular white 
matter lesions on a three point scale. 
Eleven categor'les of deep subcortical 
white matter lesions with respect to 
number and size. 
Combined score deep subcortical white 
matter lesions and periventricular white 
matter lesions on a three point scale; in 
addition per location on a four point 
scale. 
Deep subcortical white matter lesions 
and periventricular white matter lesions 
separately (total score 0-48). 
Combined score deep subcortical white 
matter lesions and periventricular white 
matter lesions on a ten point scale. 
Combined score deep subcortical white 
matter lesions and periventricular white 
matter lesions on a ten point scale. 
Age 
mean age: 73.8yrs. 
age range: 65-84yrs. 
mean age: not given. 
age range: 21-80yrs. 
mean age: 65.1 yrs. 
age range: 36-95yrs. 
mean age: not given. 
age range: 55-85yrs. 
mean age: 70.7yrs. 
age range: 65yrs. 
mean age: 62.4yrs. 
age range: > 55yrs. 
Prevalence 
27.0% 
21-30yrs:20.0%; 
71-80yrs: 100.0%. 
62.3% 
39.0% and 22.0% for 
periventricular and 
subcortical white 
matter lesions, 
respectively 
95.6% 
85.0% 
Schmidt (37) population based study Combined score deep subcortical white mean age: 62.1 yrs. 44.8% 
Austrian Stroke (n=355) matter lesions and periventricular white age range: 45-75yrs. 
Prevention Study matter lesions on a four point scale. 
Padovani (39) healthy volunteers Combined score deep subcortical white mean age: 62.1yrs. 50.0% 
(n=50) matter lesions and periventricular white age range: not given. 
matter lesions on a four point scale. 
Tupler (40) healthy volunteers Deep subcortical white matter lesions mean age: 61.8yrs. 72.7% 
(n=66) scored only on a four point scale. age range: 45-84yrs. 
Boone (41) healthy volunteers Combined volumetric analysis of deep mean age: 62.8yrs. 54.0% 
(n=100) subcortical white matter lesions and age range: 45-83yrs. 
periventricular white matter lesions. 
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creased age-specific prevalence and severity of white matter lesions was 
found among women as compared to men {figure 1),7 
To date only one study specified age specific prevalence per location. 
Ylikoski et al reported a prevalence of 21 % of peri ventricular white matter 
lesions in subjects below 75 years (mean age 64.1 years) increasing to 
65% in subjects over 75 years (mean age 82.3 years). The prevalence of 
deep subcortical white matter lesions was 11% in subjects below 75 
years, increasing to 38% in over 75 years.31 
Incidence 
Until now no data on the incidence of white matter lesions have been re-
ported. Large population based follow-up studies in order to detect inci-
dence of white matter lesions are currently being carried out. 
Risk factors 
Blood pressure 
Hypertension and increase in both systolic and diastolic blood pressure 
have been found to be major risk factors for presence of white matter 
lesions in almost all studies that investigated this relation. 4 ,5,8,9,31,35 The 
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Figure 1 
Sex specific severity 
of white matter 
lesions - The 
Rotterdam Study 
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Rotterdam Study investigated the role of blood pressure in age categories 
from 65 to 74 years and 75 to 84 years. They found that the association 
between hypertension, systolic and diastolic blood pressure and presence 
of white matter lesions was only significant in the youngest age group. In 
the oldest age group there was a non-significant inverse association 
between blood pressure and presence of white matter lesions. 
The ARIC study looked in great detail at the role of hypertension, its 
duration, and its treatment and control, on white matter lesions and in 
different ethnic groups (African and European Americans). Logistic re-
gression was used to estimate odds ratios of having white matter lesions 
grade ;>3 (range 0-9) as compared to grade <3. Subjects with hypertension 
had more than twice as often white matter lesions grade ;>3 (OR 2.3; 
95%CI 1.7-3.2) and subjects with longer lasting hypertension had a 
higher risk than subjects with a shorter duration of hypertension (OR 
2.5;95%CI 1.8-3.4 and OR 1.7;95%CI 1.0-2.9, respectively). The relation 
between hypertension and white matter lesions was similar for both 
ethnic groups. Subjects treated for hypertension, but whose blood 
pressure did not get under control had the highest risk of white matter 
lesions grade ;>3 ( OR 3.4;95%CI 2.3-5.0), followed by the untreated and 
the treated subjects whose blood pressure did get under control (OR 
2.0;95%CI 1.2-3.1 and OR 1.9;95%CI 1.3-2.9, respectively). Surprisingly, 
the Helsinki Aging Study found no association between hypertension and 
white matter lesions. The relation mth hypertension or blood pressure 
levels has not been investigated for periventricular or deep subcortical 
white matter lesions separately. 
Atherosclerosis 
Few studies investigated the association between presence of atheroscle-
rosis and white matter lesions. 8,28,42 The Cardiovascular Health Study 
found in the univariate analyses a significant association between an in-
dicator of intracranial atherosclerosis) intima media thickness of the in-
ternal carotid artery wall) and presence of white matter lesions. They 
found no association mth the ankle-to-brachial index) as an indicator of 
peripheral atherosclerosis. 42 They did not investigate these associations in 
multivariate models. Results from the Rotterdam Study2S showed that an 
increased intima media thickness was associated with increased presence 
of white matter lesions (OR 1.5;95%CI 1.1-2.1, per 100ilm increase) and 
that the presence of plaques in the carotid artery wall (another indicator 
of intracranial atherosclerosis) was associated mth the presence of white 
matter lcsions (OR 3.9;95%CI 1.0-14.5). In addition they showed an in-
verse relation between ankle-to-brachial index and severity of white mat-
15 
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ter lesions. Fazekas et a1. 9 and Lindgren et al.35 also investigated the role 
of intracranial atherosclerosis and white matter disease, In rather small 
population based samples they were not able to show an association be-
tween stenosis of the extra cranial carotid artery and presence of white 
matter lesions. Many studies have confirmed the relation between hyper-
tension and presence of white matter lesions, but the mechanism by 
which hypertension exerts its action on the cerebral white matter is not 
known. 4 ,5,8,9,31,35 
Neuropathological research suggests an important role of blood pres-
sure and hypertension in the pathogenesis of atherosc1erosis, 18,22 In order 
to find out whether atherosclerosis has an independent effect on the oc-
currence- of white matter lesions or is an intermediate between hyperten-
sion and white matter lesions, analyses should be performed within strata 
of atherosclerosis. 
In none of the studies described above this stratification was per~ 
formed. 
Diabetes mellitus 
Many studies investigated the relation between diabetes mellitus and 
presence of white matter lesions,4,S,8,<J,31,32 but only a few, relatively small 
studies, showed an association between diabetes mellitus and presence of 
white matter lesions. 2,31,43 There is extensive evidence that diabetes mel-
litus is a risk factor for cardiovascular disease. It has been suggested that 
this is mediated by an increased degree of atherosclerosis. 44 In a large 
population based study serum level glucose and the prevalence of diabe-
tes mellitus was significantly associated -with indicators of atherosclerosis 
such as atherosclerotic plaques in the carotid arteries and ankle-to-bra-
chial index. 45 
Fibrinogen 
Fibrinogen is strongly associated -with preclinical atherosclerosis and also 
with other cardiovascular risk factors. 46-48 Elevated fibrinogen levels have 
been reported in subjects suffering from Binswanger's disease. Results 
from the Rotterdam Study showed an association between increased 
plasma fibrinogen levels and presence of white matter lesions. 4 In the 
Cardiovascular Health Study a similar association was found. 8 Ii is yet 
unclear whether this elevated fibrinogen level is causally related to the 
white matter lesions, or is merely the consequence of the underlying small 
vessel disease, 
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Cholesterol 
Cholesterol is a well-established risk factor for cardiovascular disease and 
mortality. By accumulating in the arterial wall it plays an important role 
in the pathogenesis of atherosclerosis. Quite a few studies3 ,4,B,28,39,42 ad-
dressed whether cholesterol levels were associated with presence of white 
matter lesions. Longstreth et al were the only ones who found an associa-
tion with low density lipoprotein (LDL) cholesterol and presence of white 
matter lesions.8 In the Rotterdam Study an association between increase 
in cholesterol and presence of white matter lesions was found in subjects 
between 65 and 74 years (OR 2.2;95%CI 1.0-4.7), but not in subjects aged 
75 years or over. 4 
Smoking 
The relation between smoking and white matter lesions has been investi-
gated in few studies 4 ,8,35 In the Cardiovascular Health Study subjects 
were divided into ever smokers versus never smokers. Ever smokers had a 
significantly higher prevalence of white matter lesions than never smok-
ers.42 In the Rotterdam Study no significant association between smoking 
and presence of white matter lesions was found. 4 
Cardiac disease 
The role of cardiac disease in the pathogenesis of white matter lesions is 
unclear. A major reason is that in most studies all kinds of different car-
diac diseases (such as coronary heart disease, left ventricular hypertrophy 
and arrhythmias) are categorized in one group in the analyses.2,9,35,39 The 
Cardiovascular Health Study did not show an association between cardiac 
disease and presence of white matter lesions.8 In the Rotterdam Study a 
significant association between a history of myocardial infarction and 
presence of white matter lesions was found (OR 3.9;95%CI 1.1-14,1).4 
Ylikoski et al reported that subjects with cardiac arrhythmias had an in-
creased risk of deep subcortical white matter lesions (OR 4,0;95%CI 1.0-
15.5), but not of periventricular white matter lesions.31 
History of stroke 
Findings from the Cardiovascular Health Study showed that a history of 
stroke is a very strong determinant of white matter lesions.8 These results 
are in congruence with data from the Rotterdam Study,4 although in that 
study presence of stroke was analyzed together vvith presence of myocar-
dial infarction as one variable (OR 4.4;95%CI 1.4-13.7). In contrast, 
Schmidt et al. 2 showed that prior stroke is not associated vvith presence of 
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white matter lesions, but is associated with severity of white matter le-
sions. 
The most likely explanation for the association between a history of 
stroke and the presence of white matter lesions is that the risk factors for 
both stroke and for presence of white matter lesions largely overlap. 
Anti-oxidants 
The association between serum anti-oxidants and presence of white mat-
ter lesions has thus far only been investigated in the Austrian Stroke Pre-
vention Study.37 In this selected population based study (response 28%) 
among 355 participants they showed that subjects with an alpha toco-
pherol level in the lowest quartile versus subjects in the highest quartile 
had an OR of 3.7 (95%CI, 1.69 to 8.1) of having severe white matter le-
sions. This was the only significant association between an anti-oxidant 
(from a panel of ten) with presence of white matter lesions. From funda-
mental research it is known that, among other factors, the release of free 
radicals leads to neuronal damage after cerebral ischemia. An attractive 
hypothesis is that ischemic damage can be attenuated by so called free 
radical scavengers, such as antioxidants. Results from large popUlation 
based studies are needed to confirm or reject these findings. 
Alcohol 
There is only one study that reported the relation between alcohol con-
sumption and presence of white matter lesions. Among 50 healthy volun-
teers the authors found no association between alcohol intake and white 
matter lesions.39 
Apolipoprotein E gene 
Few studies investigated the association between the ApoE genotype and 
presence of white matter lesions.49 ,so The ApoE gene product is a 34 KD 
protein, which has an important function in the transportation of lipids 
and plays a role in repair of damaged (neuronal) membranes. Previous 
studies have shown an association between the ApoE*4 allele and athero-
sclerosis. In the CHS ApoE4 carriers had no increased prevalence of white 
matter lesions.49 In contrast, Schmidt et al. found an increased risk 
among ApoE*2 carriers for 'microangiopathy related cerebral damage' 
(white matter lesions and lacunar infarctions).5o The authors suggested 
that the ApoE*2 allele is associated with impaired repair mechanisms. 
However, due to a low response rate, selection bias may have played a 
role in this study. Moreover, two different outcome measures (white mat-
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ter lesions and silent infarctions) with a probably different pathogenesis 
were considered as one outcome variable 
Ethnicity 
Currently there are two large studies in the United States, the ARIC study 
and the Cardiovascular Health Study in which the relation between eth-
nicity and white matter lesions was studied. 5,8 Both studies found that 
African Americans had more white matter lesions than European Ameri-
cans. The ARIC study investigated this relation in greater detail and 
showed that this elevated risk could be explained through higher mean 
systolic and diastolic blood pressure levels among African Americans. 
When in the model systolic and diastolic blood pressure were introduced 
the association between white matter lesions and ethnicity was not sig-
nificant anymore. s 
Conclusion and recommendations for 
future research 
Most studies showed an increase in prevalence of white matter lesions 
with increasing age. Gender differences have been reported in some stud-
ies but this needs further confirmation. Many studies confirmed the asso-
ciation between hypertension and white matter lesions. Various other risk 
factors have been investigated, Although several vascular risk factors 
seem associated, the results from the diverse studies are not unequivocaL 
For some other vascular determinants, as atherosclerosis, it is not clear 
whether it is in the causal chain between hypertension and white matter 
lesions or it is a separate risk factor for presence of white matter lesions. 
A major problem in comparing results from various studies is that 
they are methodologically very different. To yield unbiased estimates of 
prevalence, incidence and determinants of white matter lesions, future 
studies should preferably be population based, prospective, not too small, 
use few exclusion criteria and have a high response. Large incidence 
studies are needed to investigate the etiology of white matter lesions. They 
should use similar rating scales in order to enable the comparison of re-
sults between studies. The periventricular and deep subcortical white 
matter have a different arterial supply and there is some evidence that 
periventricular white matter lesions have different risk factors than deep 
subcortical white matter lesions.31 Besides it is unclear whether the small 
or large sized white matter lesions have the same etiology. Therefore fu-
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ture studies should use a rating scale which scores white matter lesions 
per region and per size. 
In order to compare the strength of an association between a risk 
factor and white matter lesions between studies standardization of risk 
factor definitions is required. There are a number of putative risk factors 
that need to be confirmed. Other specific risk factors may be selected for 
investigation on the basis of plausible etiologic hypothesis and with the 
aim to elucidate the underlying pathophysiologic mechanism of white 
matter lesions emergence. 
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Abstract 
Sex difference in the prevalence 
of cerebral white matter lesions 
White matter lesions are frequently observed on MRI scans of elderly non-de-
mented and demented people. They are attributed to degenerative changes 
of small vessels and are implicated in the pathogenesis of cognitive decline 
and dementia. There is evidence that especially periventricular white matter 
lesions are related to cognitive deC/inel whereas subcortical white matter /e~ 
sions may be related to late-onset depression. We report the frequency distri-
bution of subcortical and per/ventricular white matter lesions I according to age 
and gender. We randomly sampled 1084 subjects aged between 60-90 years 
from the general population. All subjects underwent 1. 5T MRI-scanning; white 
matter lesions were rated separately for the subcortical region and the peri-
ventricular region. Of all subjects 8 percent were completely free of subcortical 
white matter lesions, 20 percent had no periventricular white matter lesions and 
5 percent had no whde matter lesions in either of these locations. The propor-
tion with white matter lesions increased with age/ similarly for men and women. 
Women had more subcortical white matter lesions than men (total volume 1.45 
ml versus 1.29 ml,- p=0.33). mainly caused by marked differences in the frontal 
white matter lesion volume (0.89 ml versus 0.70 mI,' p=O.OB). Periventricular 
white matter lesions were a/so more frequent among women than men (mean 
grade 2.5 versus 2.3; p=0.07). Also severe degrees of subcortical white matter 
lesions were more common in women than in men (OR 1.1; 95% C/ 0.B-l.5) and 
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periventricular whde mailer lesions (OR 7.2; 95% C! 0.9-7.7), albeit not statisti-
cally significant. In conclusion, the prevalence and the degree of cerebral white 
matter lesions increased wdh age. Women had a higher degree of white mat-
ter lesions than men This may underlie the observation of a higher inCidence of 
dementia in women than in men, particularly at later age. 
Introduction 
White matter lesions are frequently observed on MRI scans of elderly peo-
ple, they are attributed to degenerative changes of long penetrating arter-
ies. 1-6 Reported prevalence ranges from 5 to 90 percent, depending on 
study design, study population and rating scales. 1-4 ,7-9 There is evidence 
that especially periventricular white matter lesions are related to cognitive 
decline,lO whereas subcortical white matter lesions may be related with 
late-onset depression. II White matter lesions can be distinguished into 
those in the subcortical and in the peri ventricular region. Only a few 
studies consider lesions in these regions separately,12-14 but some based 
their analysis on a summary score of subcortical and periventricular 
white matter lesions,14 as in other studies. I -3 Although it is well estab~ 
lished that the prevalence of white matter lesions increases with age, little 
is kno\VI1 about site specific frequency, including possible differences be~ 
tween the subcortical and periventricular region, and the lobar location of 
the lesions. This distinction may be of potential interest since the subcor-
tical and periventricular white matter lesions might have a different 
pathogenesis and may result in different cognitive or motor consequences. 
Some studies reported a higher prevalence of white matter lesions among 
women then men. 1· 3 The differences were however not statistically signifi-
cant, and were only reported for total white matter lesions. 
From a population-based sample of subjects over 60 years of age, we 
report the age and sex specific frequency distribution of either type of 
white matter lesions by lobar location. 
Materials and methods 
Study population 
The Rotterdam Scan Study was designed to study determinants and cog-
nitive consequences of age related brain abnormalities in the elderly. In 
1995-1996, 1904 subjects aged between 60-90 years were randomly se-
lected in strata of age (5 years) and sex from two large ongoing prospective 
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follow-up cohort studies, the Zoetermeer Study and the Rotterdam Study. 
Both studies have been described in detail elsewhere. 1S ,16 In short, the 
Zoetermeer Study is a prospective population based study among 10361 
subjects, aged between 5-91 years at baseline, which studies determi-
nants of chronic diseases. The Rotterdam Study is a population based 
prospective cohort study, among 7983 elderly subjects aged 55 years and 
over, which studies determinants of neurological, cardiovascular, loco-
motor and ophthalmologic diseases in the elderly. 
For the Rotterdam Scan Study subjects were invited by a letter, and 
subsequently contacted by telephone. Upon agreement to participate a list 
of contraindications was reviewed in order to assess eligibility (dementia; 
blindness; or presence of MRI contraindications, including prosthetic 
valves, pacemaker, cerebral aneurysm clips, a history of intra ocular 
metal fragments, cochlear implants and claustrophobia). From 1904 in-
vited subjects 1724 were eligible. Complete information was obtained, in-
cluding a cerebral MRI scan, from 1084 persons (response rate 63 per-
cent; 568 from the Rotterdam Study and 516 from the Zoetermeer Study). 
Each participant signed an informed consent form. The study was ap-
proved by the medical ethics committee of Erasmus University Rotterdam, 
The Netherlands. 
MRI Scanning protocol 
In all participants an axial Tl, T2 and Proton Density (PD) weighted cere-
bral MRI scan was made on a 1.5T MRI scan. Subjects recruited from the 
Zoetermeer Study were scanned with a 1.5T MR Gyroscan (Philips, Best, 
The Netherlands) and participants from the Rotterdam Study were 
scanned with a 1.5T MR VISION (Siemens, Erlangen, Germany). In order 
to provide comparability the following pulse sequences were applied: at 
the Gyroscan T1 (TR 485 ms, TE 14 ms), T2 (TR 2236, TE 90 ms) and PD 
(TR 2236 ms, TE 20 IDS); and at the VISION: T1 (TR 700 ms, TE 14 IDS), 
T2 (TR 2200 ms, TE 80 ms) and PD (TR 2200 IDS, TE 20 ms) Slice thick-
ness was 6 mm and 5 mm respectively, with an inter-slice gap of 20.0 
percent. The images were printed on hard copy with a reduction factor of 
2.7. 
White matter lesions rating scale 
White matter lesions were considered present if these were hyper-intense 
on both PD and T2 weighted images and not hypo-intense on Tl weighted 
images. White matter lesions were distinguished into those in the su bcor-
tical and periventricular region. The number and size of subcortical white 
matter lesions was rated on hard copy according to their largest diameter 
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in categories of small «3 mm), medium (3-10 mm) or large lesions (>10 
mm). In order to calculate the volume of subcortical white matter lesions 
on hard copy, they were considered to be spherical with a fixed diameter 
per size category (range 0-29.5 ml.). Periventricular white matter lesions 
were rated semi-quantitatively per region: adjacent to the frontal horns 
(frontal capping); adjacent to the lateral wall of lateral ventricles (bands), 
and adjacent to the occipital horns (occipital capping), on a scale ranging 
from 0 to 3. The overall degree of periventricular white matter lesions was 
calculated by adding up the scores for the three separate categories 
(range 0-9). White matter lesions could be rated for all subjects except in 
two individuals in whom the quality of the MRl scan did not allow reliable 
rating of the subcortical white matter lesions. All MRI scans were exam-
ined by two raters from a pool of four experienced raters. In case of a dis-
agreement of more than one point l a consensus reading was held; in all 
other cases the readings of both readers were averaged. The inter- and 
intra-rater studies showed a good to excellent agreement. Weighted kap-
pas for grading the periventricular white matter were between 0.79-0.90. 
For total subcortical white matter volume the inter- and intra-rater intra-
class correlation coefficient was 0.88 and 0.95, respectively. 
Statistical analyses 
The prevalence of white matter lesions was defined as the presence of any 
white matter lesion (regardless of size or location) in the brain. The rela-
tion between the prevalence of white matter lesions and age was assessed 
by means of age and sex adjusted linear regression analyses. The fre-
quency distribution of either type of white matter lesions was calculated 
by 10 years age strata (60-70, 70-80 and 80-90 years). The relation be-
tween sex and white matter lesions was assessed by means of age ad-
justed linear regression with white matter lesions as the dependent vari-
able. Analysis of covariance was performed to obtain sex specific mean 
volume of subcortical white matter lesions per 10 years age stratum or 
the mean grade of the peri ventricular white matter lesions. Sex differences 
for each category (0,1,2 and 3) of periventricular white matter lesions, per 
region, were analyzed with the Chi-Square test. There is increasing evi-
dence that there exists a dose dependent relationship between severity of 
white matter lesions and cognitive consequences 1,2 and that especially the 
presence of severe white matter lesions is associated with a reduced cog-
nitive function. 1O ,17 We therefore separately analyzed severe subcortical 
and peri ventricular white matter lesions per sex by means of an age cor-
rected logistic regression model. White matter lesions were dichotomized 
at the upper quintile of their distribution, which reflects severe white 
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matter lesions. The associations are presented 
percent confidence interval (OR; 95%CI) 
as odds ratios with a 95 
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Results 
The overall response rate was 63 percent; it decreased with age from 73 
percent in subjects aged between 60-70 years to 48 percent in partici-
pants aged between 80-90 years. Responders were therefore significantly 
younger than non-responders (mean age 72.4 years versus 75.9 years, 
p<O.OOl), whereas there was no sex difference. 
In our study 8 percent of all subjects were completely free of subcor-
tical white matter lesions, 20 percent had no periventricular white matter 
lesions and 5 percent had no white matter lesions in either of these loca-
tions. Frequency of white matter lesions strongly depended on age (figure 
1). Of subjects aged between 60-70 years, about 13 percent were com-
pletely free of subcortical white matter lesions and 32 percent was free of 
peri ventricular matter lesions, whereas for subjects aged between 80-90 
years these percentages were 0 and 5, respectively. This age effect was 
similar for men and women. The prevalence of subcortical and peri-
ventricular white matter lesions significantly increased with 0.2 percent 
and 0.4 percent per year, respectively. 
Table 1 shows the volume of subcortical white matter lesions per 10 
years age stratum by sex. The mean volume of subcortical white matter 
lesions was highest in the frontal lobe, followed by the parietal, occipital 
and temporal lobes. This applied to both sexes and all age groups. The 
mean volume of subcortical white matter lesions increased from 0.6 ml 
(SE 0.1) for subjects between 60-70 years of age to 3.2 m!. (SE 0.4) for 
individuals aged between 80-90 years (p <0.01). Women had greater vol-
umes of subcortical white matter lesions than men (total volume 1.45 ml 
versus 1.29; p~0.33), mainly caused by differences in the volume of fron-
tal white matter lesions (0.89 ml versus 0.70; p~0.08). 
Table 2 shows sex-specific mean grades of periventricular white 
matter lesions per 10 years category. The mean grade of periventricular 
white matter lesions increased from 1.5 (SE 0.1) for subjects between 60-
70 years of age to 2.4 (SE 0.1) for individuals aged between 80-90 years (p 
<0.01). The mean grade of the total periventricular white matter lesions 
was higher among women than men (2.5 (SE 0.1) versus 2.3 (SE 0.1); 
p~0.07), mainly caused by the significant difference in severity of frontal 
capping between men and women in all age categories. 
Table 3 shows the proportion of subjects with different degrees of 
peri ventricular white matter lesions for each of the three different loca-
tions per 10 years age-stratum. For all age categories and at every loca-
tion, proportionally more women than men had the most severe periven-
tricular white matter lesions. 
Table 1 
Mean volume of subcortical white matter lesions per lobar location per 10 years age stratum.* 
60-70 years (n=465) 70-80 years (n=417) 
Lobar location men women men women (n=226) (n=239) (n=203) (n=214) 
Frontal 0.23 (0.06) 0,43 (0.06)1 0.15 (0.12) 0.90 (0.12) 
Parietal 0.25 (0.05) 0.26 (0.05) 0.50 (0.07) 0,45 (0.06) 
OCCipital 0.01 (0.01) 0.02 (0.01) 0.05 (0.02) 0.02 (0.02) 
Temporal 0.00 (0.00) 0.00 (0.00) om (0.02) 0.00 (0.00) 
Whole brain 0,49 (0.10) 0.72 (0.10) 1.31 (O.lB) 1.3B (O.lB) 
* Expressed as milliliter white matter lesion volume on hard copy (SE) 
I p < 0.05 
Table 2 
BO-90 years (n=200) 
men women 
(n=94) (n=106) 
1.71 (0.31) 1.92 (0.29) 
1.25 (0.17) 1.23 (0.17) 
0.16 (0.05) 0.12 (0.04) 
0.05 (0.02) 0.02 (0.02) 
3.1B (O,4B) 3.31 (0,44) 
Sex specific mean grade of periventricular white matter lesions per region per 10 years age stratum.* 
60-70 years (n=466) 70-BOyears (n=41B) BO-90 years (n=200) 
Lobar location men women men women men women (n=226) (n=240) (n=204) (n=214) (n=94) (n= 1 06) 
Frontal capping 0.5 (0.0) 0.6 (0.0)1 O.B (0.1) 1.0 (0.1)' 1.3 (0.1) 1.5 (0.1)1 
Bands 0.6 (0.0) 0.5 (0.0) 0.9 (0.1) 1.0 (0.1) 1,4 (0.1) 1.5 (0.1) 
OCCipital capp"lng 0.3 (0.1) 0.3 (0.1) 0.1(0.1) O.B (0.1) 1.4 (0.1) 1.4(0.1) 
Total periventricular 1,4(0.1) 1.5 (0.1) 2,4 (0.1) 2.B (0.1) 4.1 (0.2) 4.4 (0.2) 
* Expressed as mean grade (SE) 
I P < 0.05 
, p<O.Ol 
overall (n=10B2) 
men women 
(n=523) (n=559) 
0.10 (O.OB) 0.B9 (0.07) 
0.53 (0.05) 0.51 (0.04) 
0.05 (0.01) 0.04 (0.01) 
om (0.00) 0.01 (0.00) 
1.29 (0.12) 1,45 (0.12) 
overall (n= 1 OB4) 
men women 
(n=524) (n=560) 
O.B (0.0) 0.9 (0.0)' 
O.B (0.0) 0.9 (0.0) 
OJ (0.0) OJ (0.0) 
2.3 (0.1) 2.5 (0.1) 
Table 3 
Sex specific frequency distribution of periventricular white matter lesions grades per region per 10 years age~stratum. 
60-70 years 70-80 years 80-90 years overall 
Location Grade men women men women men women men women 
(n=226) (n=240) (n=204) (n=214) (n=94) (n=106) (n=524) (n=560) 
Frcntal capping 0 50.0 42.4 29.9 22.9 14.9 8.5 35.9 28.5 
1 40.6 41.7 43.1 42.0 39.4 31.1 41.4 39.8 
2 8.9 14.6 25.5 33.2 40.4 51.9 21.0 28.8 
3 0.5 1.3 1.5 1.9 5.3 8.5 1.7 2.9* 
Bands 0 43.8 46.2 27.0 25.7 8.5 10.4 30.9 31.6 
1 45.6 43.8 51.0 45.8 43.6 35.8 47.3 43.1 
2 9.7 8.3 18.6 21.0 30.9 34.9 17.0 18.2 
3 0.9 1.7 3.4 7.5 17.0 18.9 4.8 7.1 
Occipital capping 0 71.7 72.4 48.2 42.5 25.6 23.6 54.2 51.8 
1 20.8 18.8 27.9 32.7 22.3 29.2 23.9 26.1 
2 6.2 7.1 18.1 17.8 34.0 25.5 15.8 14.6 
3 1.3 1.7 5.8 7.0 18.1 21.7 6.1 7.5 
Numbers are percentages 
* p=D.005 (Overall Chi-Square test). 
Sex d;fference in the prevalence of cerebral white matter lesions I 
Women had more severe periventricular (OR 1.2; 95% CI 0.9-1.7) and 
subcortical white matter lesions (OR 1.1; 95% CI 0.8-1.5) than men, espe-
cially in the frontal region (OR 1.6; 95% CI 1.2-2.1 and OR 1.6; 95% CI 
1.2-2.2, for severe frontal periventricular and subcortical white matter 
lesions, respectively). 
Discussion 
OUT study shows that the severity of subcortical and periventricular white 
matter lesions is dependent on age and sex. We confirmed the significant 
association between severity of white matter lesions and age. In addition 
we showed that women morc often had white matter lesions of both 
kinds, especially in the frontal region. 
The strength of this study is its large number of elderly people, in-
cluding institutionalized persons. Another important feature of our study 
is the distinction between white matter lesions in the subcortical and the 
periventricular region, and according to lobe. 
However, some potential methodological shortcomings need to be 
considered. Our study had a response rate of 73 percent in subjects aged 
60-70 years decreasing to 48 percent in participants aged between 80-90 
years. This may lead to selection bias, especially in the oldest age cate-
gory. We consider it likely that if participation in our study were related to 
the degree of white matter lesions, this would probably have resulted in 
persons with more severe white matter lesions participating less, There-
fore the mean volume of subcortical white matter lesions and the mean 
grade of periventrieular white matter lesions had probably been underes-
timated. This particularly applies to the oldest participants, among which 
the response was lowest. However, we consider it unlikely that the sex 
difference for white matter lesions has been influenced by of selection 
bias) since the response rate was similar for men and women in any age 
category. 
Another point of concern is the validity of the white matter lesions 
rating scale, since there is potential for measurement error in this proce-
dure. Although we chose anatomical landmarks to separate the lobes we 
cannot exclude that some misclassification occurred, As it is unlikely that 
this misclassification would be different for the sexes or age categories, 
and the resulting bias will be non-differential. When subcortical and peri-
ventricular white matter lesions are both abundantly present, it may 
sometimes be difficult to distinguish between the two. However) our intra 
-and inter-rater studies showed an excellent to high reliability, suggesting 
that this was not a major problem in our study. 
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An important aspect of our rating scale is that it distinguishes be-
tween subcortical and peri ventricular white matter lesions while also their 
severity was recorded. This will allow us to evaluate whether white matter 
lesions in these two regions have a different pathogenetic background and 
different clinical correlates. 
Our study showed that su beartieal white matter lesion volume was 
highest in the frontal and parietal lobes, a factor twenty and hundred 
higher than in the occipital and temporal lobes, respectively. Although the 
frontal and parietal lobes are larger than the occipital and the temporal 
lobe~ this difference can not explain the vast difference in white matter 
lesion volume. Scheltens et al. found in a study of 24 'normal' elderly 
subjects (mean age 68.0 years) that the severity of white matter lesions 
was highest in the frontal lobe. IS This observation was even morc marked 
in subjects suffering from Alzheimer's disease. They explained this finding 
by overrepresentation of the frontal and parietal lobe compared with the 
occipital and the temporal lobes axial slices, 18 We cannot exclude that we 
have relatively overestimated the frontal or parietal lobes, but again the 
magnitude of the difference in the volume of white matter lesions seems 
out of proportion to this, 
Our study confirms previous findings of a relatively high prevalence 
and severity of white matter lesions among women. This was also found in 
the Cardiovascular Health Study and the Atherosclerosis Risk in Com-
munities Study.',3 This could be mainly attributed to the significant dif-
ferences for the subcortical and periventricular white matter lesions in the 
frontal region. It is unclear how these sex differences must be explained. 
One possibility is an increased susceptibility for ischemia of the brain 
secondary to the reduction in estrogen levels after menopause plays a 
role. The occurrence of hypoxia or ischemia in the cerebral white matter is 
commonly considered as an intermediate factor in the pathogenesis of 
white Inatter lesions.6 Estrogens have important functions in the brain, 
including an increase in cerebral blood flow, protection against oxidative 
stress, stimulation of synaptogenesis and prevention of neuronal atro-
phy.19-21 The post-menopausal estrogen reduction might make the female 
brain more vulnerable by reduction of cerebral blood flow (ischemia) and 
impairment of neuronal repair mechanisms. This hypothesis is supported 
by in vitro studies that showed protective effects of estrogens on meno-
pause-related cerebra] damage by excitotoxicity and the action of free 
radicals, as occurs during cerebral ischemia.22-26 As there is a morpho-
logical and epidemiological overlap between vascular dementia and Alz-
heimer's disease, the increased prevalence of cerebral white matter le-
sions in women could underlie the higher incidence of Alzheimer's disease 
among women, even after adjustment for prolonged life expectancy, espe-
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cially at high ages.27 This hypothesis about the possible role of estrogens 
is supported by the finding of a significantly increased incidencc of Alz-
heimer's disease among womcn who did not use estrogen replacement 
therapy.28,29 
In conclusion, prevalence of cerebral white matter lesions increased 
with age. Women more often had severe white matter lesions compared to 
men. Large prospective population based studies are needed to investigate 
what underlies these differences and in particular to investigate whether 
estrogens playa part in the presence and development of white matter 
lesions and the attendant cognitive decline. 
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Blood pressure and 
cerebral white matter 
lesions 

3.1 
Abstract 
A follow-up study of blood 
pressure and cerebral white 
matter lesions 
White matter lesions are often observed on cerebral MRI-scans of elder/y peo-
ple. They are thought to play an important role in the pathogenesis of demen-
tia. Cross-sectional studies have shown an association between elevated blood 
pressure and whde matter lesions. We prospectively studied the relation be-
tween blood pressure level and changes with white matter lesions. In 1995-1996 
we randomly sampled 1084 subjects aged between 60-90 years from two pro-
spective population-based studies. One study had its baseline blood pressure 
measurement 20 years before, the other 5 years before. All subjects underwent 
1. 5T MRI-scanning and white matter lesions in the subcortical and periventricu-
lor regions were rated separately. The level of diastolic blood pressure as-
sessed 20 years ago was significantly associated with subcortical and periven-
tricular white matter lesions (RR 1.3; 95% Cl1.0-1.7 and RR 1.2; 95% CI 1.0-1.6 
per 10 mm Hg, respectively). These associations were similar for systolic blood 
pressure. We found a J-shaped association between a 20-year change in dia-
stolic blood pressure and subcortical white matter lesions (RR 2.2; 95% Cl1.0-5.2 
and RR 3.2 95%; CI 1.4-7.4 for a decrease or an increase over 10 mm Hg, re-
spectively). There was a linear association between the concurrent level of dia-
stolic blood pressure and white matter lesions in subjects wdhout a history of 
myocardial infarction, while this association was J-shaped in subjects with a 
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history of myocardial infarction. This study suggests a J-shaped relation be-
tween a long-term change in diastolic blood pressure, current diastolic blood 
pressure level and white matter lesions in a high risk group. Our results indicate 
that the J-shape relationship of diastolic blood pressure is not restricted to car-
diovascular diseasel but is a/so manifest in cerebrovascular disease. 
Introduction 
Cerebral white matter lesions are frequently observed on magnetic reso-
nance imaging (MRI) scans of elderly, non-demented persons. 1-3 There is 
growing evidence that these white matter lesions play an important role in 
the development of cognitive decline and dementia. 3 -6 Population-based 
MRI studies have shown a linear association between both diastolic and 
systolic blood pressure level and severity of cerebral white matter le-
sions. 1-3 However, this relation has been studied only cross-sectionally or 
in studies with a short follow Up,2 whereas blood pressure is known to 
change during aging, possibly in part due to atherosclerosisJ·8 Witteman 
et a1. have shown that the relation between a change in diastolic blood 
pressure and progression of atherosclerosis is J~shaped.8 In accordance 
with that observation, other studies among elderly subjects suggested 
that both a low and high diastolic blood pressure are associated with in-
creased risk of cardiovascular disease, in particular among subjects with 
preexisting heart disease.9 -12 There is conflicting evidence whether this J-
curve applies to the relation between blood pressure and cerebrovascular 
disease,13-15 and it is not known how white matter lesions are related to 
blood pressure changes over time. 
We studied the presence of white matter lesions in relation to blood 
pressure level and change over a long period (20 years) and a short period 
(5 years) in a longitudinal population-based study. In addition, we investi-
gated the association of white matter lesions with level of concurrent 
blood pressure, and also with change of blood pressure levels assessed 5 
and 20 years before, among subjects with and without a history of myo-
cardial infarction. 
Subjects and Methods 
Study Population 
The Rotterdam Scan Study was designed to study determinants and con-
sequences of brain abnormalities in the elderly. In 1995-1996, 1904 sub-
A follow-up study of blood pressure and cerebral white molter lesions I 
jects aged between 60-90 years were randomly selectcd in strata of age (5 
years) and sex from two large ongoing prospective follow-up cohort siud-
ies, the Zoetermeer Study and the Rotterdam Study. The Zoctermeer 
Study had its baselinc data-collection from 1975-1978; the mean follow 
up period was 19.6 years. Thc Eotterdam Study had the baselinc data 
collection from 1990-1993; mean follow up period was 4.8 years. Both 
studies have been described in detail elsewhere. 16,17 In brief, the Zoeter-
meer Study is a prospective population-based study among 10361 sub-
jects, aged between 5-91 years at baseline, of determinants of various 
chronic diseases. The Rotterdam Study is a population-based prospective 
cohort study, among 7983 elderly subjects aged 55 years and over, of de-
terminants of neurological, cardiovascular, locomotor and ophthalmologic 
diseases in the elderly. 
For the follow-up examination in the Rotterdam Scan Study subjects 
were invited by Ictter, and subsequently contacted by telephone. Upon 
agreement to participate in the study a list of contraindications was re-
viewed in order to assess eligibility (non eligible were those with dementia 
or blindness; or presence of MRI contraindicaiions, including prosthetic 
valves, pacelnakcr, cerebral aneurysm clips, a history of intra ocular 
metal fragment, cochlear implants and claustrophobia). Of the baseline 
Zoetermeer Study and the Rotterdam Study cohorts 22% and 24°A) of the 
eligiblc population for the Rotterdam Scan Study, had died before follow-
up. From 1904 invited subjects 1724 were eligible. Complete information, 
including a cerebral MRI scan, was obtained from 1084 persons (response 
63%); 568 werc from the Rotterdam Study (response 68%) and 516 from 
the Zoetermeer Study (response 58%). The response rate declined from 
73% among subjects aged between 60-70 years to 48% among partici-
pants aged between 80-90 ycars in 1995-1996. Each participant signed 
an informed consent form. The study was approved by the medical ethics 
committee of Erasmus University. 
Measurement of Risk Factors 
Physical examinations and questionnaires were administered in a similar 
way both at baseline and follow up in the two sUb-populations of the 
Rotterdam Scan Study. Blood pressure level was measured twice on the 
right arm in sitting position, by means of a random zero sphygmomano-
meter. The average of these measurements was used. Hypertension was 
defined as a systolic blood pressure:2: 160 mm Hg and/or a diastolic blood 
pressure :2: 95 mm Hg and/ or self reported use of blood pressure lowering 
drugs. Height and weight were measured without shoes in light clothing. 
The body mass index was calculated as weight divided by height square. 
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Information on smoking behavior was obtained through standardized 
questionnaires, which were checked by a physician during an interview. 
Serum total cholesterol was measured at baseline using an automated 
enzymatic method, 18 Diabetes mellitus was considered present at baseline 
if the participant was taking oral anti-diabetics or insulin (in both sub-
populations), and in addition if the random or post-load glucose level was 
higher than 11.1 mmol/l (in subjects originating from the Rotterdam 
Study). 19 A 12 lead ECG was recorded and stored digitally during baseline 
data-collection of the Rotterdam Study (n=555) and at follow-up (n=960). 
ECGs were missing mostly due to technical reasons (disturbances in 
power supply or technical problems with the recorder). All ECGs were 
analyzed by the Modular ECG Analysis System (MEANS).2o,2l For myocar-
dial infarction the MEANS diagnosis was used. 
MRI Scanning Protocol 
An axial T1, T2 and Proton Density (PD) weighted cerebral MRI scan was 
made on a 1.5T MRI scan in all participants. Subjects recruited from the 
Zoetermeer Study were scanned with a 1.5T MR Gyroscan (Philips, Best, 
The Netherlands) and participants from the Rotterdam Study were 
scanned with a 1.5T MR VISION (Siemens, Erlangen, Germany). In order 
to achieve comparability the following pulse sequences were applied: at 
the Gyroscan Tl (TR 485 ms, TE 14 ms), T2 (TR 2236 ms, TE 90 ms) and 
PD (TR 2236 ms, TE 20 ms); and at the VISION: Tl (TR 700 ms, TE 14 
ms), T2 (TR 2200 ms, TE 80 ms) and PD (TR 2200 ms, TE 20 ms). Slice 
thickness was 6 mm and 5 mm respectively, with an inter-slice gap of 
20.0%. The images were printed on hard copy with a reduction factor of 
2.7. 
White Matter Lesions Rating Scale 
White matter lesions were considered present if these were hyper-intense 
on both PD and T2 weighted images and not hypo-intense on Tl weighted 
image. White matter lesions were distinguished into those in the subcorti-
cal and perivenLricular region. The number and size of subcortical white 
maLLer lesions were rated on hard copy according La their largest diameter 
in categories of small «3 mm), medium (3-10 mm) or large lesions (>10 
mm). In order to calculate the volume of subcortical white matter lesions 
on hard copy) they were considered to be spherical with a fixed diameter 
per size category. Periventricular white matter lesions were rated semi-
quantitatively per region: adjacent to the frontal horn (frontal capping), 
adjacent to the lateral wall of the lateral ventricles (bands) and adjacent to 
the occipital horn (occipital capping), on a scale including 0 (no white 
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matter lesions), 1 (pencil-thin periventricular lining), 2 (smooth halo or 
thick lining), and 3 (large confluent white matter lesions). The overall de-
gree of periventricular white matter lesions was calculated by adding up 
the scores for the three regions (range 0-9). All MRI scans were examined 
by two raters from a pool of four experienced raters. In case of disagree-
ment of more than one point, a consensus reading was held; in all other 
cases the readings of both readers were averaged. The inter- and intra-
rater studies showed a good to excellent agreement. Weighted kappas for 
grading the periventricular white matter were between 0.79-0.90. For total 
subcortical white matter volume the inter- and intra-rater intra-class cor-
relation coefficients were 0.88 and 0.95, respectively. 
Statistical Analysis 
We calculated relative risks (RR), as estimated by the odds ratio, by 
means of age and sex adjusted logistic regression to quantify the associa-
tion between blood pressure and presence of severe white matter lesions. 
White matter lesions were dichotomized at the upper quintile. Additional 
adjustments were made for possible baseline confounding factors, in-
cluding body mass index (kg/m2), serum total cholesterol level (mmol/l), 
smoking behavior (never, former, current) and diabetes mellitus (absent/ 
present). 
The association between baseline blood pressure level and presence 
of white matter lesions was assessed both in quartiles of the blood pres-
sure distribution and with blood pressure as a continuous variable in the 
multivariate model. Since this relation proved to be linear, we only pre-
sent the results of the continuous analysis. We also investigated the pres-
ence of white matter lesions as a function of long-term change in blood 
pressure among subjects from the Zoetermeer Study and as a function of 
short-term change in blood pressure among subjects from the Rotterdam 
Study. Changes in blood pressure were grouped in four categories in or-
der to distinguish between subjects with a decrease or an increase in 
blood pressure. For a change in diastolic blood pressure these categories 
were < -10 mm Hg, -10-0 mm Hg, 0-10 mm Hg and" 10 mm Hg, whereas 
for systolic blood pressure these categories were < 0 mm Hg, 0-20 mm Hg, 
20-40 mm Hg and " 40 mm Hg. The second category was used as the ref-
erence for change in both diastolic and systolic blood pressure upon data 
inspection. 
It has been suggested that a J-shaped association between diastolic 
blood pressure level and cardiovascular risk is mainly restricted to sub-
jects with preexisting symptomatic coronary heart diseaseY-12 We there-
fore investigated the relation between quartiles of concurrent diastolic 
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blood pressure level and white matter lesions among subjects with (n=99) 
and without (n=861) a history of myocardial infarction (identified during 
follow up). To show a possible J-shaped association in this analysis, the 
third quartile was used as the reference upon data inspection. The same 
analyses were performed for systolic blood pressure. We were not able to 
investigate the relation by category of change in blood pressure and white 
matter lesions in subjects with a history of myocardial infarction due to 
small numbers. All relative risks are presented with a 95% confidence in-
terval (95% CI). 
Results 
Table I presents both baseline and follow up characteristics of the study 
population. Mean age of the participants was 72.3 years (SD 7.4) at follow 
up, 52% of then was female. The mean systolic and diastolic blood pres-
sure at follow-up was 147.3 mm Hg (SD 21.6) and 78.7 mm Hg (SD 11.7), 
respectively. Of all participants 51.3% had hypertension at follow-up, 
Table 1 
Characteristics of the Total Study Population in 1995/1996 (Follow-up, at MRI ascertain-
ment) and the Baseline characteristics of the Long-Term (Baseline 1975-1978) and 
Short-Term (Baseline 1990-1993) Part of the Study Population.* 
Characteristic Baseline Baseline Follow up 
1975-1978 1990-1993 (1995-1996) 
Number of subjects 516 568 1084 
Number according to age at follow up 
60-70 years 253 213 466 
70-80 years 213 205 418 
80-90 years 50 150 200 
Mean age (years) 51.2 (6.6) 69,0 (8,0) 72.3 (7.4) 
Women (%) 53.3 51.1 52.0 
Body Mass Index (kg/m2) 25.0 (3.0) 26.3 (3.4) 26,6 (4.0) 
Systolic BP (mm Hg) 131,5 (17.1) 136,8 (20,4) 147.3 (21.6) 
Diastolic BP (mm Hg) 81.4 (10.8) 73.2 (10.9) 78.7 (11.7) 
Serum cholesterol (mmol/I)) 6.1 (1,1) 6.7 (1.2) not determined 
Hypertension (%) 25,2 39,2 51.3 
Diabetes Mellitus (%) 1,0 6,9 6.9 
Smokers (%) 
current 36.7 20,0 17.7 
former 34.4 45.5 44.7 
never 28.8 34.5 37.6 
* Values are unadjusted means (standard deviation) or percentages. 
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Table 2 
The Relative Risk of Baseline Blood Pressure for Presence of Cerebral White Matter lesions.* 
Relative risk of white matter lesions per 10 mm Hg increase in blood pressure 
(95% confidence interval)t 
Subcortical white matter lesions 
age at MRI 
60-70 
70-80 
80-90 
overall 
Periventricular white matter lesions 60-70 
70-80 
80-90 
overall 
diastolic blood pressure 
baseline baseline 
(1975-1978) (1990-1993) 
1.5 (1.0-2.3) 1.6 (1.1-2.4) 
1.3 (0.9-1.9) 1.2 (0.9-1.6) 
1.1 (0.6-2.2) 1.9 (1.3-2.7) 
1.3 (1.0-1.7) 1.5 (1.2-1.8) 
1.9 (1.2-3.1) 1.5 (0.9-2.2) 
1.2 (0.9-1.6) 1.1 (0.8-1.5) 
0.8 (0.5-1.5) 1.4 (1.0-1.9) 
1.2 (1.0-1.6) 1.3 (1.1-1.6) 
* dichotomized at the upper quintile of the severity distribution of white matter lesions. 
t age and sex adjusted. 
systolic blood pressure 
baseline baseline 
(1975-1978) (1990-1993) 
1.2 (0.9-1.6) 1.1 (0.9-1.4) 
1.2 (0.9-1.4) 1.1 (0.9-1.2) 
1.1 (0.8-1.6) 1.0 (0.9-1.1) 
1.1 (1.0-1.3) 1.1 (1.0-1.2) 
1.5 (1.1-2.1) 1.1 (0.9-1.1) 
1.1 (0.9-1.3) 1.0 (0.9-1.2) 
1.0 (0.7-1.3) 0.9 (0.8-1.1) 
1.1 (1.0-1.3) 1.0 (0.9-1.1) 
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Non-responders from the original Zoetermeer Study and the original Rot-
terdam Study differed significantly from responders with respect to age 
(75.6 vcrsus 70.8 years; p <0.001 and 76.6 versus 73.7 years; p <0.01 
respectively), but not with respect to sex, diastolic blood pressure and the 
prevalence of hypertension at baseline. Non-responders from the Zoeter-
meer Study, but not from the Rotterdam Study, had a higher systolic 
blood pressure (135.3 mm Hg versus 132.8 mm Hg, p~0.05) at baseline. 
At follow-up, 20% and 8% of all participants were without any peri-
ventricular or subcortical white matter lesions, respectively. The median 
volume of subcortical white matter lesions on hard copy was 3.8 ml and 
the median grade of peri ventricular white matter lesions was 2 (on a scale 
from 0-9). Both median volume of subcortical white matter lesions and 
mean grade of peri ventricular white matter lesions increased significantly 
with age. 
The presence of white matter lesions linearly increased with increas-
ing baseline blood pressure level (table 2). The relative risks of concurrent 
diastolic blood pressure level for subcortical and periventricular white 
matter lesions were 1.4 (95% CI 1.2-1.6) and 1.2 (95% CI 1.1-1.4) per 10 
mm Hg increase of blood pressure level, respectively. For concurrent sys-
tolic blood pressure level these relative risks were 1.2 (95% CI 1.1-1.2) 
and 1.1 (95% Cl 1.0-1.2) per 10 mm Hg increase of blood pressure level, 
respectively. The associations were strongest in the youngest age group. 
Adjustment for other confounders, including smoking status, presence of 
diabetes and body mass index, did not alter the magnitude of the asso-
ciations. The same was true when subjects using anti-hypertensive drugs 
were excluded from the analyses. When the analyses for concurrent blood 
pressure levels were performed in the Rotterdam and Zoetermeer popula-
tion separately, the associations were similar to those based on the entire 
Rotterdam Scan Study population. 
Table 3 presents the relative risks of white matter lesions by blood 
pressure change over 20 years. Subjects with a decrease or an increase in 
diastolic blood pressure of more than 10 mm Hg had significantly more 
often periventricular or subcortical white matter lesions than the refer-
ence group. This J-shaped association was most marked for subcortical 
white matter lesions. The J-curve remained when subjects on anti-hy-
pertensive drugs at baseline or follow up (n~166) were excluded from the 
analysis. For change in systolic blood pressure, subjects with an increase 
of 40 mm Hg or more, more often had both types of white matter lesions, 
while a decrease of systolic blood pressure was not significantly associ-
ated with either type of white matter lesions. The associations were 
strongest in the youngest subjects. The relative risks for subcortical white 
matter lesions for subjects aged between 60-70 years at MRI-scanning 
46 
Table 3 
The Relative Risk of a Change in Blood Pressure over 20 Years for Presence of Severe White Matter lesions* (RR with 95% 0). 
Category (mm Hg) 
Subcortical white matter lesions 
Adjusted for age and sex 
Adjusted for age, sex and cardiovascular risk factorst 
Periventricular white matter lesions 
Adjusted for age and sex 
Adjusted for age, sex and cardiovascular risk factorst 
Category (mm Hg) 
Subcortical white matter lesions 
Adjusted for age and sex 
Adjusted for age, sex and cardiovascular risk factors t 
Peri ventricular white matter lesions 
Adjusted for age and sex 
Adjusted for age, sex and cardiovascular risk factorst 
<-10mmHg 
(n=99) 
2.2 (1.0-5.2) 
2.3 (1.0-5.4) 
1.8 (0.9-3.5) 
1.7 (0.8-3.4) 
< Omm Hg 
(n=94) 
1.2 (0.5-2.6) 
1.3 (0.6-2.9) 
1.2 (0.6-2.6) 
1.3 (0.6-2.7) 
Change in diastolic blood pressure 
-10-0 mm Hg 0-10 mm Hg 
(n= 149) (n= 150) 
1.0 (ref) 1.7 (0.8-4.0) 
1.0 (ref) 1.8 (0.8-4.1) 
1.0 (ref) 1.0 (0.5-2.0) 
1.0 (ref) 1.0 (0.5-2.2) 
Change in systolk blood pressure 
0-20 mm Hg 
(n=204) 
1.0 (ref) 
1.0 (ref) 
1.0 (ref) 
1.0 (ref) 
20-40 mm Hg 
(n= 138) 
0.9 (0.4-1.9) 
0.9 (0.4-2.0) 
0.8 (0.4-1.7) 
1.0 (0.5-2.1) 
* dichotomized at the upper quintile of the severity distribution of white matter lesions. 
t cardiovascular risk factors: diabetes mellitus, smoking behaviour, serum cholesterol and long-term change in body mass index. 
ref = reference group. 
2:: 10 mm Hg 
(n=112) 
3.2 (1.4-7.2) 
3.3 (1.4-7.5) 
1.6 (0.8-3.2) 
1.8 (0.9-3.9) 
2:: 40 mm Hg 
(n=74) 
2.8 (1.4-5.8) 
2.7 (1.3-5.6) 
1.9 (0.9-3.8) 
2.1 (1.0-4.3) 
Table 4 
The Relative Risk of a Change in Blood Pressure over 5 Years for Presence of Severe White Matter lesions* (RR with 95% 0). 
Category (mm Hg) 
Subcortical white matter lesions 
Adjusted for age and sex 
Adjusted for age, sex and cardiovascular risk factorst 
Periventricular white matter lesions 
Adjusted for age and sex 
Adjusted for age, sex and cardiovascular risk factorst 
Category (mm Hg) 
Subcortical white matter lesions 
Adjusted for age and sex 
Adjusted for age, sex and cardiovascular risk factorst 
Peri ventricular white matter lesions 
Adjusted for age and sex 
Adjusted for age, sex and cardiovascular risk factorst 
<-10mmHg 
(n~58) 
1.4 (0.7-3.0) 
1.5 (0.7-3.4) 
1.1 (0.5-2.5) 
1.2 (0.5-2.7) 
< a mm Hg 
(n~165) 
1.3 (0.7-2.5) 
1.1 (0.7-1.9) 
1.3 (0.8-2.2) 
1.3 (0.8-2.3) 
Change in diastolic blood pressure 
-10-0 mm Hg 
(n~ 144) 
1.0 (ref) 
1.0 (ref) 
1.0 (ref) 
1.0 (ref) 
0-10 mm Hg 
(n~209) 
1.7 (0.9-2.6) 
1.5 (0.9-2.7) 
1.2 (0.7-2.1) 
1.2 (0.7-2.2) 
Change in systolic blood pressure 
0-20 mm Hg 
(n~233) 
1.0 (ref) 
1.0 (ref) 
1.0 (ref) 
1.0 (ref) 
20-40 mm Hg 
(n~ 138) 
1.5 (0.9-2.6) 
1.3 (0.7-2.3) 
1.3 (0.8-2.2) 
1.2 (0.7-2.2) 
* dichotomized at the upper quintile of the severity distribution of white matter lesions. 
t cardiovascular risk factors; diabetes mellitus, smoking behaviour, serum cholesterol and long~term change in body mass index. 
ref = reference group. 
;:::: 10 mm Hg 
(n~156) 
1.0 (0.6-1.8) 
0.8 (0.4-1.5) 
1.0 (0.6-1.9) 
0.9 (0.5-1.7) 
~ 40 mm Hg 
(n~31) 
2.1 (0.9-2.5) 
1.9 (0.7-5.2) 
0.9 (0.3-2.6) 
1.1 (0.3-3.3) 
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Figure 1 
The association between concurrent diastolic blood pressure level (in quortiles) and 
white matter lesions in subjects with or without a history of myocardial infarction. 
were 3_5 (95% CI 0_7-17.4) and 5.1 (95% CI 1.2-17.4) for a decrease or 
increase of more than 10 mm Hg in diastolic blood pressure, respectively 
(data not shown in table 3)_ Exclusion of subjects with a history of myo-
cardial infarction virtually did not change the magnitude of the associa-
tions (not shown in table 3)_ 
Table 4 shows the association between changes in blood pressure 
over 5 years and presence of white matter lesions. No clear association 
between a short-term change in diastolic or systolic blood pressure and 
white matter lesions was observed. This was irrespective of a history of 
myocardial infarction (not shown in table 4)_ 
Figure 1 shows that the association between quartiles of concurrent 
diastolic blood pressure level and presence of white matter lesions in 
subjects with a history of myocardial infarction was J-shaped for both 
types of white matter lesions. If subjects on current anti-hypertensive 
treatment (n~46) were excluded from this group the J-curve became even 
more pronounced) though the confidence intervals became wider. We 
found no clear association 'With current systolic blood pressure level 
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among subjects with a history of myocardial infarction. In subjects with-
ou t a history of myocardial infarction there was a linear association be-
tween current diastolic blood pressure level and white matter lesions (fig 
1), and this relation was similar for systolic blood pressure. 
Discussion 
We studied the occurrence of cerebral white matter lesions in relation to 
baseline blood pressure and long-term and short-term changes in blood 
pressure in a prospective population-based study among elderly subjects. 
We found that levels of diastolic and systolic blood pressure were associ-
ated with the presence of both subcortical and peri ventricular cerebral 
white matter lesions. There was a J-shaped association between a change 
of diastolic blood pressure over a 20 years and presence of cerebral white 
matter lesions. In subjects with a history of myocardial infarction the as-
sociation between current diastolic blood pressure level and both types of 
white matter lesions was J-shaped, while this relation was linear in other 
subjects. 
The strength of this study is its large number of elderly participants 
from the general population, including institutionalized persons. Another 
important feature is that this study is the first longitudinal study of its 
kind, with a follow-up of almost 20 years. However, some limitations and 
methodological issues need to be pointed out. The overall response rate 
was 63%, leading to potential selection bias, especially among the oldest 
participants. However, we consider it unlikely that selection bias has 
played a major role in our study since there were only small, mainly non-
significant, differences with respect to baseline blood pressure and 
prevalence of hypertension between responders and non-responders. We 
cannot exclude that our relative risks are somewhat underestimated be-
cause we performed our study in survivors of the two baseline studies. 
Subjects who had died between baseline examination and follow up may 
have had a more severe decrease or increase in blood pressure compared 
to those who survived. 
We found the strongest associations in the youngest age category. 
There are various explanations for this. One is selective survival among 
the oldest age category. Subjects now aged between 80-90 years were 
aged between 60-70 years 20 years ago. It seems plausible that only the 
healthiest subjects survived another 20 years and could again participate 
at follow up. Another explanation for the weak association at higher ages 
between blood pressure levels and white matter lesions might be that in 
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elderly subjects presence of a risk factor has less discriminative power 
and that many other risk factors for white matter lesions co-exist. 
One should consider that the association between blood pressure and 
white matter lesions might be confounded by other vascular risk factors. 
However, adjustment for differences in cardiovascular risk factors did not 
significantly alter the observed associations between blood pressure and 
white matter lesions. This suggests that these associations can not or 
only partly be attributed to confounding by other cardiovascular risk fac-
tors, and that white matter lesions are independently related to, and per-
haps a consequence of, elevated blood pressure levels, or of blood pres-
sure changes. 
The rationale of investigating the relation of white matter lesions as a 
function of a change of diastolic blood pressure is that change may be a 
better predictor of cardiovascular disease than the actual level of blood 
pressure, since the level is the resultant of a life-long exposure to factors 
that have influenced the blood pressure, but does not provide information 
on the previous blood pressure level. 8 We found a J-shaped relation be-
tween change of diastolic blood pressure over a period of 20 years on the 
one hand and subcortical and periventricular white matter lesions on the 
other. This J-curve could in part be attributed to the subjects with a his-
tory of a myocardial infarction. If those subjects were excluded from the 
analyses the J-shaped association persisted. This is in agreement with 
our finding of a J-shaped relation between concurrent diastolic blood 
pressure level and white matter lesions in subjects with a history of myo-
cardial infarction and not in those without. A J-shaped association is a 
common finding in the relation between diastolic blood pressure level and 
cardiovascular disease and mortality, although its explanation is still a 
matter of debate. 9-12,22 Many studies have shown that the J-shaped rela-
tion between diastolic blood pressure level and cardiovascular disease is 
confined to subjects at high risk (especially those with a history of myo-
cardial infarction or a diseased coronary circulation).9-12 Our findings are 
in accordance with that observation. It has also been suggested that a too 
aggressive anti- hypertensive treatment, with lowering of blood pressure 
beyond a critical point, might contribute to this J-shape. ll However, if we 
excluded subjects on blood pressure lowering drugs the J-shape re-
mained. 
A possible explanation for the J-shaped association might be that 
among persons with advanced vascular pathology, possibly on the basis 
of longstanding hypertension, cerebral autoregulation is impaired. Those 
persons are presumably the ones with a severe decrease in diastolic blood 
pressure8 or with a history of myocardial infarction, whereas in healthy 
individuals during a reduction or increase of blood pressure the cerebral 
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blood flow is maintained via the mechanism of autoregulation. 23 As a re-
sult of the impaired autoregulation, the lower limit of blood pressure at 
which the autoregulation still functions properly shifts towards a higher 
blood pressure level,23,24 so that even normotensive levels of blood pres-
sure may result in hypo-perfusion of the white matter in these persons. 25 
In subjects with an impaired autoregulation, a reduction of cerebral blood 
flow will primarily affect areas with an already marginal blood supply un-
der physiological conditions, such as the subcortical and periventricular 
white matter. 26-28 This is in agreement with the finding of impaired auto-
regulation and a reduction of cerebral blood flow among subjects with 
periventricular white matter lesions. 29 ,3o In contrast, in people with a life-
long low diastolic blood pressure autoregulation is not impaired, and they 
therefore have a normal cerebral blood flow, even at a low blood pressure 
level. In our study those people were indeed at the lowest risk for white 
matter lesions. 
This study suggests a J -shaped relation between a 20 year change in 
diastolic blood pressure, current diastolic blood pressure level and white 
matter lesions in a high risk group. Our results indicate that the J-shape 
relationship of diastolic blood pressure is not restricted to cardiovascular 
disease, but also applies to cerebrovascular disease. This may have im-
portant clinical implications for the treatment of hypertension in these 
high-risk group subjects. Further prospective studies are needed in order 
to unravel the causal chain of events between blood pressure changes, 
cerebral perfusion and emergence of white matter lesions. 
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Abstract 
Duration and treatment of 
hypertension and cerebral 
white matter lesions 
Background White matter lesions are frequently observed on cerebral mag-
netic resonance imaging scans of elderly people and are thought to play an 
important role in the pathogenesis of dementia. Hypertension has been associ~ 
ated wiTh the presence of white matter lesions but this has almost exclusively 
been investigated in cross-sectional studies. We prospectively studied the as-
sociation of these lesions with previous and current hypertension/ and a/so its 
duration and treatment. 
Methods We randomly sampled 1084 subjects aged between 60-90 years from 
two prospective population-based studies. One half of the study subjects had 
ds baseline hypertension assessment in 1975-1978, the other in 1990-1993. All 
subjects underwent 1.5T MRI-scanning; white matter lesions in the subcortical 
and periventricu/ar regions were rated separately. 
Results Subjects with hypertension had an increased rate of both types of white 
matter lesions. Duration of hypertension was associated with both periven-
trieu/ar and subcortical white matter lesions. There was a strong effect modifi-
cation by age in this relation. For participants aged between 60-70 years during 
fol/ow-up, with over 20 years of hypertension, the relative risks for subcortical 
and periventricular white matter lesions were 21.8 (95% C/ 4.6-103) and 16.1 
(95% C/ 3.4-773) respectively compared wdh normotensive subjects. Subjects 
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wlfh current hypertension (controlled or uncontrolled) had a moderately in-
creased rate of subcortical white matter lesions (RR 1.9; 95% C/ 1.2-2.9 and RR 
3.0; 95% C/ 1.9-4.9, respectively) compared with normotensive subjects. For 
periventricular white matter lesions these associations were similar. 
Conclusions OUf results suggest that the most unbiased risk estimates are from 
subjects aged 40-50 at baseline and 60-70 at follow-up. There is a dose de-
pendent relation between duration of hypertension and whIte matter lesions. 
Effective treatment reduces the rate of both types of white mailer lesions and 
may thus prevent or reduce the attendant cognitive impairment or dementia. 
Introduction 
Cerebral white matter lesions are frequently observed on magnetic reso-
nance imaging (MRI) scans of elderly, non-demented people l -3 There is 
grovving evidence that these white matter lesions play an important role in 
the development of cognitive decline and dementia. 3-6 The pathogenesis of 
white matter lesions remains largely unknovvn, but it is generally consid-
ered that hypertension and other vascular risk factors are involved. 1-3,7,8 
The relation between hypertension and white matter lesions has thus far 
been investigated mainly in cross-sectional studies of elderly subjects,l,3 
in one study with a relatively short follow-up of about 6 years,2 and in a 
male cohort from the NHBLI twin study, with 25 years of follow Up9 Re-
sults from one of the two longitudinal studies suggested that effective 
treatment of hypertension may reduce the risk for white matter lesions,2 
and recently the Syst-Eur investigators reported that in people with iso-
lated systolic hypertension antihypertensive treatment significantly re-
duced the incidence of dementia. 10 
Hypertension in the elderly may have been present for a long period. If 
hypertension early in life would indeed be related to white matter lesions 
later in life, effective treatment of hypertension may prevent or delay the 
emergence of white matter lesions and of the attendant cognitive im-
pairment, 
We prospectively investigated the association between duration and 
treatment status of hypertension and the presence of cerebral white mat-
ter lesions, 
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Methods 
Study Population 
The Rotterdam Scan Study was designed to study determinants and con-
sequences of age related brain abnormalities in the elderly. In 1995-1996, 
1904 subjects aged between 60-90 years were randomly selected in strata 
of age (5 years) and sex from two large ongoing prospective follow-up co-
hort studies, the Zoetermeer Study and the Rotterdam Study. The 
Zoetermeer Study had its baseline data collection from 1975-1978; the 
mean follow-up period was 19.6 years. The Rotterdam Study had the 
baseline data-collection from 1990-1993; mean follow-up period was 4.8 
years. Both studies have been described in detail elsewhere. 11 ,12 In short, 
the Zoetermeer Study is a prospective population-based study among 
10361 subjects, aged between 5-91 years at baseline; the study originally 
addressed determinants of chronic diseases. The Rotterdam Study is a 
population-based prospective cohort study, among 7983 elderly subjects 
aged 55 years and over, which studies determinants of neurological, car-
diovascular, locomotor and ophthalmologic diseases in the elderly. 
For the follow-up examination in the Rotterdam Scan Study subjects 
were invited by a letter, and were subsequently contacted by telephone. 
Upon agreement to participate in the study a list of contraindications was 
reviewed in order to assess eligibility (dementia; blindness; or presence of 
MRI contraindications, including prosthetic valves, pacemaker, cerebral 
aneurysm clips, a history of intra-ocular metal fragments, cochlear im-
plants or claustrophobia). From 1904 invited subjects 1724 were eligible. 
Complete information was obtained, including a cerebral MRI scan, from 
1084 persons (response 63%); 568 from the Rotterdam Study (response 
68%) and 516 from the Zoetermeer Study (response 58%). The response 
rate declined from 73% among subjects aged between 60-70 years to 48% 
among participants aged between 80-90 years (in 1995-1996). Each par-
ticipant signed an informed consent from. The study was approved by the 
medical ethics committee of the Erasmus University. 
Measurement of risk factors 
Physical examinations and standardized questionnaires were adminis-
tered in a similar way both at baseline and at follow-up in the two sub-
populations of the Rotterdam Scan Study. At baseline and follow-up, 
blood pressure was measured two times on the right arm with a random 
zero sphygmomanometer in sitting position, The average of these meas-
urements of systolic blood pressure and diastolic blood pressure was 
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used. Hypertension was defined as a diastolic blood pressure;::: 95 mm Hg 
and/ or a systolic blood pressure ~ 160 mm Hg and/or the self reported 
use of blood pressure lowering medication. Information on blood pressure 
lowering medication was assessed by means of a computerized, struc-
tured questionnaire, which was checked by a physician. 
Height and weight were measured in light clothing. The body mass 
index was calculated as weight divided by height square. Information on 
smoking behavior was obtained with the use of a standardized question-
naire, which was checked by a physician during the interview. Diabetes 
mellitus was considered present if the participant was taking oral anti 
diabetics or insulin (both sub-populations) or if the random or post load 
glucose level was higher than 11.1 mmol/l (subjects originating from the 
Rotterdam Study). 13 
MRI Scanning protocol 
From all participants an axial Tl, T2 and Proton Density (PD) weighted 
cerebral MRI scan was made on a 1.5T MRI scan. Subjects recruited from 
the Zoetermeer Study were scanned with a 1.5T MR Gyroscan (Philips, 
Best, The Netherlands) and participants from the Rotterdam Study were 
scanned with a 1.5T MR VISION (Siemens, Erlangen, Germany). In order 
to provide comparability the following pulse sequences were applied: at 
the Gyroscan T1 (TR 485 ms, TE 14 ms), T2 (TR 2236, TE 90 ms) and PD 
(TR 2236 ms, TE 20 ms); and at the VISION: T1 (TR 700 ms, TE 14 ms), 
T2 (TR 2200 ms, TE 80 ms) and PD (TR 2200 ms, TE 20 ms). Slice thick-
ness was 6 mm and 5 mm respectively, with an inter-slice gap of 20.0%. 
The images were printed on hard copy with a reduction factor of 2.7. 
White Matter Lesions Rating Scale 
White matter lesions were considered present if these were hyper-intense 
on both PD and T2 weighted images and not hypo-intense on Tl weighted 
images. White matter lesions were distinguished into those in the subcor-
tical and periventricular regions. The number and size of subcortical 
white matter lesions was rated on hard copy according to their largest 
diameter in categories of small «3 mm), medium (3-10 mm) or large le-
sions (>10 mm.l. In order to calculate the volume of subcortical white 
matter lesions on hard copy) they were considered to be spherical with a 
fixed diameter per size category. Periventricular white matter lesions were 
rated semi-quantitatively per region: adjacent to frontal horns (frontal 
capping); adjacent to lateral wall of lateral ventricles (bands), and adja-
cent to occipital horns (occipital capping), on a scale ranging from 0 (no 
white matter lesions), 1 (pencil-thin periventricular lining), 2 (smooth halo 
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or thick lining) to 3 (large confluent white matter lesions). The overall de-
gree of periventricular white matter lesions was calculated by adding up 
the scores for the thrce separate categories (range 0-9). All MRI scans 
were examined by two raters from a pool of four experienced raters. In 
case of disagreement by more than one point, a consensus reading was 
held; in all other cases the readings of both readers \-vere averaged. The 
inter- and intra-rater studies showed a good to excellent agreement. 
Weighted kappas for grading the pcriventricular \vhite matter were be-
tween 0.79-0.90. For total subcortical white matter volume the inter- and 
intra-rater intra-class correlation coefficient was 0.88 and 0.95, respec-
tively. 
Statistical Analysis 
The rclation bet\veen hypertension, its duration and treatment, and white 
maHer lesions was assessed by age and sex adjusted logistic regression 
with the presence of severe white matter lesions as the dependent vari-
able. The strength of the association was expressed as the relative risk 
(RR), as estimated by the odds ratio, and is presented with 95%) confi-
dence intervals (95%) CI). White matter lesions were dichotomized at the 
upper quintile. Subjects without severe white matter lesions \:jlcre the ref-
ercnce group (lower four quintilcs). Additional adjustments \vere made for 
possible confounding factors, including body mass index, smoking be-
havior (never, former, current) and diabetes mellitus. 
Duration of hypertension \vas studied in each of the two sub-popula-
tions separately, by putting dumm.y variables into the model for duration 
of hypertension. In participants originating from the Rotterdam Study du-
ration could be estimated as less than 5 );ears (hypertension present in 
1995/1996 but not in 1990-1993), or over 5 years (hypertension present 
in 1990-1993 and in 1995/1996). Whereas in participants originating 
from the Zoetermeer Study duration could be estimated as less than 20 
years (hypertension present in 1995/1996 but not in 1975-1978); or over 
20 years (hypertension present in 1975-1978 and in 1995/1996). Sub-
jects VI,Tlthout hypertension at baseline and at follow-up \vere the reference 
group. Subjects who vv'ere hypertensive at baseline (1990-1993 or 1975-
1978), but no longer during the 1995-1996 data collection were excluded 
from the analysis (n=27 and n="23, respectively). 
The relation bet ween duration of hypertension and the presence of 
\vhite matter lesions may be biased by selective survival, since hyperten-
sion is related to mortality. 14 Increased mortality might particularly occur 
with longstanding hypertension and among elderly subjects. We ad-
dressed this topic b)' age stratified analysis because \\le expected a smaller 
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effect of selective mortality in the youngest age category, In addition we 
compared the baseline prevalence of hypertension between survivors and 
those who died before the follow up assessment by means of age and sex 
adjusted analysis of covariance (ANCOVA). 
The association between treatment status and white matter lesions 
was studied cross-sectionally by the introduction of dummy variables for 
treatment into the model. Participants who were identified as hypertensive 
during the data-collection of the Rotterdam Scan Study (1995-1996) were 
defined as treated if they reported the use of blood pressure lowering 
medication. Otherwise they were classified as untreated. Subjects were 
considered as treated and controlled if their systolic blood pressure was 
below 160 mm Hg and their diastolic blood pressure below 95 mm Hg. If 
their blood pressure still fulfilled criteria of hypertension they were classi-
fied as uncontrolled. Subjects without hypertension in 1995-1996 served 
as the reference group. In addition we separately estimated the duration 
of hypertension for the two sub-populations of the Rotterdam Scan Study 
(according to the previous criteria) by treatment status, in order to find 
out whether the association between treatment status and white matter 
lesions was confounded by duration (severity) of hypertension. 
Results 
Table 1 presents baseline and follow-up characteristics of both partici-
pants and non-participants of the two SUb-populations of the Rotterdam 
Scan Study. The number of 60-70, 70-80 and 80-90 year old subjects 
were 213, 205 and 150 for those originating from the Rotterdam Study 
and 253, 213 and 50 subjects for those of the Zoetermeer Study, respec-
tively. Of all subjects 20°/r) had no pcriventricular white matter lesions, 
whereas 8% of all subjects was completely free of subcortical white matter 
lesions. Median volume of subcortical white matter lesions on hard copy 
was 3.9 ml. and the median grade of peri ventricular white matter lesions 
was 2 (range 0-9). 
In both sub-populations non-participants were significantly older. 
Non-participants from the Zoetermeer Study had a significantly higher 
systolic blood pressure than participants did (137.2 mm Hg versus 131.4 
mm Hg, p<O.05). The proportion with hypertension was approximately 
25%, larger in participants than in non-participants in both sub-popula-
tions, but thc difference was not statistically significant. 
Cumulative mortality among eligible subjects from the Zoetermeer 
sub-population in the age groups 40-50 years, 50-60 years and 60-70 
years at baseline (1975-1978) was 8%, 17% and 47% respectively. For 
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Table 1 
Characteristics of the baseline and follow-up (1995/1996, MRI ascertainment), in the Zoetermeer Study Study part (baseline1975-1978) and in the 
Rotterdam Study part (baseline 1990-1993) of the Rotterdam Scan Study.* 
Zoetermeer Study 
Baseline Follow-up 
Participants Non-participants 
(n~516) (n~269) 
Mean age (years) 51.2 (6.6) 56.1 (7.1)' 70.8 (6.5) 
Women (%) 53.2 59.7 53.5 
Systolic BP (mm Hg) 131.4 (17.1) 137.2 (18.0)' 148.8 (22.7) 
Diastolic BP (mm Hg) 81.3 (10.9) 83.0 (11.5) 81.0 (11.6) 
Body Mass Index (kg/m2) 25.0 (3.0) 25.3 (3.1) 27.0 (3.7) 
Hypertension (%) 25.5 31.4 51.2 
Diabetes mellitus (%) 1.0 0.2 8.2 
Smokers (%) 
current 37.1 38.3 15.9 
former 34.6 25.1 55.3 
never 28.3 36.6+ 28.8 
*Values are unadjusted means (SD) or percentages_ 
t P<O.OOl (age and sex adjusted ANCOVA or Chi-Square test when applicable). 
t P<O.05 (age and sex adjusted ANCOVA or Chi-Square test when applicable). 
Rotterdam Study 
Baseline Follow-up 
Participants Non-participants 
(n~568) (n~371) 
69. 1 (8.0) 72.0 (8.0)' 73.6 (8.0) 
50.3 58.5 50.0 
136.8 (20.4) 139.3 (20.2) 146.1 (20.4) 
73.2 (10.9) 71.3 (10.9) 76.6 (11.4) 
26.3 (3.4) 26.3 (3.4) 26.3 (3.5) 
39.2 48.6 51.6 
6.7 11. 9 7.5 
19.4 18.8 19.4 
45.0 38.4 45.7 
35.6 42.7 34.9 
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eligible subjects from the Rotterdam sub-population, who were aged be-
tween 55-65 years, 65-75 years and 75-85 years at baseline (1990-1993), 
cumulative mortality for the relevant age category until follow up was 
10%, 28% and 62% respectively. 
In the Zoetermeer Study the difference in the prevalence of 
hypertension between those who had died before follow-up and those 
eligible was not significant in the youngest age category, and borderline 
significant in the 70-80 years and 80-90 years age category. In 
participants from the Rotterdam Study prevalence of hypertension in 
those who had died before follow-up was significantly higher than in those 
eligible for the youngest and middle age category, but not in the 80-90 
years category (table 2). 
Table 3 presents the association between duration of hypertension 
and presence of white matter lesions per age stratum. For participants 
aged between 60-70 years at follow-up, with over 20 years of hyperten-
sion, the relative risks for subcortical and periventricular white matter 
lesions were 21.8 (95% CI 4.6-103.2) and 16.1 (3.4-77.3) respectively, 
compared with non-hypertensives. There was a dose-response relation 
between the duration of hypertension and presence of either type of white 
matter lesions. A marked effect modification by age was observed. 
Table 4 shows the cross-sectional association between treatment 
status and presence of cerebral white matter lesions. Since these associa-
tions were similar in both SUb-populations they are presented for the 
study popUlation as a whole. Subjects who had hypertension despite the 
use of blood pressure lowering drugs had the highest relative risk of hav-
ing both types of white maller lesions, followed by the treated but con-
Table 2 
Baseline prevalence of hypertension in eligible subjects compared with those who had 
died before follow-up, in the Zoetermeer Study part (baseline 1975-1978) and in the 
Rotterdam Study part (baseline 1990-1993) of the Rotterdam Scan Study.* 
Age at follow-up 
(years) 
Hypertension (%) 
60-70 
70-80 
80-90 
overall 
Zoetermeer Study 
Eligible Dead at p-valuet 
follow-up 
20.0 26.6 0.63 
29.8 43.9 0.06 
36.7 52.7 0.06 
27.9 37.8 0.03 
* Values are age and sex adjusted percentages. 
t P-value by means of ANCOVA. 
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Rotterdam Study 
Eligible Dead at p-valuet 
follow-up 
28.2 56.0 0.0003 
41.7 59.8 0.001 
56.9 58.8 0.67 
44.2 55.1 0.0006 
Table 3 
The relation between duration of hypertension and presence of severe cerebral white matter lesions (RR and 95%CI).* 
White matter lesionst Age category Duration of hypertension:!: 
Subcortical 60-70 
70-80 
80-90 
overall 
Periventricular 60-70 
70-80 
80-90 
overall 
Zoetermeer Study 
No hypertension§ < 20 years 
(n~228) (n~ 155) 
1.0 6.0 (1.5-24_5) 
1.0 2.4 (0.9-6.4) 
1.0 1.0 (0.2-5.7) 
1.0 2.5 (1.3-4.9) 
1.0 2_0 (0.5-8.9) 
1.0 0.7 (0.3-1. 7) 
1.0 0.8 (0.2-4.0) 
1.0 1.0 (0.5-1.8) 
> 20 years 
(n~ 1 07) 
21.8 (4.6-103) 
1.3 (0.4-3.9) 
0.3 (0.0-2.3) 
2.2 (1.0-4.7) 
16.1 (3.4-77.3) 
1.3 (0.6-2_8) 
0_2 (0.0-1.1) 
1.6 (0.8-3.0) 
* Adjusted for age, sex, diabetes mellitus, body masS index, smoking behavior. 
t Represents the upper quintile of the white matter lesions severity distribution. 
No hypertension§ 
(n~241) 
1.0 
1.0 
1.0 
1.0 
1.0 
1.0 
1.0 
1.0 
Rotterdam Study 
< 5 years 
(n~97) 
3.6 (1.1-11.4) 
0.9 (0.3-2.6) 
1.7 (0.5-5.2) 
1.7 (1.0-3.2) 
3.3 (0.9-11.4) 
1.2 (0.4-3.6) 
1.0 (0.3-2.9) 
1.5 (0.8-2.8) 
> 5 years 
(n~191 ) 
1.5 (0.5-4.8) 
2.5 (1.1-5.9) 
1.2 (0_5-2.6) 
1.9 (1.1-3.1) 
1.9 (0.5-6_8) 
2.4 (1.0-6.0) 
1.1 (0.5-2.5) 
1.7 (1.0-2.8) 
:J: Hypertension: systolic blood pressure 2: 160 mm Hg and/or diastolic blood pressure 2: 95 and/or the use of blood pressure lowering drugs. 
§ Reference group (subjects without hypertension neither at baseline nor at follow up). 
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trolled and the untreated hypertensives. Again, the association between 
treatment status and white matter lesions was most marked within sub-
jects aged between 60 and 70 years. 
Participants without hypertension had a mean systolic and diastolic 
blood pressure of 136.4 mm Hg (SD 14.0) and 74.7 (SD 9.8) respectively. 
These values were similar to those in participants with treated and con-
trolled hypertension (mean systolic blood pressure 137.0 (SD 13.8); mean 
diastolic blood pressure 74.0 (SD 9.6). In contrast, for participants with 
treated uncontrolled and untreated hypertension these levels were 173.5 
(SD 13.9) and 170.1 (SD 13.7) for systolic blood pressure and for diastolic 
blood pressure 88.0 (SD 9.7) and 88.4 (SD 9.6), respectively. There was 
no effect modification by age for these differences between the treated and 
untreated groups. 
In the Rotterdam Study most of the untreated hypertensives (75%) 
had hypertension for less than 5 years, whereas this was the case for only 
25% of both treated groups. In the Zoetermeer study 66% of the untreated 
hypertensives had hypertension for less than 20 years, whereas this was 
about 52% for both treated groups. 
Table 4 
The cross-sectional relation between hypertension, treatment status and the presence 
of severe cerebral white matter lesions (RR and 95% CI). * 
White matter Age Hypertension Hypertension treatment statust 
lesionst (years) (all) 
Untreated Treated, Treated, 
(n~189) controlled uncontrolled (n~134) (n~220) 
Subcortical 60·70 4.5 (2.2·9.6) 4.2 (1.7·10.4) 3.4 (1.3-8.6) 8.5 (3.1-22.7) 
70·80 1.7 (1.0·2.8) 1.5 (0.7·2.9) 1.6 (0.8·3.1) 2.1 (1.0-4.4) 
80-90 1.5 (0.8-2.9) 1.2 (0.5-2.9) 1.3 (0.6·2.9) 2.0 (0.8·4.9) 
overall 2.2 (1.5·3.1) 1.9 (1.2·2.9) 1.9 (1.2·2.9) 3.0 (1.9·4.9) 
Peri ventricular 60·70 2.7 (1.3·5.8) 1.9 (07-5.4) 2.4 (0.9·6.3) 5.4 (2.0·14.8) 
70·80 1.4 (0.8-2.2) 1.2 (0.6-2.2) 1.1 (0.5·2.0) 2.3 (1.2·4.6) 
80·90 1.1 (0.6·2.1) 0.8 (0.3-1.8) 1.4 (0.6-2.9) 1.0 (0.4·2.3) 
overall 1.5 (1.1·2.1) 1.2 (07-1.8) 1.4 (0.9·2.2) 2.1 (1.3-3.4) 
* Adjusted for age, sex, diabetes mellitus, body mass index, smoking behavior. 
t Represents the upper quintile of the white matter lesions severity distribution. 
, Hypertension: systolic blood pressure ::?:160 mm Hg and/or diastolic blood pressure 
::?:95 and/or the use of blood pressure lowering drugs. 
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Discussion 
We studied the effect of hypertension, its duration and its treatment 
status on cerebral white matter lesions in a prospective, population-based 
study among elderly subjects. We found that current hypertension, and 
hypertension established 5 or 20 years ago, was associated with the pres-
ence of white matter lesions, subcortical as well as periventricular. In ad-
dition, our results suggest that effective treatment reduces the risk for 
both types of white matter lesions, compared with ineffective treatment. 
When a risk factor such as hypertension is associated with increased 
mortality,14 the association between hypertension earlier in life and white 
matter lesions later in life is likely to be biased by selective mortality, es-
pecially with advancing ages. This selective mortality is a particular con-
cern in the Zoetermeer Study sub-population, in which follow-up was 
longest. We addresscd this issue by comparing the prevalence of hyper-
tension in three age strata between survivors and those who had died be-
fore the follow-up. Indeed, in the youngest age stratum there was no sig-
nificant difference for hypertension between survivors and those who had 
died before the follow-up, whereas this difference was significantly differ-
ent in the highest age categories. It seems therefore plausible to argue 
that relative risks in the youngest age category represent the most un-
biased risk estimates. In the Rotterdam Study sub-population selective 
survival plays a less prominent role because baseline data collection was 
already relatively late in life and the follow-up period was short (5 years). 
Therefore it seems plausible that individuals with long-lasting hyperten-
sion would have died before baseline collection of the Rotterdam Study. In 
addition to this, selection bias may have influenced our findings, espe-
cially in the oldest age category where the response rate was lowest, as 
subjects who refused to participate had higher systolic blood pressures 
than participants at baseline did. The relative risk for white matter lesions 
with hypertension in the two higher age strata may have been underesti-
mated, by a decreased susceptibility to the effects of hypertension among 
survivors, and by selective non-participation of survivors with white mat-
ter lesions and cognitive impairment. 
How hypertension exactly contributes to white matter lesions re-
mains to be elucidated. A possible explanation can be that long-standing 
hypertension results in a decrease in cerebral blood flow by impairment of 
the cerebral autoregulation. l5 The cerebral blood flow is maintained in 
healthy subjects at a constant level between blood pressure levels in the 
order of 60-150 mm HgIS However, these limits shift upward in subjects 
with chronic hypertension and this may lead to transient decreases in 
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cerebral blood flow during periods of lower blood pressure, even at blood 
pressure levels considered normal for normotensive subjects.16~18 Most 
vulnerable are areas with an already marginal blood supply under 
physiological conditions, such as the subcortical and periventricular 
white matter. 19,20 As a consequence the white matter, of chronic hyperten-
sives might suffer from ischemia during episodes of a relatively low blood 
pressure. This is in line with the observation of severe periventricular 
white matter lesions in hypertensive subjects who have an impaired cere-
bral autoregulation) 18 and with our observation of the strongest associa-
tions in subjects with the longest duration of hypertension. 
The association between hypertension treatment status and white 
matter lesions may be confounded by differences in actual blood pressure 
levels or in duration (severity) of hypertension between the groups. For 
example, blood pressure levels in untreated subjects may be lower than in 
those treated and controlled, thereby explaining the lower risk for white 
matter lesions. However, we found much lower systolic and diastolic blood 
pressures in treated controlled persons than in the untreated. We there~ 
fore consider it unlikely that the higher risk for white matter lesions 
among the treated and controlled can be explained by higher levels of cur-
rent blood pressure. Another potential source of bias is a different dura~ 
tion of hypertension among the groups. The reason that an untreated hy-
pertensive subject does not receive blood pressure lowering drugs may be 
that hypertension had been present for a relatively short period of time 
and had not yet been detected. Therefore they may be at lower risk for 
having white matter lesions. Indeed we showed that among untreated hy~ 
pertensives the proportion of subjects with a shorter duration of hyper~ 
tension was relatively high. However, we consider it unlikely that this bias 
has influenced the associations for the two treated groups, because they 
were all treated during the follow~up, and as there was no major differ-
ence in the duration of hypertension between the treated controlled and 
treated uncontrolled subjects. 
A possible explanation for our finding that treated, but uncontrolled 
hypertensives have the highest risk for either type of white matter lesion 
may be that adequate control of hypertension may lead to a lower risk of 
cerebral arteriolosclerosis and thereby prevent the occurrence of cerebral 
ischemia. 2,20 A recent clinical trial of antihypertensive drugs in systolic 
hypertension showed a reduced incidence of dementia in the treated 
group;lO this may be through sparing of white matter, although this as-
pect was not studied. 
In conclusion, we found that a 20 year duration of hypertension in-
creased the risk for white matter lesions about 20-fold. Effective treat-
ment of hypertension reduces the proportion of white matter lesions. This 
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offers potential therapeutic possibilities in preventing and reducing the 
development of white matter lesions and the attendant cognitive decline 
or dementia. 
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Abstract 
Aortic atherosclerosis at middle 
age predicts cerebral white 
matter lesions in the elderly 
Background Magnetic resonance imaging scons of the brains of elderly people 
frequently show white matter lesions. Clinically, these lesions are associated 
with cognitive impairment and dementia. A relation between atherosclerosis 
and white matter lesions was found in some small cross sectional studies. How-
ever, atherosclerosis is a gradual process that starts early in life. We investi-
gated the longitudinal association between aortic atherosclerosis assessed 
during mid-life and late-life and cerebral white matter lesions. 
Methods We randomly sampled subjects aged between 60-90 years from two 
population-based follow-up studies in which subjects had their baseline exami-
nations in 1975-1978 (mid-life) and in 1990-1993 (late-life). In 1995-1996 subjects 
underwent 1.5T MRI-scanning; white matter lesions were rated in the deep sub-
cortical and periventricu/ar regions separately. Aortic atherosclerosis was as-
sessed on abdominal X-rays that were obtained from 277 subjects in midlife 
and 536 subjects in late-life. 
Findings The presence of aortic atherosclerosis during mid-life was significantly 
associated with the presence of periventricular white matter lesions approxi-
mately 20 years later (adjusted relative risk 2.6; 95% CI 1.3-5.2); this relation 
was dose dependent No association was found between mid-life aortic 
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atherosclerosis and subcortical white matter lesions (adjusted relative risk r 1; 
95% C/ 0.5-23), nor between late-lile aortic atherosclerosis and white matter 
lesions. 
Interpretation The pathogenetic process that leads to cerebral periventricular 
white matter lesions starts already in or before midlife. The critical period for 
intervention directed at prevention of white matter lesions, and its cognitive 
consequences, may be long before these lesions become clinically detectable. 
Introduction 
Cerebral magnetic resonance imaging (MRI) scans of elderly, non-de-
mented people frequently show white matter lesions,l-3 There is evidence 
that white matter lesions are associated with cognitive decline and de-
mentia. 2 ,4-6 We previously showed an association between atherosclerosis 
and white matter lesions in a small cross-sectional population-based 
study among elderly sUbjects.? However, atherosclerosis is a gradual pro-
cess, which already starts in the first decades of life, when prevalence of 
white matter lesions is very IOW. 8- 11 If atherosclerosis early in life is a pre-
dictor for white matter lesions in later years, intervention in early life 
might help prevent cognitive decline and possibly dementia. Aortic calcifi-
cation observed on an abdominal X-ray is associated with generalized 
atherosclerosis and has proved to be a good predictor for the development 
of vascular events at variou s sites, including the brain. 12-15 Cerebral white 
matter lesions can be located in the periventricular or the subcortical re-
gion. It is not known whether these two types of lesions have the same 
causes. It has been suggested that especially severe periventricular white 
matter lesions are associated with impaired cognitive performance.6 
We studied the association between presence and severity of aortic 
atherosclerosis assessed during mid-life or late-life and the later presence 
of cerebral white matter lesions in the Rotterdam Scan Study. 
Methods 
Study population 
The Rotterdam Scan Study was designed to study determinants and the 
consequences of cerebral white matter lesions in the elderly. In 1995-
1996, 1904 subjects aged between 60-90 years were randomly selected in 
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strata of age (5 years) and sex from two large ongoing prospective follow-
up cohort studies that had their baseline examinations during subjects' 
mid -life (the Zoetermeer Study) or late-life (the Rotterdam Study). Mean 
age of subjects during mid-life was 53.7 years (SD 5.5) years and during 
late-life 68.7 years (SD 8.0). The Zoetermeer Study had its baseline data 
collection in 1975-1978; the mean follow-up period since then was 19.6 
years. The Rotterdam Study had its baseline data collection from 1990-
1993; the mean follow-up period was 4.8 years. The Zoetermeer Study is a 
population-based follow-up study among 10361 subjects, aged between 5-
91 years, and originally focused on determinants of various chronic dis-
eases. The Rotterdam Study is a population-based prospective follow-up 
cohort study, among 7983 elderly subjects aged 55 years and over, which 
focuses on determinants of neurological, cardiovascular, locomotor and 
ophthalmologic disorders in the elderly. Both studies have been described 
in detail elsewhere. 16.17 
For the Rotterdam Scan Study subjects were invited by letter, and 
subsequently contacted by telephone. Upon a subject's agreement to par-
ticipate in the study a list of contra-indications was reviewed in order to 
assess eligibility (dementia; blindness; or presence of MRI contra-indica-
tions, including prosthetic valves, pacemaker, cerebral aneurysm clips, 
intra-ocular metal fragments, cochlear implants and claustrophobia). 
From 1904 invited subjects 1724 were eligible. Complete information, in-
cluding a cerebral MRI scan was obtained from 1084 persons (response 
63%); 568 from the Rotterdam Study (response 68%) and 516 from the 
Zoetermeer Study (response 58%). Each participant signed an informed 
consent form. The study was approved by the medical ethics committee of 
Erasmus University, 
Measurement of aortic atherosclerosis 
Abdominal X-rays were taken in subjects of 45 years and over at the time 
of baseline data collection of the Zoetermeer Study (response 82%). From 
305 subjects out of the 401 subjects in our study who were aged over 45 
years at the time of baseline data collection, a lateral abdominal X-ray 
had been obtained. During the follow-up study (1995-1996) X-rays of 277 
subjects could be retrieved. Abdominal X-rays were also obtained during 
the baseline examination of the Rotterdam Study. From 536 of our par-
ticipants an abdominal X-ray had been obtained (response 94%). Aortic 
atherosclerosis was considered present if calcified deposits were visible as 
linear densities in an area parallel and anterior to the lumbar spine, Se-
verity of atherosclerosis was rated as mild when deposits were between 0-
I em and as moderate-to-severe when deposits were ~ 1 em, 
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Measurement of other baseline covariates 
All measurements were done in a similar way at baseline and follow-up in 
both sUb-populations of the Rotterdam Scan Study. Height and weight 
were measured without shoes in light clothing. The body mass index was 
calculated as weight divided by height square. Blood pressure was meas-
ured two times on the right arm by means of a random zero sphygmoma-
nometer in sitting position. The average of these measurements was used. 
Hypertension was defined as a systolic blood pressure ~ 160 mm Hg 
and( or a diastolic blood pressure ~ 95 mm Hg and( or the self reported 
use of blood pressure lowering medication. Information on smoking was 
obtained through a standardized questionnaire, which was checked by a 
physician during the interview. Diabetes mellitus was considered present 
if the participant was taking oral anti-diabetics or insulin (both sub 
populations) or if the random or post load glucose level was higher than 
11.1 mmol(l (subjects originating from the Rotterdam Study).!B Serum 
total cholesterol was measured by an automated enzymatic method. 19 
MRI Scanning protocol 
From all participants an axial Tl, T2 and PD weighted cerebral MRI scan 
was made on a loST MRI scan. Subjects recruited from the Zoetermeer 
Study were scanned with a 1.5T MR Gyroscan (Philips, Best, The Nether-
lands) and participants from the Rotterdam Study were scanned with a 
1.5T MR Vision (Siemens, Erlangen, Germany). In order to provide compa-
rability the following pulse sequences were applied: at the Gyroscan: Tl 
(TR 700 ms, TE 14 ms), T2 (TR 2200 ms, TE 80 ms) and PD (TR 2200 ms, 
TE 20 ms); and at the Vision Tl (TR 485 ms, TE 14 ms), T2 (TR 2236, TE 
90 ms) and PD (TR 2236 ms, TE 20 ms). Slice thickness was 6 mm and 5 
mm respectively, Vlith an inter-slice gap of 20.0%. The images were 
printed on hard copy with a reduction factor of 2.7. 
White matter lesions rating scale 
White matter lesions were considered present if visible as hyperintense on 
both proton density (PD) and T2 weighted images and not hypointense on 
Tl weighted image. White matter lesions were distinguished into deep 
subcortical and periventricular regions. The number and size of deep sub-
cortical white matter lesions was rated on hard copy according to their 
largest diameter in categories of small «3 mm), medium (3-10 mm) or 
large lesions (> 10 mm). In order to calculate a deep subcortical white 
matter lesion volume on hard copy, white matter lesions were considered 
to be spherical with a fixed diameter per size category. Periventricular 
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white matter lesions were rated semi-quantitatively per region: adjacent to 
frontal horn (frontal capping), adjacent to lateral wall of lateral ventricles 
(bands) and adjacent to occipital horn (occipital capping) on a scale 
ranging from 0 (no white matter lesions), 1 (penciHhin periventricular 
lining), 2 (smooth halo or thick lining) to 3 (large confluent white matter 
lesions). The overall degree of periventricular white matter lesions was 
calculated by adding up the scores for the three separate categories 
(range 0-9). 
All MRI scans were examined by two raters from a pool of four expe-
rienced raters. In case of a disagreement of more than one point, a con-
sensus reading was held; in all other cases the readings of both readers 
were averaged. The inter- and intra-rater studies showed a good to excel-
len! agreement. Weighted kappas for grading the periventricular white 
matter lesions were between 0.79-0.90. For total deep subcortical white 
matter volume the inter-reader and intra-rater intraclass correlation coef-
ficients were 0.88 and 0.95, respectively. 
Statistical analysis 
The relation between aortic atherosclerosis and white matter lesions was 
assessed by means of age and sex adjusted logistic regression with the 
presence of severe white matter lesions as the dependent variable. The 
relative risk (RR), as estimated by the odds ratio, was used to quantify the 
association. White matter lesions were dichotomized at the upper quintile 
of their distribution, reflecting presence of severe white matter lesions. 
Subjects without severe white matter lesions were the reference group 
(lower four quintiles). The association between mid-life and late-life aortic 
atherosclerosis and presence of white matter lesions was studied by en-
tering aortic atherosclerosis as a dichotomous variable (no versus mild or 
moderate-to-severe) into the model. A possible dose-response relation 
between severity of aortic atherosclerosis and white matter lesions was 
studied by creating dummy variables for the extent of aortic atherosclero-
sis. Additional adjustments were made for possible baseline confounding 
factors including body mass index, total serum cholesterol, diabetes mel-
litus, hypertension and smoking (never, former or current). The relative 
risks are presented with a 95% confidence interval (95% el). 
Results 
Table 1 shows the baseline characteristics of the study population. The 
overall response rate was 62.9%, and declined from 73% among subjects 
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Table 1 
Characteristics of participants in the Rotterdam Scan Study during mid-life (assessment 
1975-1978) and late-life (assessment 1990-1993)* 
Characteristic Mid-life assessment late-life assessment 
Number of subjects 277 536 
Women (%) 57.5 48.9 
Mean age (years) 53.8 (5.5) 68.7 (8.0) 
Mean age at MRI (1995-1996) 73.3 (5.5) 73.4 (7.9) 
Body Mass Index (kg/m') 25.3 (2.9) 26.3 (3.4) 
Systolic BP (mm Hg) 133.8(17.3) 136.7 (20.7) 
Diastolic BP (mm Hg) 82.4 (10.7) 73.2 (10.8) 
Serum cholesterol (mmolfl» 6.2 (1.1) 6.7 (1.2) 
Aortic atherosclerosis (%) 21.3 58.6 
Hypertension (%) 30.5 38.4 
Diabetes Mellitus (%) 0.3 4.4 
Smokers (%) 
current 36.0 20.2 
former 33.2 45.5 
never 30.8 34.3 
* Values are unadjusted means (SD) or percentages. 
Table 2 
The relative risk (95% el) of severe white matter lesions* associated with mid-life and 
late-life aortic calcification. 
Aortic calcification in Aortic calcification in 
mid-life late-life 
absent present absent present 
Number of subjects 218 59 222 314 
Periventricular white matter lesions 
Modell 1.0 (ref) 2.5 (1.3-4.8) 1.0 (ref) 0.9 (0.6-1.4) 
Model 2 1.0 (ref) 2.6 (1.3-5.2) 1.0 (ref) 1.0 (0.6-1.7) 
Subcortical white matter lesions 
Modell 1.0 (ref) 1.0 (0.5-2.0) 1.0 (ref) 1.1 (0.6-1.7) 
Model 2 1.0 (ref) 1.1 (0.5-2.3) 1.0 (ref) 1.1 (0.6-1.8) 
*Dichotomized at the upper quintile of the severity distribution of white matter lesions 
Model 1: adjusted for age and sex. 
Model 2: adjusted for age, sex, baseline presence of diabetes mellitus, hypertension, 
smoking behaviour, serum cholesterol, body mass index. 
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Figure 1 
Periventricular lesions 
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Subcortical lesions 
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The association between mid-life severity of aortic atherosclerosis and presence of 
severe white matter lesions 20 years later (relative risks, with 95% CI given in 
parentheses). 
aged between 60~ 70 years to 48% among participants aged between 80~90 
years in 1995~1996. Non~participants from the original Zoetermeer Study 
and the original Rotterdam Study were significantly older than partici~ 
pants (75.6 versus 70.8 years; p <0.001 and 76.6 versus 73.7 years; p 
<0.01, respectively). There was no significant difference according to sex, 
diastolic blood pressure and the prevalence of aortic calcification or hy-
pertension at baseline. Non~participants from the Zoetermeer Study had a 
higher systolic blood pressure (135.3 mm Hg versus 132.8 mm Hg; 
p=0.05) at baseline compared to participants, whereas this was not sig~ 
niflcantly different for subjects from the Rotterdam Study. 
Prevalence of aortic atherosclerosis was 21 % at mid-life and 59% at 
late-life. During mid-life, in 218 subjects there was no aortic atherosclero-
sis, whereas mild and moderate-to-severe aortic atherosclerosis was ob-
served in 25 and 34 subjects, respectively. During late~life, there were 192 
subjects without any aortic atherosclerosis, whereas mild and moderate-
to-severe aortic atherosclerosis was observed in 99 and 175 subjects, re-
spectively. At follow~up, 21% of all participants were without any peri~ 
ventricular white matter lesions and 8% without subcortical white matter 
lesions. 
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Table 2 shows that the presence of aortic atherosclerosis during mid-
life is significantly associated with the presence of severe periventricular 
white matter lesions 20 years later (RR 2.6; 95% CI 1.3-5.2), but not with 
deep subcortical white matter lesions (RR 1.1; 95% CI 0.5-2.3). These as-
sociations were similar for men and women. In contrast, presence of aor-
tic atherosclerosis during late-life was not associated with either type of 
white matter lesion. 
Figure 1 shows a dose dependency between the extent of aortic 
atherosclerosis in mid-life and the presence of periventricular white mat-
ter lesions 20 years later (Plrend=O.002). There was no such association 
with deep subcortical white matter lesions (p",nd=0.6S). For mild and 
moderate-ta-severe aortic atherosclerosis in late-life the relative risks of 
having periventricular white matter lesions were 1.0 (95% CI 0.5-1.9) and 
0.7 (95% CI 0.4-1.3), and for deep subcortical white matter lesions 1.2 
(95% CI 0.6-2.3) and O.S (95% CI 0.4-1.4), respectively. Again there were 
no major sex differences in these associations. 
Discussion 
We found a dose-dependent relation between severity of aortic atheroscle-
rosis during mid-life and the presence of peri ventricular white matter le-
sions 20 years later. There was no association between the presence of 
aortic atherosclerosis in late-life and white matter lesions. A strength of 
this study is its large number of elderly participants from the general 
population, including institutionalized persons. Another important featurE 
is that this study is the first longitudinal study of its kind, with a follow-
up of almost 20 years. 
Some limitations and methodological issues need to be addressed. 
The overall response rate was 63%, and this may have led to selection 
bias, especially among the oldest participants. Yet, we consider it unlikely 
that selection bias has played a major role in our study since there were 
only small, non-significant, differences between participants and non-
participants. We cannot exclude that our relative risks are somewhat un-
derestimated because we performed our study in survivors of the two 
baseline studies. Subjects who had died between baseline examination 
and follow-up may have had more severe aortic atherosclerosis compared 
to those who survived. 
Another limitation is that there was no neuro-imaging available at 
baseline of the study. This makes it difficult to provide definitive proof of a 
temporal relation between aortic atherosclerosis and white matter lesions. 
As for the validity of radiographic assessment of aortic calcification for the 
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diagnosis of atherosclerosis, in an autopsy study it was shown that radio-
graphically detected aortic calcification represented true intimal athero-
sclerosis. 12 When compared with computed tomography it was shown that 
calcifications seen at the X-ray were in the vessel wall in all cases. 20 
The association between aortic atherosclerosis and cerebral white 
matter lesions was found only for aortic plaques in mid-life, and not for 
those found in late-life. The explanation may be that subjects who already 
had mild or severe aortic atherosclerosis during mid-life, had progressed 
to more severe atherosclerosis at the time of the MRI scan than subjects 
with a similar degree of aortic atherosclerosis at a much higher age. Ap-
parently, it takes many years before atherosclerosis progresses to such a 
severe stage that it is reflected in the brain. This interpretation is sup-
ported by our finding that severity of aortic atherosclerosis is associated 
with the presence of white matter lesions in a dose-dependent fashion. 
Another explanation for the weak association between late-life aortic 
atherosclerosis and white matter lesions might be that in elderly subjects 
presence of atherosclerosis has less discriminative power because many 
other risk factors for white matter lesions co-exist. 
The association between aortic atherosclerosis and white matter le-
sions was confined to periventricular white matter lesions. This suggests 
that different pathophysiological processes underlie periventricular and 
subcortical white matter lesions, possibly related to vascularization. As 
the peri ventricular white matter is an arterial border zone, already mar-
ginally perfused under physiological circumstances, it is especially vul-
nerable by a decrease of cerebral blood flow. 21-23 In contrast, the subcorti-
cal white matter is not an arterial watershed area,24 Atherosclerosis in-
duces hyalinisatioD, tortuosity and elongation of vessels in the periven-
tricular white matter.22,25·27 This may contribute to a decrease in blood 
flow in the periventricular white matter, leading to ischemia.22 This expla-
nation is supported by studies that found an association between peri-
ventricular white matter lesions and atherosclerosis-related factors as 
hypertension, diabetes mellitus, and presence of silent infarcts. 28 
In conclusion, our study shows that aortic atherosclerosis during 
mid-life is a major risk factor for periventricular white matter lesions in 
the brain at older age. Our results suggest that the presence of athero-
sclerosis at middle age is already predictive for the presence of white 
matter lesions later in life. Any therapeutic intervention should therefore 
preferably take place at the early stages of atherosclerosis. 
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Abstract 
Carotid or peripheral 
atherosclerosis and 
cerebral white matter lesions 
Introduction Cerebral white matter lesions are frequently observed on MRI 
scans of elderly, non-demented people, There is evidence that white matter 
lesions are involved in the pathophysiology of cognitive decline and dementia, 
White matter lesions can be distinguished into those in the periventricular or in 
the subcortical region. Pathological and epidemiological studies have sug-
gested involvement of atherosclerosis in the pathogenesis of these lesions, Our 
study reports on the association between indicators of atherosclerosis at differ-
ent sites and while matter lesions in a population based study among 1084 
elderly subjects, 
Methods We randomly sampled 1084 subjects aged between 60-90 years from 
two prospective population-based studies, All subjects underwent ultrasono-
graphy of the carotid artery,- also the ankle-to-brachial index was measured In 
addilion 1,5T MRI-scanning was performed; while matter lesions in the subcorti-
cal and periventricular regions were rated separately. 
Results Presence of plaques in the carotid artery was sigmficantly associated 
wilh periventricular white matter lesions (Ptrend=0,03), but not with the subcorti-
cal white matter lesions (Ptrend=O, 18). The intima media thickness was associ-
ated (borderline significance) with periventricular white matter lesions 
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(Ptrend=O.06), but not wtfh subcortical white matter lesions (Ptrend=0.73). There 
was no association between the ankle-la-brachial index and periventricular 
white matter lesions or subcortical white matter lesions. 
Conclusion We found an association between atherosclerosis of the carotid 
artery and especially per/ventricular white matter lesions. This may underlie 
findings of a relation between atherosclerosis and dementia. Carotid athero-
sclerosis (a site near the brain) may be a better marker for cerebral arteriolo-
sclerosis, than peripheral arterial disease. 
Introduction 
Cerebral white matter lesions are frequently observed on magnetic reso-
nance imaging (MRI) scans of elderly, non-demented people,l-3 There is 
evidence that white matter lesions are involved in the pathogenesis of 
cognitive decline and dementia. 2 ,4-6 In addition there is evidence for a re-
lation between atherosclerosis and dementia.7 White matter lesions can 
anatomically be distinguished into lesions located in the periventricular 
and in the deep subcortical region. It is not known whether these different 
white matter lesions have the same causes, but pathological and epidemi-
ological studies have indicated an important role of arteriolosclerosis in 
the white matter as an intermediate factor. 8 - 12 Nowadays, several non-
invasive techniques for detecting early stages of atherosclerosis at differ·· 
ent arterial sites are available. High resolution B-mode ultrasonography of 
the carotid artery can visualize plaques and the intima-media thickness 
(arterial wall thicknessL13,14 whereas the ankle-to-brachial· index repre-
sents atherosclerosis of the lower arteries, IS There are no studies available 
that have related these indicators with the two types of white matter le-
sions over their full range of severity. In this study we report the associa-
tion between indicators of atherosclerosis at two different sites and white 
matter lesions, in a population-based study among 1084 elderly subjects. 
Methods and subjects 
Study population 
The Rotterdam Scan Study was designed to study determinants and con-
sequences of age related brain abnormalities in the elderly. In 1995-1996, 
1904 subjects aged between 60-90 years were randomly selected in strata 
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of age (5 years) and sex from two large ongoing prospective follow-up co-
hort studies, the Zoetermeer Study and the Rotterdam Study. The 
Zoetermeer Study had its baseline data collection from 1975-1978; the 
mean follow-up period was 19.6 years. For the Rotterdam Study the base-
line data-collection took place from 1990-1993; the mean follow-up period 
was 4.8 years. Both studies have been described in detail elsewhere. 16 ,17 
In short, the Zoetermeer Study is a prospective population-based study 
among 10361 subjects, aged between 5-91 years at baseline; it originally 
addressed determinants of chronic diseases. The Rotterdam Study is a 
population-based prospective cohort study, among 7983 elderly subjects 
aged 55 years and over, which studies determinants of neurological, car-
diovascular, locomotor and ophthalmologic diseases in the elderly. 
For the follow-up examination in the Rotterdam Scan Study subjects 
were invited by letter, and subsequently contacted by telephone. Upon 
agreement to participate in the study a list of contraindications was re-
viewed in order to assess eligibility (dementia; blindness; or presence of 
MRI contraindications, including prosthetic valves, pacemaker, cerebral 
aneurysm clips, a history of intra-ocular metal fragments, cochlear im-
plants and claustrophobia). From 1904 invited subjects 1724 were eligi-
ble. Complete information, including a cerebral MRI scan, was obtained 
from 1084 persons (response rate 63%); 568 from the Rotterdam Study 
(response rate 68%) and 516 from the Zoetermeer Study (response rate 
58%). The overall response rate was 63%, and declined from 73% among 
subjects aged between 60-70 years to 48% among those aged between 80-
90 in 1995-1996. Each participant signed an informed consent form. The 
study was approved by the medical ethics committee of the Erasmus Uni-
versity. 
Measurement of atherosclerosis 
Carotid arteries 
In each subject ultrasonography of both carotid arteries was performed 
with a 7.5 MHz linear array transducer and a Duplex scanner (ATL UI-
traMark IV, Advanced Technology Laboratories, Bethel, WA). For subjects 
originating from the Rotterdam Study baseline carotid ultrasonography 
was available. The carotid arteries were evaluated for the presence 
(yes/no) of atherosclerotic lesions (plaques), defined as a focal widening 
relative to adjacent segments, with protrusion into the lumen of only cal-
cified deposits or a combination of calcifications and non-calcified mate-
rial. This measurement was performed for the left- and right-sided com-
mon carotid artery, bifurcation and internal carotid artery, both at the 
anterior and posterior wall, leading to a total plaque score ranging from 0-
85 I 
I Chapter42 
12. The intima-media thickness of the common carotid wall (wall thick-
ness) was measured on a longitudinal 2-dimensional ultrasound image of 
the carotid artery. The near and far walls of the carotid artery are dis-
played as two bright white lines, separated by a hypo-echogenic space. 
The distance of the leading edge of the first bright line on the far wall (lu-
men-intima interface) and the leading edge of the second bright line (me-
dia-adventitia interface) indicates the intima-media thickness. 18 ,19 The 
actual measurement of the intima-media thickness was performed off-line 
and was performed only in subjects from the Rotterdam Study, and only 
at baseline. The mean intima-media thickness of the ncar and far wall of 
the common carotid atery wal was used in the analysis. However, we con-
sider this a good reflection of current intima-media thickness since rate of 
progression of this measurement is about O.OlD mm/year or 0.006 
mm/year, in subjects with or without carotid artery plaques, respec-
tively.20 
Ankle-ta-brachial index 
The presence of atherosclerosis in the arteries of the lower limbs was as-
sessed by means of the ankle-to-brachial index. From subjects originating 
from the Rotterdam Study baseline ankle-to-brachial index measurements 
were available as well. The ankle-to-brachial index was computed by 
measuring blood pressure in the tibial artery using an 8 MHz continuous 
wave Doppler probe (Huntleigh 500D, Huntleigh Technology, Bedford-
shire, UK) and a random zero sphygmomanometer, with the participant 
supine. Blood pressure was measured on the right arm by means of a 
random zero sphygmomanometer in sitting position. The ankle-to-bra-
chial index was defined as the systolic blood pressure measured at both 
the left and right posterior tibial artery divided by the systolic blood pres-
sure of the right arm. The lowest ankle-to-brachial index in either leg was 
used in the analyses. Subjects with an ankle-to-brachial index less than 
0.9 were considered to suffer from peripheral arterial disease. 21 ,22 
Measurement of other covariates 
The body mass indcx was calculated as weight divided by height square. 
Information on smoking was obtained with a standardized questionnaire, 
which was checked by a physician during the interview. Diabetes mellitus 
was considered to be present if the participant was taking oral anti dia-
betics or insulin. 
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MRI Scanning protocol 
From all participants an axial Tl, T2 and PD weighted cerebral MRI scan 
was made on a 1.5T MRI scan. Subjects recruited from the Zoetermeer 
Study were scanned with a lo5T MR Gyroscan (Philips, Best, The Nether-
lands) and participants from the Rotterdam Study were scanned with a 
1.5T MR Vision (Siemens, Erlangen, Germany). In order to provide compa-
rability the following pulse sequences were applied: at the Gyroscan: T1 
(TR 700 ms, TE 14 ms), T2 (TR 2200 ms, TE 80 ms) and PD (TR 2200 ms, 
TE 20 ms); and at the Vision T1 (TR 485 ms, TE 14 ms), T2 (TR 2236, TE 
90 ms) and PD (TR 2236 ms, TE 20 ms). Slice thickness was 6 mm and 5 
mm respectively, with an inter-slice gap of 20.0%. The images were 
printed on hard copy with a reduction factor of 2.7. 
White matter lesions rating scale 
White matter lesions were considered present if these were hyper-intense 
on both PD and T2 weighted images and not hypo-intense on T1 weighted 
images. White matter lesions were distinguished into those in the subcor-
tical or periventricular regions. The number and size of subcortical white 
matter lesions was rated on hard copy according to their largest diameter, 
in categories of small «3 mm), medium (3-10 mm) or large lesions (>10 
mm). In order to calculate the volume of subcortical white matter lesions 
on hard copy, the lesions were considered to be spherical with a fixed di-
ameter per size category. Periventricular white matter lesions were rated 
semi-quantitatively per region: adjacent to the frontal horns (frontal cap-
ping); adjacent to the wall of the lateral ventricles (bands), and adjacent to 
the occipital horns (occipital capping), on a scale ranging from 0 (no white 
matter lesions), 1 (pencil-thin periventricular lining), 2 (smooth halo or 
thick lining) to 3 (large confluent white matter lesions). The overall degree 
of periventricular white matter lesions was calculated by adding up the 
scores for the three separate categories (range 0-9). All MRI scans were 
examined by two raters from a pool of four experienced raters. In case of 
disagreement by more than one point, a consensus reading was held; in 
all other cases the readings of both readers were averaged. The inter- and 
intra-rater studies showed good to excellent agreement. Weighted kappas 
for grading the periventricular white matter were between 0.79-0.90. For 
total subcortical white matter volume the inter- and intra-rater intra-class 
correlation coefficient was 0.88 and 0,95, respectively, 
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Data analyses 
The relation between indicators of atherosclerosis and white matter le-
sions was assessed by means of age and sex adjusted analysis of covari-
ance (ANCOVA); we obtained the mean grade of periventricular white 
matter lesions or the mean volume of subcortical white matter lesions 
(milliliter, (ml)) per quintile of the distribution of the intima-media thick-
ness, the carotid artery plaques and the ankle-to-brachial index. In addi-
tion we calculated the mean grade of the peri ventricular white matter le-
sions or the mean volume of subcortical white matter lesions for subjects 
with or without peripheral arterial disease. Additional adjustments were 
made for body-mass-index (continuous), smoking (never, former or CUf-
rent) and diabetes mellitus (dichotomous). 
Results 
Table 1 presents characteristics of the study population. At follow-up, 
20% and 8% of all participants were without any peri ventricular or sub-
cortical white matter lesions, respectively. The median volume of subcor-
Table 1 
Characteristics of the study population in 1995/1996 (at MRI assessment)* 
Number of subjects 
Age (yrs) 
Women{%) 
Body Mass Index 
Diabetes Mellitus (%) 
Smokers 
Current (%) 
Former (%) 
Never CYo) 
Systolic BP (mm Hg) 
Diastolic BP (mm Hg) 
Hypertension (%) 
Indicators of atherosclerosis 
Intima media thickness (mm)t 
Plaques carotid arteries (%) 
Ankle-to-brachial index 
Peripheral arterial disease (%)+ 
* Values are unadjusted means (SD) or percentages. 
1084 
72.3(7.4) 
52.0 
26.6 (4.0) 
6.9 
17.7 
44.7 
37.6 
147.3 (21.6) 
78.7 (11.7) 
51.3 
0.76 (0.13) 
62.3 
1.1 (0.2) 
16.6 
t Only measured in the Rotterdam Study at baseline (1990-1993). 
+ Defined as an ankle-ta-brachial index below 0.9. 
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Carotid artery plaques (quintiles) 
Figure 1 - The association between carotid artery plaques (in quintiles of the distribution) 
and periventricular (mean grade) and subcortical (mean volume) white matter lesions 
(SE), adjusted for age, sex, body-mass index, smoking and diabetes mellitus. 
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Inlima media thickness (quintiles) 
Figure 2 - The association between intima-media thickness (in quintiles of the distribu-
tion) and periventricular (mean grade) and subcortical (mean volume) white matter 
lesions (SE), adjusted for age, sex, body-mass index, smoking and diabetes mellitus. 
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Figure 3 - The association between ankle-to-brachial index (in quintiles of the distribu-
tion) and periventricular (mean grade) and subcortical (mean volume) white matter 
lesions (SE), adjusted for age, sex, body-mass index, smoking and diabetes mellitus. 
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tical white matter lesions on hard copy was 3.8 ml and the median grade 
of periventricular white matter lesions was 2 (on a scale from 0-9). Both 
median volume of subcortical white matter lesions and mean grade of 
peri ventricular white matter lesions increased significantly with age. Re-
sponders originating from the Rotterdam Study were significantly younger 
than non-responders (mean age 68.9 versus 71.1 years, p<O.OOI), had a 
lower carotid intima media thickness (0.76 versus 0.78 mm, p=0.05) and 
had a higher ankle-to-brachial index (1.07 versus 1.09, p=0.02). There 
was no significant difference between carotid plaques at baseline in re-
sponders versus non-responders in the Rotterdam Study (mean 1.7 
plaques in both groups, p=0.75). These baseline data were not available in 
the Zoetermeer Study. 
At follow-up, 20% and 8% of all participants were without any peri-
ventricular or subcortical white matter lesions, respectively. Median vol-
ume of deep subcortical white matter lesions on hard copy was 3.9 ml 
and the median grade of periventricular white matter lesions was 2. Both 
the median volume of deep subcortical white matter lesions and the mean 
grade of periventricular white matter lesions increased significantly "With 
age. 
The intima media thickness (Rotterdam Study) was associated with 
periventricular white matter lesions, the trend almost reaching statistical 
significance (ptrend""O,06), but not with the subcortical white matter lesions 
(pt"nd=0.73; figure 1). Presence of plaques in the carotid artery was signifI-
cantly associated with periventricular white matter lesions (ptrend=O.03), 
but not with subcortical white matter lesions (ptrend=O.18; figure 2). There 
was no association between the ankle-to-brachial index and either peri-
ventricular white matter lesions or subcortical white matter lesions (figure 
3). In addition there was no significant difference between subjects with or 
without peripheral arterial disease in the mean grade of periventricular 
white matter lesions (2.6 (SD 2.0); for both groups) and the mean volume 
of subcortical white matter lesions (1.6 m!. (SD 2.0) and 2.0 m!. (SD 3.2)), 
respectively. These associations were similar if the analysis were per-
formed for the Rotterdam and Zoetermeer Study separately. 
Discussion 
We found a clear, dose-dependent relationship between the severity of 
intima-media thickness or the presence of plaques in the carotid artery on 
the one hand and periventricular white matter lesions on the other. These 
associations were much less clear for subcortical white matter lesions. 
There was no association between the ankle-to-brachial index and either 
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type of white matter lesions. There was no significant difference in sever-
ity of periventricular and subcortical white matter lesions between sub-
jects with or without peripheral arterial disease. 
The strength of this study is its large number of elderly subjects from 
the general population, including institutionalized persons. However, 
some limitations and methodological issues need to be discussed. There 
were significant differences in baseline age and indicators of atherosclero-
sis between responders and non-responders, at least in the Rotterdam 
Study (for the Zoetermeer study there were no such baseline indicators of 
atherosclerosis available). However, we consider it unlikely that the rela-
tion between atherosclerosis and white matter lesions is different in non-
responders than in responders from the Zoetermeer Study than in those 
from the Rotterdam Study. This is supported by our findings of similar 
associations between all indicators of atherosclerosis and white matter 
lesions in the two sub-populations. Another limitation is that there was 
no neum-imaging available at baseline of the study. This makes it difficult 
to investigate a temporal relation between atherosclerosis and white mat-
ter lesions. 
An important point is the validity of the atherosclerosis measure-
ments. Increased carotid intima-media thickness may not necessarily re-
flects atherosclerosis. It may merely reflect a physiological adaptation of 
the vessel wall in a response to mechanical stress, secondary to variations 
in flow or wall tension. 23 However, in several studies ultrasonographically 
detected increases in carotid wall thickness and its progression were 
found to be associated with cardiovascular risk factors. 13,24-26 These find-
ings support the idea that increased carotid wall thickness, as detected by 
ultrasonography, reflects a valid index of atherosclerosis. 
All atherosclerosis indicators were based on single measurements. 
This may have led to misclassification. However, all atherosclerosis as-
sessments were done without prior knowledge of the degree of white mat-
ter lesions; therefore we consider it unlikely that this misclassification is 
related to the extent of white matter lesions. Any measurement error was 
likely to be random, and would have biased our findings towards the null 
hypothesis, leading to an underestimation of the strength of the associa-
tions. 
The association between indicators of atherosclerosis in the carotid 
arteries and white matter lesions was most marked for periventricular 
white matter lesions. There was no association between ankle-to-brachial 
index and any type of white matter lesions. This might be explained by 
the fact that the ankle- to-brachial index is a ratio of two systolic blood 
pressures, and may lead to spurious associations,27 especially in subjects 
with a high systolic blood pressure. In contrast, ultrasonographically de-
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tected carotid wall thickness and plaques are a reflection of the athero-
sclerotic state of the carotid artery and might therefore be a more valid 
indicator of atherosclerosis. 28,29 
We found a significant dose-dependent association of periventricular 
white matter lesions with intima media thickness and carotid artery 
plaques, but not for with subcortical white matter lesions. This suggests 
that different pathophysiological events underlie peri ventricular and sub-
cortical white matter lesions, possibly related to vascularization. As the 
periventricular white matter is marginally perfused under physiological 
circumstances it is especially vulnerable by a decrease of cerebral blood 
flow, 12,30.31 Atherosclerosis induces hyalinization, tortuosity and elonga-
tion of vessels in the periventricular white matter.9,12,32,33 These arteriolar 
changes may contribute to a decrease in blood flow in the periventricular 
white matter, leading to ischemic damage. 12 This notion is supported by 
studies that found an association between specifically peri ventricular 
white matter lesions and atherosclerosis related factors as hypertension, 
diabetes mellitus, presence of silent infarcts.34, 35 
In conclusion, we found an association between indices of atheroscle-
rosis in the carotid artery and periventricular white matter lesions, 
whereas this was not found for subcortical white matter lesions. This may 
have implications for the relation between atherosclerosis and dementia.7 
There was no relation between both types of lesions and peripheral arte-
rial disease. Carotid atherosclerosis (a site near the brain) may better re-
flect cerebral atherosclerosis and arteriolosclerosis, than peripheral arte-
rial disease, which probably represents a more general marker of athero-
sclerosis. 
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Abstract 
Atrial fibrillation and 
cerebral white matter lesions 
Background Cerebral white matter lesions are often observed on MRI scans of 
elderly non-demented and demented persons. Their pathogenesis is not fully 
understood but cerebral hypoperfusion may be involved Atrial fibrillation is a 
common finding in elderly subjects and may lead to a reduced cardiac output 
with cerebral hypoperfusion. We investigated the association between atrial 
fibrillation and the presence of white matter lesions. 
Methods In 1995-1996 we randomly sampled 1084 subjects from two ongoing 
prospective population based studies. From each participant an ECG was re-
corded; atrial fibrillation and left ventricular hypertrophy were diagnosed with 
a computer program. For one of the two groups (558 subjects) earlier ECGs 
were available (mean follow-up 4.7 years). All subjects underwent 1.5T MRI-
scanning- white matter lesions were separately rated for the per/ventricular 
and subcortical region. 
Results The prevalence of atrial fibrillation was 1.9% among subjects under the 
age of 75 years and 5.5% in subjects over the age of 75 years. Subjects with 
atria! fibrillation had more than twice as often severe periventricu/ar white 
matter lesions (RR 2.5; 95%C/ 1.1-56) but no increased risk of subcortical white 
matter lesions (RR 1.3; 95% C/ 0.6-3 I). For 8 persons with atrial fibrillation and 
left ventricular hypertrophy these figures were 6.7 (95%C/ 0.6-74.2) and 2.0 (95% 
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C! 0.5-S.O), respectively. Far subjects wifh atrial fibrillation both at baseline and 
at follow up the relative risks were 70 (95%C! 1.3-39.6) and O.S (95% C! 0.2-3.9), 
respectively. 
Conclusions Atrial fibrillation is associated with periventricular whife matter le-
sions/ but not with subcortical white matter lesions. Effective treatment of atrial 
fibrillation may possibly reduce the development of white matter lesions and of 
the attendant cognitive decline or dementia. 
Introduction 
White matter lesions are often observed on cerebral magnetic resonance 
imaging (MRI) scans of elderly, non-demented persons.!·3 Evidence is ac-
cumulating that these white matter lesions play an important role in the 
development of cognitive decline and dementia. 3 ,6 Their pathogenesis is 
not fully understood, but cerebral hypo-perfusion may be involved.?·9 
Atrial fibrillation is a common finding among the elderly and could 
lead to a reduced cardiac output, resulting in cerebral hypo-perfusion. 1O- 12 
Atrial fibrillation has been associated with cognitive function,13 and de-
mentia. 14 It is possible that not only large infarcts from embolism to the 
brain, but also white matter lesions underlie this association. 14 
White matter lesions can be distinguished according to their location 
in the peri ventricular and the subcortical region. It has been suggested 
that especially periventricular white matter lesions are associated with 
impaired cognitive performance,6 Because of its terminal arterial supply 
the periventricular white matter is especially vulnerable to a reduction in 
cerebral blood flOW,9,15,16 To date, only a few, and relatively small, popula-
tion based studies have addressed the relation between atrial fibrillation 
and white matter lesions. 17 ,18 
In the current study we investigated the association between atrial 
fibrillation and presence of cerebral white matter lesions in a population-
based study among the elderly. We hypothesized that atrial fibrillation 
would be associated with white matter lesions, in particular in the peri-
ventricular region, 
Methods 
Study population 
The Rotterdam Scan Study was designed to study determinants and cog-
nitive consequences of age related brain abnormalities in the elderly, In 
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1995-1996, 1904 subjects aged between 60-90 years were randomly se-
lected in strata of age (5 years) and sex from two large ongoing prospective 
follow-up cohort studies, the Zoetermeer Study and the Rotterdam Study. 
The Zoetermeer Study had its baseline data-collection from 1975-1978, 
whereas the Rotterdam Study had the baseline data-collection from 1990-
1993. Both studies have been described in detail elsewhere. 19,2o In short, 
the Zoetermeer Study is a prospective population based study among 
10361 subjects, aged between 5-91 years at baseline, which originally 
aimed at identifying determinants of chronic diseases. The Rotterdam 
Study is a population based prospective cohort study, among 7983 elderly 
subjects aged 55 years and over, which addresses determinants of neu-
rological, cardiovascular, locomotor and ophthalmologic diseases in the 
elderly. 
For the follow-up examination in the Rotterdam Scan Study subjects 
were invited by a letter, and subsequently contacted by telephone. Upon 
agreement on participation in the study a list of contraindications was 
reviewed in order to assess eligibility (dementia; blindness; or presence of 
MRI contraindications, including prosthetic valves, pacemaker, cerebral 
aneurysm clips, a history of intra-ocular metal fragments, cochlear im-
plants and claustrophobia). Of 1904 invited subjects, 1724 were eligible. 
Complete information, including a cerebral MRI scan, was obtained from 
1084 persons (response 63%); 568 from the Rotterdam Study (response 
68%) and 516 from the Zoetermeer Study (response 58%). The response 
rate declined from 71% among subjects aged under 75 years to 52% 
among participants aged over 75 years in 1995-1996. Non-responders 
were significantly older. Each participant signed an informed consent 
form. The study was approved by the medical ethics committee of the 
Erasmus University. 
Measurement of atrial fibrillation 
As part of the data-collection in the Rotterdam Scan Study a 12-lead ECG 
was recorded and stored digitally by means of an ACTA electrocardiograph 
(ESAOTE, Florence, Italy) in 960 subjects. Eleven percent of all subjects 
had a missing ECG at follow up, mostly for technical reasons (distur-
bances in power supply or technical problems with the recordcr). At base-
line, ECGs had also been obtained, in a similar way, in the Rotterdam 
Study (mean follow-up 4.7 years; n~558), but not in the Zoetermeer 
Study. All ECGs were processed by the Modular ECG Analysis System 
(MEANS).'! The program provides a rhythm and contour interpretation, 
and has been extensively evaluated. 21 .23 For atrial fibrillation, left ven-
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tricular hypertrophy and myocardial infarction the MEANS interpretation 
was used. 
Measurement of other covariates: 
Physical examinations and questionnaires were administered in a similar 
way at baseline and follow up. Blood pressure was measured twice on the 
right arm in sitting position, by means of a random zero sphygmomano-
meter. The average of these two measurements was used. Hypertension 
was defmed as a systolic blood pressure of;: 160 mm Hg and/or a dia-
stolic blood pressure of;: 95 mm Hg or the self reported use of blood pres-
sure lowering drugs. The ankle-to-brachial index was used as an indicator 
of atherosclerosis and was assessed by taking the ratio of the systolic 
blood pressure measured at the tibial artery to the systolic blood pressure 
measured at the right arm with a random zero sphygmomanometer, in 
sitting position. Blood pressure in the tibial artery was measured with a 8 
MHz continuous wave Doppler probe and a random zero sphygmomano-
meter, in supine position (Huntleigh 500D, Huntleigh Technology, Bed-
fordshire, UK). Subjects with an ankle-to-brachial index less than 0.9 
were considered to suffer from peripheral arterial disease. 24 ,25 
MRI Scanning protocol 
In all participants an axial T1, T2 and PD weighted cerebral MRI scan was 
made on a 1.5T MRI scan. Subjects recruited from the Zoetermeer Study 
were scanned with a 1.5T MR Gyroscan (Philips, Best, The Netherlands) 
and participants from the Rotterdam Study were scanned with a 1.5T MR 
Vision (Siemens, Erlangen, Germany). In order to provide comparability 
the following pulse sequences were applied: at the Gyroscan: Tl (TR 700 
ms, TE 14 ms), T2 (TR 2200 ms, TE 80 ms) and PD (TR 2200 ms, TE 20 
ms); and at the Vision Tl (TR 485 ms, TE 14 ms), T2 (TR 2236, TE 90 ms) 
and PD (TR 2236 ms, TE 20 ms). Slice thickness was 6 mm and 5 mm 
respectively, with an inter-slice gap of 20,0%. The images were printed on 
hard copy with a reduction factor of 2.7. 
White matter lesions rating scale 
White matter lesions were considered present if areas were hyperintense 
on both PD and T2 weighted images and not hypointense on the T1 
weighted image. White matter lesions were distinguished into the subcor-
tical and peri ventricular region. The number and size of subcortical white 
matter lesions was rated on hard copy according to their largest diameter 
in categories of small «3 mm), medium (3-10 mm) or large lesions (>10 
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mm). In order to calculate the volume of subcortical white matter lesions 
the lesions on hard copy were considered to be spherical with a fixed dia-
meter per size category. Periventricular white matter lesions were rated 
semi-quantitatively per region (frontal, lateral or occipital) on a scale of 0 
(no white matter lesions), 1 (pencil-thin periventricular lining), 2 (smooth 
halo or thick lining) and 3 (large confluent periventricular white matter 
lesions). The overall degree of periventricular white matter lesions was 
calculated by adding up the scores for the three separate categories 
(range 0-9). 
Two raters from a pool of four experienced raters examined all MRI 
scans. In case of a disagreement of more than one point, a consensus 
reading was held; in all other cases the readings of both readers were av-
eraged. The inter- and intra-rater studies showed a good to excellent 
agreement. Weighted kappas for grading the periventricular white matter 
were between 0.79-0.90. For total subcortical white matter volume the 
inter-reader and intra-rater intraclass correlation coefficient was 0.88 and 
0.95, respectively. In addition, all MRI scans were evaluated for the pres-
ence of infarcts. 
Statistical analysis 
The relation between atrial fibrillation and white matter lesions was as-
sessed with age and sex adjusted logistic regression with the presence of 
severe white matter lesions as the dependent variable. The associations 
were expressed as the relative risk (RR), as estimated by the odds ratio, 
with a 95% confidence interval (95% Clio White matter lesions were di-
chotomized at the upper quintile, which reflects severe white matter le-
sions. Additional adjustments were made for possible confounding fac-
tors, including hypertension, atherosclerosis (as measured by the ankle-
to-brachial index) and previous myocardial infarction (based on ECG). 
Firstly, the analyses were performed within the whole study population. 
Secondly, analyses were performed in subjects with and without a stroke, 
defined by evidence of an infarct on the MRI scan. 
It has been suggested that subjects with both atrial fibrillation and 
impaired left ventricular function have a more severe reduction in cardiac 
output, and are at a higher risk for cerebral blood flow disturbances than 
those with atrial fibrillation alone. 11,26 We therefore investigated the asso-
ciation with white matter lesions first in subjects without atrial fibrillation 
or left ventricular hypertrophy (reference), and compared these with sub-
jects who had atrial fibrillation without left ventricular hypertrophy, with 
subjects without atrial fibrillation but with left ventricular hypertrophy 
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and also with subjects who had both atrial fibrillation and left ventricular 
hypertrophy, by creating dummy variables for the three index groups. 
In 558 subjects originating from the Rotterdam Study baseline ECGs 
were available. This enabled us to investigate the association between 
white matter lesions and atrial fibrillation for only a single examination 
and for prolonged atrial fibrillation. We hypothesized that subjects with 
atrial fibrillation at both examinations would be at higher risk for having 
white matter lesions than subjects without atrial fibrillation or subjects 
with atrial fibrillation at only a single examination. 
Table 1 
Characteristics of the total study population of the Rotterdam Scan Study.* 
Number of subjects 
Age at follow up 
60-75 years 
75-90 years 
Age (years) 
Women (%/) 
Total periventricular white matter lesions (grade) 
Total volume subcortical white lesions (mI.) 
Hypertension (%) 
Peripheral atherosclerosis (%) 
Atrial fibrillation (%) 
Myocardial infarction (%) 
left ventricular hypertrophy (%) 
* values are unadjusted means (SD) or percentages. 
n.a.: not available 
Table 2 
ECG available 
960 
607 
353 
72.2 (7.5) 
52.1 
2.6 
1.6 
51.5 
15.8 
3.2 
10.3 
2.9 
ECG missing 
124 
77 
47 
72.6 (7.4) 
48.4 
2.4 
1.3 
50.5 
22.2 
n.a. 
n,a. 
n.a. 
The relation between atrial fibrillation and presence of severe cerebral white matter 
lesions (RR and 95%CI).* 
overall 
< 75 years 
;;:.: 75 years 
Relative risk of white matter lesions (95% CI) 
periventriculart 
2.5 (1.1-5.6) 
1.6 (0.3-7.9) 
3.2 (1.1-9.0) 
subcorticalt 
1.3 (0.6-3.1) 
0.5 (0.1-4.3) 
1.9 (0.7-5.0) 
* adjusted for age, sex, myocardial infarction, hypertension and peripheral athero-
sclerosis. 
t dichotomized at the upper quintile of the severity distribution of white matter lesions, 
participants in the lower four quintiles are the reference group. 
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Results 
Table 1 presents characteristics of the study population. Mean age of the 
participants was 72.2 years (SD 7.5) and 52% of them was female. The 
prevalence of atrial fibrillation was 1.9% among subjects below 75 years 
of age and 5.5% in subjects of 75 years or over. There was no significant 
difference between subjects with or without an ECG according to either 
type white matter lesions or age. 
Of all participants 21% and 8% were without any periventricular or 
subcortical white matter lesions, respectively. Both the volume of subcor-
tical white matter lesions and the mean grade of periventricular white 
matter lesions increased significantly with age. 
Table 2 shows the cross-sectional association between atrial fibrilla-
tion and white matter lesions. Persons with atrial fibrillation more often 
had severe periventricular white matter lesions (RR 2.5; 95%CI 1.1-5.6), 
but not severe subcortical white matter lesions (RR 1.3; 95%CI 0.6-3.1). 
These associations were similar for men (RR for peri ventricular white 
matter lesions 2.4; 95%CI 0.8-6.8; and RR for subcortical white matter 
lesions 1.4; 95%CI 0.5-4.1) and women (RR 2.8; 95%CI 0.7-10.6 and RR 
1.4; 95%CI 0.4-5.7). The associations were more marked in subjects of 75 
years or over than in subjects below the age of 75 years. Of 30 subjects 
with atrial fibrillation 7 had a cerebral infarct on MRI scan, against 111 of 
930 subjects without atrial fibrillation. The association between atrial fib-
rillation and white matter lesions was of the same magnitude in subjects 
with or without a visible infarct on the MRI scan. 
The relative risks for periventricular white matter lesions for subjects 
with atrial fibrillation and no left ventricular hypertrophy (n ~26) and for 
those with both atrial fibrillation and left ventricular hypertrophy (n~4), 
compared to the reference group, were 2.1 (95%CI 0.9-5.0) and 6.8 
(95%CI 0.6-75.8), respectively. For subcortical white matter lesions no 
such associations were observed. There was no significant association 
between white matter lesions and left ventricular hypertrophy among 
subjects without atrial fibrillation (n~22). 
Table 3 presents the associations in the part of the cohort on which 
baseline ECGs were available, for subjects with atrial fibrillation at both 
baseline and follow up examination and at only a single examination. 
There were 2 subjects with atrial fibrillation at baseline, but not at follow 
up, 8 persons without atrial fibrillation at baseline, but with atrial fibril-
lation at follow up, and 8 subjects with atrial fibrillation on both occa-
sions. Subjects with atrial fibrillation detected at only one examination 
still had significantly more often severe peri ventricular white matter le-
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Table 3 
Relation between atrial fibrillation and severe cerebral white matter lesions for persons 
who had atrial fibrillation at one examination (baseline or follow-up) or at two examina-
tions (baseline and follow-up) compared to individuals without atrial fibrillation (RR and 
95%CI).* 
Severe white matter Jesionst 
Periventricular 
Subcortical 
absenf 
1.0' 
1.0' 
Atrial fibrillation 
at one at both 
examination examinations 
2.5 (1.1-5.6) 7.0 (1.3-39.6) 
2.0 (0.5-8.0) 0.8 (0.2-3.9) 
* Adjusted for age, sex, myocardial infarction, hypertension and peripheral athero-
sclerosis. 
t Dichotomized at the upper quintile of the severity distribution of white matter lesions 
.j: Reference group. 
sions than those without atrial fibrillation (RR 2.5; 95%CI 1.1-5_6), but 
not subcortical white matter lesions (RR 2.0; 95%CI 0.5-8.0). Among 
subjects with atrial fIbrillation at both baseline and follow-up examination 
the risk of severe periventricular white matter lesions was even higher (RR 
7.0; 95%CI 1.3-39.6); this was again not found for subcortical white mat-
ter lesions (RR 0.8; 95%CI 0.2-3.9). 
Discussion 
We found an association between atrial fIbrillation and periventricular 
white matter lesions in the cross-sectional part of our study, In addition, 
subjects who had atrial fibrillation at two examinations almost 5 years 
apart showed an even higher prevalence of periventricular white matter 
lesions. Subjects with atrial fibrillation and concomitant left ventricular 
hypertrophy were at the highest risk of having peri ventricular white mat-
ter lesions. These associations were not found for subcortical white matter 
lesions. The strength of this study is its large number of elderly people 
from the general popUlation, including institutionalized persons. Another 
important feature is the availability of an ECG recorded 5 years before 
MRI scanning, in part of our popUlation, 
The overall response rate was 63%, which raises the question of se-
lection bias. Since non-responders were older than responders, it is likely 
that non-responders have higher degrees of white matter lesions, How-
ever, we could not think of any reason why the association between atrial 
fibrillation and presence of white matter lesions would be different in non-
1
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responders than in responders, but we can of course not fully rule out 
that selection bias may have played a part in our findings. 
About 11% of all subjects with an MRI sean were excluded from the 
analyses because of a missing EeG. Selection bias might have occurred if 
participation in the EeG measurement were related to the presence of 
white matter lesions. However, in our study missing EeGs were mostly 
explained by technical problems of the ECG recorder. Also, the severity of 
white matter lesions was similar in subjects with or without an EeG. We 
therefore consider it unlikely that missing EeG measurements are related 
to white matter lesions. 
We probably underdiagnosed the prevalence of atrial fibrillation, 
since we only used one 10 second resting EeG for the detection of rhythm 
disturbances. We therefore could not detect all episodes of paroxysmal 
atrial fibrillation. Findings by Manolio et al. indicated that 74% of all pa-
tients with atrial fibrillation identified during a 24-hour ambulatory ECG 
assessment were detected with a 10 second ECG recording.27 Since this 
misc1assification is most likely not related to presence of white matter le-
sions and is therefore non-differential, it will have reduced the strength of 
the association between atrial fibrillation and white matter lesions to-
wards the null hypothesis. 
The association between atrial fibrillation and periventricular white 
matter lesions might be confounded by the underlying cause of atrial fib-
rillation, including ischemic heart disease, atherosclerosis and hyperten-
sion. 26,28 However, adjustments for these variables did not alter the 
strength of the association between atrial fibrillation and white matter 
lesions, which suggests a direct effect of atrial fibrillation on the periven-
tricular white matter. 
There are two possible ways in which atrial fibrillation may result in 
the emergence of white matter lesions. The first is a reduction of cerebral 
perfusion by a reduced cardiac output in patients -with atrial fibrillation, 
especially at a fast ventricular rate (i.e. during periods of increased activ-
ity)26 Especially among elderly people, who may already have a compro-
mised cerebral circulation, atrial fibrillation further reduces brain perfu-
sion. 2(,,2<),3o A chronic reduction in cerebral blood flow might lead to is-
chemia of the white matter, reflected in white matter lesions, especially in 
the presence of the compromised cerebral circulation in the aging brain. 
This hemodynamic contribution to the pathogenesis of periventricular 
white matter lesions is further supported by our finding of an even 
stronger association between atrial fibrillation and periventricular white 
matter lesions in the subgroup of subjects with impaired left ventricular 
function. This is a group of subjects with an even greater reduction of 
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cardiac output and cerebral perfusion than subjects -with atrial fibrillation 
alone, 1 1,26 
The second possible explanation is that atrial fibrillation leads to the 
formation of intracardiac thrombus, which may result in arterial 
thrombo-embolism,26 Such thrombi might occlude large or small arteries 
in the brain, resulting in overt stroke28 or in micro-infarction of brain tis-
sue, including the white matter. If this explanation were involved in the 
pathogenesis of white matter lesions one would expect a stronger asso-
ciation between atrial fibrillation and white matter lesions among subjects 
with evidence of infarction than in those without. As we found no differ-
ence in this respect between subjects with or without recognizable in-
farcts, this suggests that thrombo-embolism is not an important factor in 
the development of white matter lesions in subjects with atrial fibrillation. 
Yet, cautious interpretation of these data is necessary since there were 
only 7 cases with both atrial fibrillation and a visible infarct on MRI scan-
ning, 
Like others we have found that atrial fibrillation was associated espe-
cially with peri ventricular white matter lesions, whereas this was less 
clear for the subcortical region. 17 This suggests that different pathophysi-
ological factors may underlie periventricular and subcortical white matter 
lesions. The periventricular white matter is an arterial border zone, al-
ready marginally perfused under physiological circumstances, which 
makes it especially vulnerable by a decrease of cerebral blood flow,9,16,31 In 
contrast, the subcortical white matter is not an-arterial watershed area.32 
We found an association between atrial fibrillation and periventricular 
white matter lesions, Others have found an association between atrial fib-
rillation and dementia and cognitive impairment, \3,14 while the association 
between white matter lesions and dementia is well established. 5 ,33,34 Ef-
fective treatment of atrial fibrillation is available and may prevent or re-
duce the development of white matter lesions and of the concomitant de-
cline in cognitive performance, especially in the elderly, 
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Abstract 
Cerebral vasomotor reactivity 
and cerebral white matter 
lesions 
Objective The pathogenesis of white matter lesions is still uncertain but an 
ischemic-hypoxic cause has been suggested Cerebral vasomotor reactivity 
reflects the compensatory dilatory mechanism of the intracerebral arterioles to 
a vasodl'latory stimulus and provides a more sensitive hemodynamic index 
than the level of resting flow 
Methods We determined the association between vasomotor reactivity and 
white matter lesions in 73 consecutive individuals from the Rotterdam Scan 
Study who also participated in the Rotterdam Study, a large population based 
prospective follow-up study of individuals aged 55 years and over. Vasomotor 
reactivity was measured by means of COTenhanced transcranial Doppler and 
in all individuals axial T" T2 and PD weighted MRI scans (I.5T) were obtained 
White matter lesions were scored according to location size and number by 
two independent readers. 
Results Vasomotor reactivity was inversely associated with the presence of 
deep subcortical and total periventricular white matter lesions (OR 0.5; 95%C/ 
0.3-1.1 and OR 0.7; 95%C/ 0.4-1.1, respectively). A strong association was found 
between impaired vasomotor reactivity and periventricu/ar white matter lesions 
adjacent to the lateral ventricular wall (OR 0.6; 95%C/ 0.4-1.0; p=O.OOI). No 
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association was found with periventricu/ar white matter lesions near the frontal 
and occipdal horns. 
Conclusions Our data confirm the association between vasomotor reactivity 
and whde malter lesions and support the hypothesis that some whde malter 
lesions may be associated wdh hemodynamic ischemic injury to the brain. 
Introduction 
White matter lesions are frequently detected on magnetic resonance 
imaging (MRI) in the elderly and the extent of these white matter lesions 
correlates positively with age 1,2 and several cerebrovascular risk factors.3,4 
The pathogenesis of these white matter lesions is still largely unknown5 ,6 
but a hemodynamic contribution has been suggested,7-10 Cerebral 
vasomotor reactivity, or cerebrovascular reserve capacity, reflects the 
compensatory dilatory mechanism to a vasodilatory stimulus of the 
intracerebral arterioles,l1 and provides a more sensitive hemodynamic 
index than the level of resting blood flOW. 12 The vasomotor reactivity can 
be estimated by means of CO2-enhanced transcranial Doppler and has 
become a well established method for evaluating possible hemodynamic 
failure for instance in occlusive carotid artery disease. B - 18 
The association between vasomotor reactivity and white matter 
lesions has never been examined in a population based study among 
elderly individuals. In series of asymptomatic individuals and individuals 
with hypertension a decreased vasomotor reactivity has been found to be 
associated with peri ventricular lesions on MRLl'J,20 There are no reports 
on the relationship between vasomotor reactivity and subcortical white 
matter lesions. 
We investigated the association between vasomotor reactivity and 
different subtypes of white matter lesions in 73 individuals selected from 
a population-based study. 
Methods 
For the current study eighty individuals were randomly selected from the 
Rotterdam Scan Study. The Rotterdam Scan Study is a population-based 
study of causes and consequences of brain changes as visible on MRI. 
Persons with dementia and contraindications for MRI were excluded. This 
study was carried out between July and September 1996 and based on 
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the part of the cohort that also participated in the Rotterdam Study, 
which focuses on determinants of neurological, cardiovascular, endocrinal 
and ophthalmologic diseases in the elderly.'l 
Transcranial Doppler monitoring was performed (Multi-Dop X-4, 
DWL, Germany) and mean cerebral blood flow velocity was continuously 
measured in the middle cerebral artery on both sides if possible, as 
follows. The subject breathed air and 5% carbon dioxide through an 
anaesthetic mask, tightly fit over mouth and nose. End-tidal CO2 pressure 
(mmHg) was recorded continuously vvith a CO2 analyzer (Multinex, 
Datascope). Individuals first breathed room air, until a steady expiratory 
end-tidal C02 was obtained. Individuals were then asked to inhale a 
Inixture of 5% carbon dioxide in 95% oxygen for 2 minutes and the end-
tidal CO2 was recorded. End -expiratory CO2 was assumed to reflect 
arterial CO 2.11 TCD-8 DWL special software (VMR-C0 2) was used. All 
transcranial Doppler data were stored on hard disk for off-line analysis. 
Vasomotor reactivity was defined as the percentage increase in blood flow 
velocity occurring during inspiration of 5% C02, divided by the absolute 
increase in end-tidal CO2 in the same time period (%/mmHg). The mean 
of the right and left vasomotor reactivity was used for the analyses if both 
middle cerebral arteries could be insonated adequately. The one-sided 
vasomotor reactivity was used if a vvindow-failure appeared on one side. 
Each subject underwent cerebral MRI scanning using a l.5 Tesla (T) 
Siemens Gyrosean. From each participant axial Tl (TR 700ms, TE 14ms), 
T2 (TR 2200, TE 80ms) and proton density (PD) (TR 2200, TE 20ms) 
weighted images were made. Slice thickness was 5mm, with a gap of 
l.Omm. All MRI scans were examined independently by two experienced 
readers. White matter lesions were considered present if visible on both 
PD and T2 weighted images and not on the Tl weighted image. White 
matter lesions were distinguished into the deep subcortical and those in 
the periventricular region (Figure 1). The number of deep subcortical 
white matter lesions was counted on hard copy according to their largest 
diameter in categories of small «3 mm), medium (3-10 mm) or large 
lesions (> 10 mm). In order to calculate a deep subcortical white matter 
lesions volume, the white matter lesions were considered to be spherical 
with a fixed diameter per size category. Periventricular white matter 
lesions were scored semi-quantitatively per region (adjacent to the frontal 
horn or frontal capping, adjacent to the lateral wall of the lateral 
ventricles or bands and adjacent to the occipital horn or occipital capping) 
at a scale ranging from 0 (no white matter lesions), 1 (pencil-thin 
periventricular lining), 2 (smooth halo or thick lining) to 3 (large confluent 
white matter lesions). Total severity of periventricular white matter lesions 
was calculated by adding up the scores of the three separate categories 
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(range 0-9). All MRI scans were examined by two raters from a pool of four 
experienced raters. In case of a disagreement of more than one point, a 
consensus reading was held; in all other cases the average of the two 
readers was calculated. Inter- and intra-rater studies showed a good to 
excellent agreement. Weighted kappas were calculated with respect to 
scoring of the periventricular white matter lesions (weighted kappa 
between 0.79-0.90). Intraclass correlation coefficients were calculated for 
deep subcortical white matter lesions (r2 = 0.88 for total volume of deep 
subcortical white matter lesions). 
To assess the relationship between vasomotor reactivity and presence 
of white matter lesions, age and sex adjusted logistic regression was used. 
In these analyses vasomotor reactivity was used as a continuous variable 
and white matter lesions were dichotomized at the upper quintile. All 
analyses were performed using BMDP statistical software.22 To detect a 
possible threshold, the association between tertiles of vasomotor reactivity 
and extent of white matter lesions was assessed using age and sex 
adjusted linear regression. 
Results 
Combined TCD and MRI data were obtained in 73 individuals (91 %). The 
other individuals had either window failure on both sides (n=4) or dif-
Table 1 
Baseline characteristics from the study population and The Rotterdam Study. 
Study population 
N=73 
Age (years) 70.2 (8.0) 
Sex (men) 74 
Ankle-brachial-index 1.2 (0.02) 
Systolic blood pressure (mmHg) 138 (21.5) 
Diastolic blood pressure (mmHg) 74(11.5) 
Hypertension 41 
Diabetes 5 
History of myocardial infarct 12 
History of stroke 3 
History of peripheral arterial diseaset 7 
Values represent means (SO) or percentages 
NS = non significant 
* pvalue was calculated performing analysis of co-variance 
Rotterdam Study 
N=7123 
72.8 (8.0) 
41 
1.1 (0.003) 
139 (21.4) 
74(11.5) 
45 
8 
11 
3 
11 
t Peripheral arterial disease was defined as ankle-brachial-index < 0.9 
pvalue 
0.003* 
<0.0001 * 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
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ficulties wearing the dose-fitting mask (n""3). MRI examination was 
tolerated well. Mean age of the study population was 70.2 years and 74% 
of all individuals were men. Except for age and sex, vascular risk factors 
were equally frequent in The Rotterdam Scan study as in The Rotterdam 
Study as a whole (Table 1). Mean vasomotor reactivity was 3.4 %/mmHg 
and ranged from 0.8-6.3%/mmHg with a normal distribution. A corre-
lation coefficient of 0.94 was found between right and left vasomotor reac-
tivity. Women tended to have a lower vasomotor reactivity than men: 
mean 3.0 versus 3.6%/mmHg (p=0.4). Sixty-eight percent of the indi-
viduals had at least some periventricular white matter lesions and 86% at 
least some deep subcortical white matter lesions. Fifty-seven percent of 
the individuals had peri ventricular white matter lesions adjacent to the 
lateral ventricular wall (bands). 
Vasomotor reactivity was inversely associated with severe deep 
subcortical and total periventricular white matter lesions (OR 0.5; 95%CI 
0.3-l.1 and OR 0.7; 95%CI 0.4-l.1 per 10% vasomotor reactivity, 
respectively). Figure 2 shows that individuals with higher vasomotor 
reactivity had a significantly lower mean score of total periventricular 
white matter lesions (p=0.01). As shown in Figure 3, individuals with 
higher vasomotor reactivity had also a significantly lower mean score of 
total deep subcortical white matter lesions volume (p=0.02). 
Table 2 gives the mean score of white matter lesions in each 
peri ventricular region per tertile of vasomotor reactivity and provides the 
mean scores for deep subcortical white matter lesions for each size in the 
different vasomotor reactivity groups. Individuals in the lowest tertile of 
vasomotor reactivity were found to have the highest mean score of white 
matter lesions in all three periventricular regions, whereas individuals in 
Table 2 
The association between cerebral vasomotor reactivity (VMR [%/mmHg]) and white 
matter lesions (WMl) per region (periventricular) and per size (deep subcortical).* 
VMR<2.7 VMR 2.7-3.7 VMR>3.7 pt 
frontal capping 0.9 (0.13) 0.4 (0.13) 0.6 (0.13) 0.06 
occipital capping 0.8 (0.14) 0.5 (0.14) 0.4 (0.14) 0.13 
bands 1.2(0.13) 0.6 (0.13) 0.6 (0.13) 0.001 
large deep subcortical WMl 1.2 (0.3) 0.5 (0.3) 0.2 (0.3) 0.02 
medium deep subcortical WML 0.3 (0.08) 0.3 (0.08) 0.2 (0.08) 0.20 
small deep subcortical WMl 0.1 (0.02) 0.06 (0.02) 0.06 (0.02) 0.03 
* Values represent mean score (SE) of periventricular and mean volume (SE) [mI.] of 
deep subcortical white matter lesions and are adjusted for age and sex. 
t p values were calculated in a test for trend. 
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Figure 2 
The association between 
tertiles of cerebral vasomotor 
reactivity (%/mmHg) and 
mean total score (SE) of 
periventricular white matter 
lesions, adjusted for age and 
sex . 
Figure 3 
The association between 
tertiles of cerebral vasomotor 
reactivity (%./mmHg) and 
mean volume (SE) of total 
deep subcortical white 
matter lesions (mI.). adjusted 
for age and sex. 
the highest terti Ie of vasomotor reactivity had the lowest mean score. The 
inverse association between vasomotor reactivity and white matter lesions 
seemed strongest with peri ventricular white matter lesions adjacent to the 
lateral ventricular wall (p=O.OOI). Better vasomotor reactivity was 
associated with less deep subcortical lesions, irrespective of the size of the 
lesions. 
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Discussion 
This is the first study to show an association between vasomotor 
reactivity, assessed by means of CO2-enhanced transcranial Doppler, and 
the presence and extent of white matter lesions in a population based 
study aJIlong elderly individuals. The results suggest that vasomotor 
reactivity is inversely associated with white matter lesions in the 
peri ventricular as well as in the deep subcortical regions. A strong 
association was found between impaired vasomotor reactivity and 
peri ventricular white matter lesions adjacent to the lateral ventricular 
wall (bands) in particular. 
There are few reports on the relationship between magnetic 
resonance white matter lesions, cerebral blood flow and the subject's 
ability to increase cerebral blood flow in response to hypercapnia. Most 
investigators have found no significant changes in resting cerebral blood 
flow in individuals with asymptomatic peri ventricular white matter 
lesions,23,24 although one study with positron emission tomography 
showed that in such patients cerebral blood flow was low compared to the 
oxygen requirements of the (surrounding) healthy brain.25 Others have 
found decreased cerebral blood flow values in areas of white matter 
lesions compared to areas with normal white matter. 23,25-27 For the 
detection of reductions in cerebral perfusion, measurements of resting 
cerebral blood flow alone may be insufficient. Cerebral perfusion may only 
be impaired in situations where there is increasing demand, due to failure 
of normal compensatory mechanisms. This can be estimated by the 
determination of vasomotor reactivity that provides a more sensitive 
hemodynamic index than the level of resting blood flow. 12 
In one study with asymptomatic individuals, the severity of 
periventricular white matter lesions was significantly and negatively 
correlated with a decrease in vasomotor reactivity and not with resting 
cerebral blood flow, which led the authors to suggest that the reduction of 
vasomotor reactivity is a more important hemodynamic marker in the 
pathogenesis of peri ventricular white matter lesions than is a decrease in 
the level of resting blood flOW. 19 This inverse association between a 
decrease in vasomotor reactivity and the severity of white matter lesions 
was subsequently found in hypertensive patients with leukoaraiosis.2o 
In our study, we found an increased mean score of periventricular 
white matter lesions, as well as an increase in severe deep subcortical 
white matter lesions volume in individuals with the lowest vasomotor 
reactivity scores. A strong and inverse association was found between low 
vasomotor reactivity and bands which suggests that periventricular 
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regions adjacent to the lateral ventricle wall harbor a circulatory 
borderzone and may have less microcirculatory anastomoses than the 
other periventricular zones. The relationship between cerebral 
hemodynamics and white matter lesions has not been fully explored. 
Hypoxia-ischemia, disturbances in the circulation of the cerebrospinal 
fluid and changes in the permeability of the blood brain barrier to 
macromolecules are thought to play an important role in the pathogenesis 
of white matter lesions.7 Several arguments support the hypothesis that 
some types of white matter lesions may be the result of ischemic injury to 
the brain.7"lo The region of the white matter immediately adjacent to the 
lateral ventricular walls receives its blood supply from the ventriculofugal 
vessels arising from the subependymal arteries, which originate either 
from the choroidal arteries or from terminal branches from the 
lenticulostriatal arteries,?·25 Anastomoses between the vessels originating 
at the surface as well as those branching off the subependymal system 
are either scarce or absent, leading to a minimal overlap between the 
territories of the different end arteries. 28"31 This pattern of vascularization 
suggests that the periventricular white matter harbors an arterial 
borderzone, particularly susceptible to injury from systemic or focal 
decreases in cerebral blood flow,7,32 although this has been challenged by 
others. 33-35 Hypoperfusion can result either from arteriolosclerotic 
changes affecting the small intraparenchymal arteries and arterioles that 
are associated with aging and with stroke risk factors,7,32,36,37 or by 
hemodynamic mechanisms in case these arteries are already maximally 
dilated, for instance in high grade carotid artery stenosis or occlusion, in 
which cerebral perfusion can become directly dependent of the systemic 
arterial blood pressure. This may explain the inability to increase focal 
blood flow in response to hypercapnia in these individuals. In the former, 
a drop in blood-pressure may result in hypoperfusion and ischemic 
changes to the deep white matter. It is very unlikely that high grade 
internal carotid artery stenosis contributes to our findings. Data on the 
prevalence of significant stenosis or occlusion of the carotid artery in a 
non-hospitalized elderly population are limited, but results from the 
Rotterdam Study show a prevalence of about 0,5-1.0%,38 We therefore 
consider it unlikely that this will affect the association we found. An 
association between white matter lesions and atherosclerotic 
abnormalities in the carotid artery, the coronary arteries and in the 
peripheral vessels has already been established.'9 It is still unclear 
however, how different types of ischemia may induce selected structural 
changes of the white matter. We did not determine systemic blood 
pressure. Although systolic and diastolic blood pressure rise during a 
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period of hypercapnia, it is still unclear whether and how this affects flow 
velocity in the cerebral arteries. 
Future studies should elucidate the clinical and pathogenetic 
relevance of vasomotor reactivity in individuals with white matter lesions. 
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Abstract 
Apolipoprotein E genotype and 
cerebral white matter lesions 
Background Cerebral white matter lesions are frequently observed on cerebral 
MRI scans of both non-demented and demented elder/y people, Cardiovascu-
lar risk faclors are major determinants of these lesions. They have been associ~ 
ated with cognitive impairment, Few studies investigated the relations between 
white matter lesions and the different APOf genotypes, A 1.5 times increase in 
risk for white matter lesions among APOf*4 carriers has been repartee/, but 
other results are inconsistent, As the presence of this allele increases the risk for 
cognitive decline and dementia, especially in the presence of atherosclerosis, 
white matter lesions might be intermediate factors in this association. We stud-
ied the association between the APOf genotype and whlfe matter lesions, 
Methods In 1995-1996 we randomly sampled 568 subjects, aged 60-90 years, 
from the Rotterdam Study In 545 participants APOf genotyping was done, all 
of whom also subjects underwent 1,5T MRI-scanning; whlfe matter lesions were 
rated for the periventricular and subcortical regions separately 
Results Subjects with the APOf2f4 genotype had the highest volume of subcor-
tical white matter lesions and the highest mean grade of periventricu/ar white 
matter lesions (2.6 ml,' Sf 0,9 and 41; Sf 0,6, respectively). For subjects with an 
APOf*4 allele compared to the APOf3f3 carriers these figures were 2.2 ml. (Sf 
0,2) versus 1,6 ml. (Sf 0,2); p <0,05), and 2.9 (Sf 0.2) versus 2.7 (Sf 0.2); 
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p=D.26), respectively Subjects wilh the APOE2E4 genotype had twice as often 
severe subcortical white matter lesions and almost seven times as often severe 
periventricular while mailer lesions as subjects with the APOE3E3 genotype (RR 
2.0.; 9S%C/ D.S-8.7 and RR 6.8; 95% 1.8-25.5, respectively). Participants with an 
APOE*4 allele had a borderline significantly increased risk for having severe 
subcortical as well as periventricular while mailer lesions (RR 1.5, 9S%C/ 0.9-2.5 
and RR 1.5, 95%C/ 0..9-2.5, respectively) compared with APOE3E3 carriers. Ad-
justment for vascular risk factors and atherosclerosis did hardly change the 
magnitude of the associations. 
Conclusion Among carriers of the A POE *4 allele there was an increased risk for 
severe white matter lesions. 
Introduction 
White matter lesions are a common finding on magnetic resonance imag-
ing (MRI) scans of elderly non-demented as well as demented people l .3 
These lesions can be distinguished in periventricular and subcortical 
white matter lesions, on the basis of their location. There is increasing 
evidence that white matter lesions play an important role in the develop-
ment of cognitive decline and dementia. 3-6 To date, there is only a single 
study that addressed the role of the apoliprotein E genotype (APOE) on 
white matter lesions. 7 In addition, Schmidt et al investigated the associa-
tion between the APOE genotype on the one hand and rnicroangiopathy 
related cerebral damage, a plethora of brain abnormalities including white 
matter lesions and lacunar infarcts on the other.8 They found that carri-
ers of the APOE2E3 allele had more often microangiopathy related cere-
bral damage than APOE3E3 carriers8 Both studies reported a non-sig-
nificant increase in risk for white matter lesions in carriers of the APOE*4 
genotype. 
The APOE*4 allele of the gene is associated with an increased risk of 
cognitive decline and dementia, in particular in the presence of athero-
sclerosis 9 The factors through which the APOE*4 allele increases the risk 
for cognitive decline and dementia is not known, though it is suggested 
that cerebral white matter lesions are involved. lO 
Apolipoprotein E (ApoE) plays a crucial role in the transport of lipopro-
teins, but also has anti-oxidant and anti-inflammatory capacities, and is 
involved in neuronal outgrowth. ll ,16 ApoE serum levels are fully deter-
mined by the apolipoprotein E gene (APOE), which has three alleles, 
APOE*2, APOE*3 and APOE*4. 
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Our objective was to study the role of the APOE genotype on the 
presence of cerebral white matter lesions in the Rotterdam Scan Study. 
Methods and subjects 
Study population 
This study is based on the Rotterdam Scan Study, designed to study de-
terminants and cognitive consequences of age related brain abnormalities 
in the elderly. The study comprises random samples of two large popula-
tion based studies, the Rotterdam Study and the Zoetermeer Study. The 
present study deals with participants from the Rotterdam sub-population. 
This study has been described in detail elsewhere." In short, the Rotter-
dam Study is a prospective population based cohort study among 7983 
subjects, aged 55 years and over in which studies of neurological, oph-
thalmological, cardiovascular and locomotor diseases (baseline data col-
lection 1990-1993) are performed. In 1995-1996, a sample of 837 sub-
jects aged between 60-90 years was randomly selected in strata of age (5 
years) and sex; 568 of them underwent MRI scanning as part of the Rot-
terdam Scan Study (response 68%). The study was approved by the medi-
cal ethics committee of the Erasmus University. Each subject signed an 
informed consent form. 
APOE genotyping 
APOE genotyping was done on coded genomic DNA samples, without 
knowledge of the white matter lesions rating. The apolipoprotein E gene 
was amplified by means of the primers and amplification conditions de-
scribed by Wenham et al. 18 The results were read by three raters inde-
pendently; in case of discrepancies the APOE genotyping was repeated. 
Measurement of covariates 
Height and weight were measured without shoes in light clothing. The 
body-mass-index was calculated as weight divided by height square. 
Blood pressure was measured two times on the right arm by means of a 
random zero sphygmomanometer, with the participant in sitting position. 
The average of these two measurements was used. As an indicator of ath-
erosclerosis the ankle-to-brachial index was evaluated by measurement of 
the blood pressure of the tibial artery using a 8 MHz continuous wave 
Doppler probe (Huntleigh 500D, Huntleigh Technology, Bedfordshire, UK) 
and for the brachial artery -with a random zero sphygmomanometer, the 
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participant being supine. The ankle-to-brachial index was defined as the 
systolic blood pressure measured at both the left and right posterior tibial 
artery divided by the systolic blood pressure of the right arm. Subjects 
with an ankle to brachial index below 0.9 were considered to have periph-
eral arterial disease. 19 ,20 Diabetes mellitus was considered present if the 
participant was taking oral anti-diabetics or insulin. 
MRI Scanning protocol 
In all participants an axial Tl, T2 and Proton Density (PD) weighted cere-
bral MRI scan was made on a I.ST MR VISION (Siemens, Erlangen, Ger-
many). The following pulse sequences were applied at the VISION: Tl (TR 
700 ms, TE 14 ms), T2 (TR 2200 ms, TE 80 ms) and PD (TR 2200 ms, TE 
20 ms) Slice thickness was S mm with an inter-slice gap of 20.0%. The 
images were printed on hard copy with a reduction factor of 2.7. 
White Matter lesions Rating Scale 
White matter lesions were considered present if these were hyper-intense 
on both PD and T2 weighted images and not hypo-intense on Tl weighted 
images. White matter lesions were distinguished into those in the subcor-
tical and peri ventricular region. The number and size of subcortical white 
matter lesions was rated on hard copy according to their largest diameter 
in categories of small «3 mm), medium (3-10 mm) or large lesions (>10 
mm). In order to calculate the volume of subcortical white matter lesions 
on hard copy, they were considered to be spherical with a fixed diameter 
per size category. Periventricular white matter lesions were rated semi-
quantitatively per region: adjacent to the frontal horns (frontal capping); 
adjacent to the lateral wall of lateral ventricles (bands), and adjacent to 
the occipital horns (occipital capping), on a scale ranging from 0 to 3. The 
overall degree of periventricular white matter lesions was calculated by 
adding up the scores for the three separate categories (range 0-9). All MRI 
scans were examined by two raters from a pool of four experienced raters. 
In case of a disagreement of more than one point, a consensus reading 
was held; in all other cases the readings of both readers were averaged. 
The inter- and intra-rater studies showed a good to excellent agreement. 
Weighted kappas for grading the periventricular white matter were be-
tween 0.79-0.90. For total subcortical white matter volume the inter- and 
intra-rater intra-class correlation coefficient was 0.88 and 0.95, respec-
tively. 
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Data analysis 
Mean volume of subcortical and mean grade of periventricular white 
matter lesions were calculated for each APOE genotype by age and sex 
adjusted analyses of covariance. Since there is evidence that in particular 
severe white matter lesions are associated with cognitive impairment we 
investigated the relation between the APOE gene and severe white matter 
lesions by means of age and sex adjusted logistic regression with the 
presence of severe white matter lesions as the dependent variable. I ,3 The 
APOE genotypes were entered in the model as dummy variables, with the 
APOE3E3 genotype as the reference group. White matter lesions were di-
chotomized at the upper quintile. 
Since previous studies investigated the effect of the APOE*4 gene on 
white matter lesions and because of the suggested synergism between 
white matter lesions and APOE*4 on the occurrence of dementia the pre-
vious analyses were done again for carriers of an APOE*4 allele 
(APOE2E4, APOE3E4 and APOE4E4) compared to the APOE3E3 group. 
Participants with and APOE2E2 and APOE2E3 genotype were excluded 
from these analyses. To study the association between APOE and white 
matter lesions irrespective of possible intermediate vascular factors addi-
tional adjustments were made for systolic and diastolic blood pressure, 
the body-mass-index, presence of diabetes mellitus and presence of pe-
ripheral arterial disease. The association was calculated as the relative 
risk (RR), as estimated by the odds ratio, and was presented with a 95% 
confidence interval (95% CI). 
Results 
DNA for Apolipoprotein E genotyping was available for 545 subjects of the 
568 participants. The distribution of the APOE genotype was in Hardy-
Weinberg equilibrium (Xdf~3~1.1, p~0.77). 
Table 1 presents the characteristics of the study population. Mean 
age of the participants was 73.6 years (SD 7.9); 49% were women. These 
figures were similar for all APOE genotypes. Subjects with the APOE2E2 
genotype (n~4) had a considerably higher prevalence of peripheral arterial 
disease (50.0%) than the others (about15%). With respect to the other 
characteristics no major differences were observed between the several 
APOE genotypes. Of all participants 20% were without periventricular 
white matter lesion and 8% without subcortical white matter lesions. 
Su bjccts with the APOE2E4 genotype had the highest volume of sub-
cortical white matter lesions and the highest mean grade of periventricu-
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Table 1 
Characteristics of the study population 
Number of subjects 
Mean age 01 follow-up (yrs) 
Women (%) 
Body Mass Index (kg/m2) 
Diabetes Mellitus (%) 
Systolic BP (mm Hg) 
Diastolic BP (mm Hg) 
Ankle-to-brachial index 
Peripheral arterial disease (%)t 
545 
73.6 (7.9) 
49.2 
26.3 (3.5) 
6.4 
146.2 (20.5) 
76.5 (11.5) 
1.1 (0.2) 
17.3 
* Values are unadjusted means (SO) or per-
centages. 
t Defined as an ankle-to-brachial index below 
0.9. 
lar white matter lesions 
(2.6 ml; SE 0.9 and 4.1; 
SE 0.6, respectively; table 
2) compared with the 
other APOE genotypes. 
Participants with at least 
one APOE*4 allele had a 
significantly increased 
volume of subcortical 
white matter lesions com-
pared to the APOE3E3 
carriers (2.2 m!. (SE 02) 
versus l.6 m!. (SE 0.2); P 
=0.025), whereas the 
mean grade of periven-
tricular white matter le-
sions was not significantly different for the two groups (2.9 (SE 0.2) 
versus 2.7 (SE 2.0); p=0.26). 
Table 3 presents the associations between severe white matter le-
sions and each APOE genotype. Subjects with the APOE2E4 genotype had 
the highest risk for severe subcortical and periventricular white matter 
lesions (RR 2.0; 95%CI 0.5-8.7 and RR 6.8; 95% l.8-25.5, respectively) as 
compared to APOE3E3 carriers. Adjustment for vascular risk factors such 
as systolic and diastolic blood pressure, diabetes mellitus, body-mass-in-
dex, and peripheral arterial disease, did not appreciably change the mag-
nitude of the associations. Participants with at least one APOE*4 allele 
had a borderline significantly increased risk for having both severe sub-
cortical and periventricular white matter lesions (RR l.5; 95%CI 0.9-2.5 
and RR l.5; 95%CI 0.9-2.5, respectively). 
Discussion 
We found that individuals with the APOE2E4 genotype had, on average, 
more subcortical and periventricular white matter lesions than subjects 
with other APOE genotypes. In addition they were at the highcst risk for 
severe subcortical as well as severe periventricular white matter lesions. 
Carriers of at least one APOE*4 gene had a significantly higher volumes of 
subcortical white matter lesions and a borderline significantly increased 
risk for both types of severe white matter lesions. 
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Table 2 
The relation between the APOE genotype and the mean volume of cerebral white matter lesions. 
Apolipoprotein E E2E2 E2E3 E2E4 E3E3 E3E4 E4E4 E4+ (n~4) (n~60) (n~12) (n~321) (n~137) (n~ 11) (n~160) 
Subcortical white matter lesions* 
Adjusted for age and sex 1.2 (1.5) 1.9 (0.4) 2.6 (0.9) 1.6 (0.2) 2.2 (0.3) 1.2 (0.9) 2.2 (0.2)' 
Adjusted for age, sex and vascular risk factorst 0.4 (1.7) 1.8 (0.4) 2.3 (0.9) 1.4 (0.2) 2.1 (0.3) 1.1 (0.9) 2.1 (0.2)' 
Periventricular white matter Jesions* 
Adjusted for age and sex 2.3 (1.0) 3.0 (0.3) 4.1 (0.6) 2.7 (0.1) 2.8 (0.2) 2.6 (0.6) 2.9 (0.2) 
Adjusted for age, sex and vascular risk factorst 1.6 (1.1) 2.9 (0.3) 3.9 (0.6) 2.6 (0.1) 2.7 (0.2) 2.5 (0.6) 2.8 (0.2) 
* Values represent mean volume for subcortical lesions or the mean grade for periventricular lesions and the standard error. 
t Vascular factors including systolic and diastolic blood pressure, body-moss-index, diabetes mellitus and presence of peripheral arterial disease. 
1: p < 0.05, with APOE3E3 as the reference group. 
Table 3 
The relation between the APOE genotype and the presence of severe cerebral white matter lesions (RR and 95% CI). 
Apolipoprotein E E2E2 E2E3 E2E4 E3E3 E3E4 E4E4 E4+ (n~4) (n~60) (n~12) (n~321 ) (n~137) (n~ll) (n~ 160) 
Subcortical white matter lesions* 
Adjusted for age and sex 1.0 (0.1-10.8) 1.4 (0.7-2.9) 2.0 (0.5-8.7) 1.0 (ref) 1.5 (0.9-2.6) 1.4 (0.3-7.0) 1.5 (0.9-2.5) 
Adjusted for age, sex and vascular risk factorst 1.4 (0.7-2.9) 1.7 (0.4-7.5) 1.0 (ref) 1.5 (0.9-2.6) 1.0 (0.1-8.4) 1.5 (0.9-2.5) 
Periventricular white matter lesions* 
Adjusted for age and sex 0.8 (0.1-8.8) 1.1 (0.5-2.3) 6.8 (1.8-25.5) 1.0 (ref) 1.3 (0.7-2.1) 2.1 (0.5-9.2) 1.5 (0.9-2.5) 
Adjusted for age, sex and vascular risk factorst 1.2 (0.6-2.5) 6.6 (1.7-24.8) 1.0 (ref) 1.3 (0.8-2.2) 2.0 (0.4-10.3) 1.4 (0.9-2.4) 
* Dichotomized at the upper quintile of the severity distribution of white matter lesions. 
Vascular factors including systolic and diastolic blood pressure, body-moss-index, diabetes mellitus and presence of peripheral arterial disease. 
Not calculated due to small numbers. 
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Some methodological issues need to be considered. Our study was 
population based, but some selection bias may have occurred due to non~ 
response. Most likely, the participation rate was lowest among subjects 
with the highest degree of white matter lesions. Besides this, since par-
ticipants with an APOE'4 allele convey the highest risk for dementia and 
since only non-demented persons were included in the study, APOE*4 
carriers may have been underrepresented. Another potential source of 
bias is survival bias, but recent findings from the Rotterdam Study sug-
gested that survival is not different across APOE genotypes. 2 ! In addition, 
the distribution of the APOE genotype was in Hardy-Weinberg equilibrium 
in our population. Therefore we consider it unlikely that either selection 
bias or survival bias has influenced our findings. 
It may be that atherosclerosis is an intermediate factor in the asso-
ciation between the APOE genotype and white matter lesions. That is, 
APOE might be a determinant of atherosclerosis, and atherosclerosis in 
turn might be a determinant of white matter lesions. However, recent 
studies fou nd no association between the APOE*4 allele and atherosclero-
sis,:n whereas the association between indicators of atherosclerosis and 
white matter lesions is well established. 1,23 Indeed, in our analysis ad-
justing for atherosclerosis and other vascular factors did not change the 
magnitude of the association between APOE*4 and white matter lesions, 
suggesting that atherosclerosis is not an intermediate factor in this asso-
ciation. 
Schmidt et al. reported an odds ratio of 3.0 for the association be-
tween carriers of the APOE2E3 allele and micro angiopathy related cere-
bral damage. We can not confirm this association in our study. However, 
a difficulty in comparing the findings of Schmidt et al with our findings is 
that their definition microangiopathy-related cerebral damage included 
not only white matter lesions but also lacunar infarcts. Among individuals 
with the APOE2E4 genotype we found tvvice as often severe subcortical 
white matter lesions and almost seven times as often severe periventricu-
lar white matter lesions than in subjects with tlie APOE3E3 genotype. We 
consider it unlikely that tlie APOE*4 allele alone is responsible for this 
association, because then we would expect to find an even higher asso-
ciation for the APOE4E4 carriers with white matter lesions. On the other 
hand, Slooter et al showed a protective effect of the APOE'2 allele for ath-
erosclerosis and dementia, 21.24 both of which have been positively related 
to white matter lesions. This makes it unlikely that the APOE*2 allele is 
responsible for the increased risk for white matter lesions in individuals 
with the APOE2E4 genotype. Perhaps it is a chance finding. 
Our finding of a 1.5 times increase in risk for white matter lesions in 
carriers of the APOE'4 allele is in line with previous studies.7,8 That the 
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observed association was not statistically significant may be the result of 
the relatively small sample size, In a larger study, including over 3000 
persons, a significant relation was found, with the same risk estimate. 7 It 
is not known how the APOE*4 allele influences the presence of white 
matter lesions. A possible explanation may be an impairment of neuronal 
repair. 15,16,25 Neuronal repair is an important process in restoring the in-
tegrity of the brain in response to injury, for example after a period of is-
chemia. Animal studies have shown that chronic hypo-perfusion of the 
white matter can result in white matter lesions.26 Individuals with an 
APOE'4 allele may be at increased risk for white matter lesions because of 
this impaired response to cerebral injury, and this in turn may underlie 
the observed association between APOE*4 and the risk for dementia 10,24 
In conclusion, we found among carriers of the APOE*4 allele a sig-
nificantly increased volume of the subcortical white matter lesions, espe-
cially in those with an APOE2E4 genotype. Subjects with the APOE2E4 
genotype also had the highest degree of periventricular white matter le-
sions. It may be that this association explains, at least in part, the in-
creased risk for carriers of the APOE*4 gene for cognitive decline and de-
mentia that was found by others. Prospective follow up studies, with the 
use of neuTo-imaging, are needed to clarify the possible interaction be-
tween APOE, white matter lesions and consequent cognitive decline and 
dementia. 
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General discussion 

General discussion ) 
This thesis describes frequency and risk factors of cerebral white mat-ter lesions in the general population, It is based on data from the 
Rotterdam Scan Study, a prospective population based study on determi-
nants and consequences of age related brain changes among 1084 sub-
jects aged between 60-90 years. 
In this chapter, the main findings will be summarized with reference 
to the results from other studies, In addition general methodological as-
pects of the study will be discussed, Inference of the results from our 
studies will be made and there is a discussion on the possible clinical im-
plications of the presence of white matter lesions, Finally, recommenda-
tions for fu ture research will be made, 
Background 
White matter lesions are frequently found on cerebral magnetic resonance 
imaging scans of elderly non-demented and demented people. 1A They are 
considered to mainly reflect small vessel pathology, however their patho-
genesis remains unclear. Age, increasing diastolic and systolic blood pres-
sure levels and indicators of atherosclerosis have consistently been re-
ported as risk factors for white matter lesions, regardless of their loca-
tion,2-s There are many other, particularly vascular, risk factors that have 
been associated with white matter lesions; but the nature of these rela-
tions is unclear and they are not consistent throughout studies, 
There is growing evidence that white matter lesions play an impor-
tant role in the development of cognitive decline and dementia,4,6-8 The 
white matter can be distinguished into two separate anatomical regions, 
namely the periventricular white matter (a strip of white matter adjacent 
to the lateral ventricles) and the subcortical white matter (the white mat-
ter just underneath the gray matter), However, only a few studies distin-
guish these two locations and report on risk factors for lesions in these 
regions separately, whereas different risk factors may underlie white 
matter lesions at different locations.9 ,lD There is evidence that especially 
periventricular white matter lesions are related to cognitive decline,11,12 
whereas subcortical white matter lesions may be related with late-onset 
depression,12,13 It is therefore important to distinguish between these two 
locations. 
To date, the associations found are mainly from cross-sectional MRI 
studies among elderly people. However, the well-established risk factors 
hypertension and atherosclerosis already occur early in life, when the 
prevalence of white matter lesions is still low, In order to gain more in-
sight in the causation of white matter lesions a study with a long-follow-
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up would be very informative. In addition to this, many risk factors are 
more discriminative at lower age (when the prevalence of the risk factor is 
still low) than at higher ages. 
The studies presented in this thesis describe the association between 
vascular risk factors and white matter lesions in a longitudinal popula-
tion-based study among 1084 subjects, aged 60-90 years. The study was 
carried out in 1995-1996. 
Main Findings 
Frequency distribution of white matter lesions 
Of all participants 20% and 8% were completely free of peri ventricular or 
subcortical white matter lesions, respectively. This means that a vast 
majority of the elderly has white matter lesions to some extent. This is in 
agreement with findings from others who reported a prevalence ranging 
from 5 to 90 percent, depending on study design, study population and 
white matter lesions rating scales.2 -4 ,14-17 It may be more informative to 
describe the frequency distribution (range) of white matter lesions, be-
cause if almost every subject has white matter lesions one cannot identify 
a risk factor for those lesions, whereas one may find risk factors that in-
fluence the frequency distribution, i.e. which factors cause a shift upward 
or downward of the frequency distribution ([or example age in figure 1, 
chapter 2.2.). Our study confirmed findings by others of an increased 
prevalence and severity of white matter lesions among women. 2-4 We 
showed that this was mainly due to a significantly higher degree of sub-
cortical and periventricular white matter lesions in the frontal region. 
Risk Factors 
Blood pressure and hypertension 
Baseline and cross-sectional diastolic and systolic blood pressure level 
was significantly associated vvith the presence of both types of white 
matter lesions. We found about a 20% to 30% increased risk for the pres-
ence of white matter lesions per 10 mm Hg increase in both baseline and 
cross-sectional blood pressure level. Recent results from the NHLBI-study 
also reported a significant association between blood pressure levels 
measured about 30 years ago and white matter lesions. 18 To our know-
ledge there are no other studies with a follow up of this duration. The 
cross-sectional findings are in line vvith the associations others found. 2-4 
134 
General discussion I 
In addition we studied the presence of white matter lesions as a 
function of blood pressure change over time. We found about a doubled 
risk [or both types of white matter lesions in subjects with a decrease or 
increase in diastolic blood pressure of 10 mm Hg or more) over a 20 years 
period. There was no such relation for systolic blood pressure. This J-
shaped association between diastolic blood pressure and both types of 
white matter lesions was especially marked in subjects 'With a history of 
myocardial infarction, whereas this relation was linear in subjects 'Without 
a history of myocardial infarction. There was a linear relation between 
systolic blood pressure and white matter lesions) regardless of a history of 
myocardial infarction. To date) others have not described this relation. In 
accordance 'With our observations) other studies among elderly subjects 
suggested that both a low and high diastolic blood pressure are aSSOCI-
ated with increased risk of cardiovascular disease, in particular among 
subjects 'With preexisting heart disease. 19-22 
The relation between increasing level of blood pressure and white 
matter lesions was further extended to the relation with hypertension. 
When a risk factor is related to mortality, selective survival may affect the 
relation between this risk factor and an outcome. Indeed) we found that 
the risk estimates in the study population as a whole were biased and we 
showed that the most unbiased risk estimates are in the 60-70 years age 
category. In the cross-sectional analysis of the whole study population, we 
found an about two-fold increased risk for both types of lesions for sub-
jects with hypertension. This was very much in agreement with findings 
by Breteler et al and Liao et aI, who also reported an approximately two 
times higher risk for white matter lesions for subjects with hypertension. 2 , 
3 For subjects aged between 60-70 years we found that subjects with hy-
pertension had an almost five-fold increased risk for subcortical white 
matter lesions and an almost three-fold increased risk for subcortical and 
periventricular white matter lesions. yv-hen duration of hypertension was 
considered we found a sixteen- to twenty-fold increase in risk for periven-
tricular and subcortical white matter lesions respectively, if individuals 
had hypertension for more than 20 years. There are currently no studies 
that have addressed this topic. 
Indicators of atherosclerosis 
We investigated the association between mid-life or late-life aortic athero-
sclerosis and white matter lesions. Individuals who had already signs of 
aortic atherosclerosis on an abdominal X-ray during mid-life, had a two 
and a half fold increased risk for peri ventricular white matter lesions, 
whereas there was no relation with subcortical lesions. We also found 
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that the degree of mid-life aortic atherosclerosis predicts the severity of 
periventricular white matter lesions later in life in a dose dependent 
fashion. There was no relation between late-life aortic atherosclerosis and 
white matter lesions. 
In addition we investigated the association between indicators of ca-
rotid atherosclerosis (intima media thickness and the plaques) and white 
matter lesions, in a cross-sectional design. There was a relation between 
carotid atherosclerosis and periventricular white matter lesions, whereas 
this relation was less clear for subcortical white matter lesions. The rela-
tion between indicators of atherosclerosis and white matter lesions has 
also been examined by others,4,S who reported similar associations. 
We found a clear relation between current atrial fibrillation and the 
presence of periventricular white matter lesions, but not for subcortical 
white matter lesions. Subjects vvith atrial fibrillation had more than twice 
as often severe periventricular white matter lesions but not subcortical 
white matter lesions. Similar associations have been described by Ylikoski 
et al and Lindgren et al 9 ,10 In contrast to our findings, Ylikoski et al found 
this relation especially for subcortical white matter lesions and not for 
those in the peri ventricular region. This may be because of a difference in 
the white matter lesions rating scale between the studies. The maximum 
degree of periventricular white matter lesions was a nodular band in their 
rating scale, whereas subcortical white matter lesions extending deep in 
the white matter to the ventricles, were considered to be in the subcortical 
region. For this reason it may be that the most severe white matter le-
sions were allocated to different regions in the two studies; i.e. to the peri-
ventricular region in our study and to the subcortical region in the study 
of Ylikoski et al 9 
A high-risk subgroup with atrial fibrillation and left ventricular hy-
pertrophy had a seven-fold increased risk for periventricular white matter 
lesions, whereas for subcortical white matter lesions no such association 
was observed. 
Vasomotor reactivity reflects the ability of small cerebral arteries to 
dilate under the influence of certain stimuli, like carbon dioxide, in order 
to increase cerebral blood flow in case of increased demands. Atheroscle-
rosis may disturb the integrity and function of the arterial wall and 
thereby its capacity to dilate in reaction to these stimuli. We found a 30% 
to 50% reduced risk per 10% increase in vasomotor reactivity for the 
presence of periventricular and subcortical white matter lesions, respec-
tively. This finding was in agreement 'Nith others who reported impaired 
cerebral haemodynamics in subjects with white matter lesions.23"26 An-
other explanation may be that an impaired vasomotor reactivity is the 
1
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functional representation of the structural changes in the brain that white 
matter lesions are. 
Apolipoprotein E genotype 
Finally we examined the relation between the apolipoprotein E genotype 
and white matter lesions. To date, there is only a single study that ad-
dressed the possible role of the apolipoprotein E genotype (APOE) in white 
matter lesions.27 In addition, Schmidt et al investigated the association 
between the APOE genotype on the one hand and microangiopathy related 
cerebral damage on the other.28 It is well established that the APOE*4 al-
lele of the gene is associated with an increased risk of cognitive decline 
and dementia, possibly in particular in the presence of atherosclerosis.29 
How the APOE*4 allele increases the risk for cognitive decline and de-
mentia is not known, though it is suggested that cerebral white matter 
lesions are involved. 30 
When we did the analysis on all individuals with an APOE*4 allele 
(those with the APOE3E3 genotype forming the reference group) APOE*4 
carriers had a borderline significantly increased risk of 50% for both types 
of lesions. We found an about seven-fold and two-fold increased risks for 
carriers of the APOE2E4 allele for periventricular lesions and subcortical 
white matter lesions compared to APOE3E3 carriers respectively, whereas 
Schmidt et al found that carriers of the APOE2E3 allele had more often 
microangiopathy related cerebral damage than APOE3E3 carriers.28 We 
have no explanation for this discrepancy. Our finding of a one and a half 
time increased risk for white matter lesions in carriers of the APOE*4 al-
lele is in line with previous studies.27 ,28 That the observed association was 
not statistically significant may be the result of the relatively small sample 
size. This is supported by the results from a larger study, including over 
3000 persons, in which a significant relation, with the same risk estimate, 
was found. 27 
Methodological considerations 
There are two major issues that should be considered when a study is 
judged on its methodological merits, namely validity and precision. Valid-
ity deals with the generalizability (external validity) and the amount of 
bias (internal validity). There are three types of biases to be distinguished, 
namely selection bias, information bias and confounding. They will be 
discussed in the following sections. Precision deals with the amount of 
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random error in a study and is basically about the reproducibility of a 
study, and will be discussed after the section on validity. 
Selection bias 
A major threat to the validity of a study is selective nOD-response. Selec-
tion bias in a follow up study occurs if participation is related to the out-
come under study, in this case white matter lesions. 
However, direct quantification of the effect of selective non-response 
is difficult since the degree of white matter lesions is not known among 
non-responders. A general assumption is that associations between risk 
factors and an outcome are different in non-responders than in respond-
ers. An indirect way for assessing the effect of selective non-response is by 
comparing baseline risk factors for white matter lesions between respond-
ers and non-responders. In our study the overall response rate was 63%, 
and declined from 73% among subjects aged between 60-70 years to 48% 
among participants aged between 80-90 years in 1995-1996. The lower 
the response rate, the higher the potential for selection bias. Yet we found 
only small, mainly non-significant, differences with respect to baseline 
risk factors between responders and non-responders and this difference 
did not vary across the age-strata. 
Another source of selection bias is survival bias. Since we conducted 
a prospective study with a long follow-up period, a certain proportion of 
the baseline cohort will have died. How could this selective mortality affect 
the associations we found? Since cardiovascular disease is a major cause 
of death among the elderly we consider it likely that especially individuals 
with one or more cardiovascular risk factors would have died. This is in 
line with our observation of a lower baseline prevalence of hypertension in 
survivors than in those who had died before the follow up. This difference 
increased with age. Furthermore, even if individuals with cardiovascular 
risk factors had not died, one might assume that these risk factors were 
less severe or did not have such a deleterious effect on their cardiovascu-
lar and probably cerebrovascular system. Therefore one would expect that 
the association between a vascular risk factor and white matter lesions 
would be weak in the highest age category. This is supported by our 
findings. It is therefore likely that the most unbiased risk estimates are 
found in the lowest age category. In this age category we generally found 
the highest relative risks. especially in the Zoetermeer sub-population. 
Confounding 
Any association between a risk factor and an outcome variable may be 
attributable to another variable, which may not have been taken into ac-
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count, a so-called confounder. A confounder is associated with both the 
determinant and the outcome under study and is not an intermediate 
factor in the causal chain leading to the outcome variable under study. A 
way to deal with confounding in epidemiological studies is to control for it 
in the analysis. For example age was an important confounder in our 
study, because it had significant relations both with any risk factor we 
studied and with either type of white matter lesions. 
Since the risk factors we studied are closely related to atherosclero-
sis, the observed associations may be confounded by cardiovascular risk 
factors such as diabetes, body mass index and hypertension. Adjustments 
were made to control for possible confounding by these factors. Through-
out our studies adjustments for cardiovascular risk factors did not sig-
nificantly alter the observed associations between a risk factor and white 
matter lesions. This suggests that the associations described between the 
risk factors for white matter lesions described in this thesis cannot, or 
can only partly be attributed to confounding by other cardiovascular risk 
factors. This may possibly indicate that white matter lesions are inde-
pendently related to, and perhaps a consequence of, the risk factors de-
scribed. 
Information bias Misclassification of white matter lesions 
Misclassification can occur in the determinant, the confounder and the 
outcome and can be related or not be related to the outcome or determi-
nant (differential or non-differential). 
White matter lesions were rated by means of a specially designed 
rating scale and were distinguished into those in the periventricular and 
in the subcortical region. Our rating scale was much more sensitive than 
that used by many others, because each lesion, however small, was 
counted separately. Through double reading and extensive inter- and in-
tra-rater studies we attempted to minimize rnisclassification of the le-
sions. We cannot exclude the possibility that we could not always make 
the proper distinction with respect to periventricular or subcortical loca-
tion of the lesions, especially if white matter lesions were extensive. How-
ever, all readers were blinded to the results of the risk factors and the 
cognitive status. Any misc1assification would therefore be non-differential 
and would have biased our findings towards the null hypothesis. 
Information bias - Misclassification of the determinant 
An important methodological issue in this thesis is the validity of the 
measurements of the determinants. Differential error may occur when 
determinants are assessed differently among those with white matter le-
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sions and in those without. It is unlikely that this has happened in our 
study because data on determinants were already obtained before the as-
sessment of a MRI scan, and data collection can therefore by no means be 
related to the outcome. However, since perfect assessment of the determi-
nants is hypothetical, non-differential error is unavoidable to some extent. 
The major point of concern of random misc1assification is dilution of the 
association towards the null hypothesis. An important point in our stud-
ies is the validity of the various atherosclerosis measurements. As for the 
validity of radiographic assessment of aortic calcification for the diagnosis 
of atherosclerosis, it was shown in an autopsy study that radiographically 
detected aortic calcification represented true intimal atherosclerosis.31 On 
comparison with computed tomography it appeared that calcifications 
seen on the X-ray were located in the vessel wall in all cases.32 
Increased carotid intima-media thickness not necessarily reflects 
atherosclerosis. It may merely reflect an adaptation of the vessel wall in a 
response to changes in shear stress and tensile stress.33 However, in sev-
eral studies ultrasonographically detected increased carotid wall thick-
ness and its progression was found to be associated with cardiovascular 
risk factors. 34-36 These findings are in favor of the idea that increased ca-
rotid wall thickness, as detected by ultrasonography, reflects a valid 
measurement of atherosclerosis. 
All atherosclerosis indicators were based on single measurements. 
This may have led to misclassification. However, we consider it unlikely 
that such misclassification is related to the extent of white matter lesions; 
therefore it would have biased our findings towards the null hypothesis. 
Misclassification may also have occurred in the relation between 
atrial fibrillation and white matter lesions. We probably underdiagnosed 
the prevalence of atrial fibrillation since we only used a single IO-second 
resting ECG for the detection of rhythm disturbances. We therefore could 
not detect all episodes of paroxysmal atrial fibrillation. Findings by Mano-
lio et al indicate that 74% of all patients with atrial fibrillation identified 
during a 24-hour ambulatory ECG assessment are detected with a 10 
second ECG recording.37 Since this misclassification is not related to 
presence of white matter lesions and is therefore non-differential, it will 
only have reduced the strength of the association between atrial fibrilla-
tion and white matter lesions towards the null hypothesis. 
Precision 
Precision reflects the amount of random error in a given measurement 
and thereby affects reproducibility of that measurement. One way to in-
crease overall precision is to increase the precision of any single me as-
1
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urement; the other is by increasing the number of measurements. In 
Rotterdam Scan Study we dealt with this problem by measuring both the 
outcome and any determinant by means of validated procedures and by 
performing duplo measurements. 
Pathogenesis of white matter lesions 
Nowadays there are a few hypotheses about the development of age re-
lated white matter lesions, which are not mutually exclusive. One hypo-
thesis suggests an ischemic origin of white matter lesions. This explana-
tion is based on the associations found in epidemiological studies between 
vascular risk factors and white matter lesions. 2-4 It is also supported by 
experimental studies of cerebral ischemia in animals.38 ,39 The other hy-
pothesis suggests that white matter lesions are secondary to expansion of 
the cerebral ventricles and is based on the frequent finding of especially 
periventricular white matter lesions in subjects -with so called normal 
pressure hydrocephalus. 39•4o 
The first hypothesis is that white matter lesions are a consequence of 
cerebral ischemia, possibly caused by cerebral hypoperfusion. Current 
opinion is that (long-lasting) hypertension induces vessel wall alterations 
(arteriolosclerosis) leading to narro-wing of the vessel lumen, ultimately, 
resulting in white matter ischemia.:19,41,42 Thanks to the long follow-up in 
part of our study we had the unique opportunity to further explore this 
hypothesis and to identify some intermediate factors in the development 
of white matter lesions. 
If hypertension had been present for a period of more than 20 years, 
the relative risk for white matter lesions increased about 20-fold in the 
most unbiased age-stratum of the study popUlation, compared to normo-
tensive subjects. The pathophysiological process by which hypertension 
leads to disease is the induction of atherosclerosis and hypertrophy in the 
wall of large or small arteries.41 ,42 It is therefore plausible to argue that 
atherosclerosis may underlie the association between hypertension and 
white matter lesions. Indeed, we observed a dose-dependent relation be-
tween severity of aortic atherosclerosis, as measured 20 years ago, and 
white matter lesions in the Zoetermeer sub-population. We could not es-
tablish whether hypertension was the result of atherosclerosis or that this 
relation was the other way around, because the change of aortic athero-
sclerosis over time was not measured. However there are some clues from 
our study that support a primary role for atherosclerosis in the patho-
genesis of white matter lesions. The first of these is our finding of a J-
shaped relation between a change in diastolic blood pressure over a 20-
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year period and white matter lesions. This favors the involvement of ath-
erosclerosis in the pathogenesis of white matter lesions, because a J-
shaped association has also been reported for the progression of athero-
sclerosis as a function of change in diastolic blood pressure.32 Secondly, 
we showed an association between indicators of atherosclerosis and white 
matter lesions in the cross-sectional analyses. 
Another hypothesis was proposed because of a high prevalence of 
white matter lesions,43 especially in the periventricular region, in subjects 
with normal pressure hydrocephalus. There are basically two explana-
tions for this finding. One is that, despite the name of the disorder, peri-
ods of increased cerebrospinal fluid pressure occur in subjects vvith di-
lated ventricles through some disorder of cerebrospinal fluid circula-
tion,40,44 and that this raises the pressure in the surrounding periven-
tricular white matter. 4S The resulting ischemia leads to the pathological 
hallmarks of white matter lesions and the typical MRI picture of periven-
tricular white matter lesions. The other explanation is increased leakage 
of cerebrospinal fluid due to an impaired barrier function of the ependy-
mal lining of the ventricles. This results in leakage of cerebrospinal fluid 
into the surrounding tissue (i.e. the periventricular white matter). In this 
view, a second factor consists of alterations in the vessel wall caused by 
the earlier mentioned risk factors for white matter lesions (hypertension, 
atherosclerosis), that hinder reabsorption of this cerebrospinal fluid from 
the parenchyma. 46,47 However the issue is whether normal pressure hy-
drocephalus being a true cause or rather the consequence of white matter 
lesions. White matter lesions in the periventricular region may not only 
occur as a result of normal pressure hydrocephalus, but vvidening of the 
ventricles may also occur ex-vacuo as a result of white matter lesions. 
Until now it is not clear whether normal pressure hydrocephalus and es-
pecially periventricular white matter lesions should be considered as two 
different entities or that they linked in a single causal chain, in which it is 
debated which is the cause or which is the consequence. To my know-
ledge there is no evidence for a relation between normal pressure hydro-
cephalus and subcortical white matter lesions and our study has no data 
on this either. 
How can these findings be combined into a plausible explanation for 
the development of white matter lesions? A possible explanation might be 
that among persons with advanced atherosclerosis and hypertrophy of the 
vascular tree, often on the basis of longstanding hypertension, cerebral 
autoregulation is impaired.48 In healthy individuals the cerebral blood 
flow is maintained via the mechanism of autoregulation, which compen-
sates for a reduction or increase of blood pressure, across a certain 
range.48 As a result of the impaired autoregulation, the lower limit of 
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blood pressure at which the autoregulation still functions properly shifts 
towards a higher blood pressure level,48,49 so that even normal levels of 
blood pressure may result in hypoperfusion of the white matter in these 
persons, 50 This reduction of cerebral blood flow will primarily affect areas 
with an already marginal blood supply under physiological conditions, 
such as the subcortical and periventricular white matter.39,51,52 Indeed, an 
impaired autoregulation and a reduction of cerebral blood flow has been 
demonstrated in subjects with periventricular white matter lesions.25 ,26 
Although the cross-sectional design of the studies did not allow a conclu-
sion about the white matter lesions being a cause or a consequence of a 
reduction of cerebral blood flow. 
Another adaptive response to prevent the brain from hypoperfusion is 
the so-called vasomotor reactivity, which is based on the ability of the 
small arteries in the brain to dilate under the influence of chemical stim-
uli (mainly carbon dioxide), thereby increasing cerebral blood flow. 53 It is 
knovm that this response can be affected by atherosclerotic changes of 
the vessel wall. 54 It can be hypothesized that an impaired vasomotor re-
sponse can no longer compensate for a reduction of cerebral blood flow, 
presumably by the inability of the atherosclerotic arteriole to dilate any 
further. This may result in ischemia. The notion that (chronic) cerebral 
hypoperfusion may indeed playa role in the development of white matter 
lesions was confirmed by our finding of an inverse association between 
vasomotor reactivity and the presence of white matter lesions. 
Another indication that cerebral hypoperfusion may be involved in 
the pathogenesis of white matter lesions comes from our finding of a J-
shaped association between diastolic blood pressure and white matter 
lesions in subjects with a history of a myocardial infarction (representing 
advanced vascular disease), and not in those without. In contrast, in peo-
ple who have had a low diastolic blood pressure all their life the auto-
regulation is not impaired, and therefore they have a normal cerebral 
blood flow, even at a low blood pressure level. In our study those subjects 
indeed showed the lowest rate of white matter lesions. 
Further evidence for a role of cerebral hypoperfusion in the development 
of white matter lesions comes from the association between atrial fibrilla-
tion and white matter lesions, Subjects with this disorder have a reduced 
cardiac output." Especially among the elderly, who may already have a 
compromised cerebral circulation, this can lead to a reduction in cerebral 
blood flow. 55-57 Given that a reduced cerebral perfusion precipitates the 
development of white matter lesions we would expect an even higher risk 
for subjects with atrial fibrillation and left ventricular hypertrophy, in 
whom the circulation is even more compromised.55,58 Indeed we found an 
about seven fold increase in risk for those individuals. We considered the 
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possibility of white matter lesions being secondary to the formation of 
thrombi less likely, because in that case we would expect a stronger asso-
ciation between atrial fibrillation and white matter lesions among subjects 
with evidence of cerebral infarction on MRI scanning. 
Most associations we found were strongest for the periventricular 
white matter lesions, whereas this was less clear for the subcortical re-
gion, This suggests that different factors may underlie periventricular and 
subcortical white matter lesions, or at least that the periventricular region 
is more susceptible for a reduction in cerebral blood flow. The periven-
tricular white matter is an arterial border zone that is already marginally 
perfused under physiological circumstances, which makes it especially 
vulnerable by a decrease of cerebral blood flOW,25,39,52 In contrast, the 
subcortical white matter is not an arterial watershed area,59 though at 
high ages, the long penetrating arteries supplying the subcortical white 
matter undergo atherosclerotic changes, that may lead to a reduction in 
blood flow in that area, 50 
On the basis of our findings the following chain of events may be 
proposed for the development of white matter lesions. Long-lasting hy-
pertension gradually induces hypertrophic and degenerative changes in 
the vessel wall of the arterioles of the white matter. This results in im-
pairment of haemodynamic responses, i.e, cerebral autoregulation and 
vasomotor reactivity. During episodes of an increased demand for cerebral 
blood flow, no compensatory mechanisms are left anymore. This may lead 
to hypoperfusion and eventually to ischemia. If the periods of ischemia 
last too long, or occur too frequently, the myelin and axons degenerate, 
leading to the typical MRI picture of white matter lesions. 
Clinical implications 
A clinically relevant finding was our observation of a lower risk for both 
types of lesions in subjects -with an adequately treated hypertension (i,e, a 
systolic blood pressure below 160 mm Hg and a diastolic blood pressure 
below 95 mm Hg) than in individuals with uncontrolled hypertension. We 
suggested that our findings are consistent with the view that adequate 
treatment reduces the presence of both types of white matter lesions and 
may thereby also prevent or reduce the attendant cognitive impairment or 
dementia, 
These observations should be interpreted -with caution and may not 
apply to all elderly subjects. For persons -with overt cardiovascular disease 
it may be that the optimum achievable blood pressure is not necessarily 
synonymous -with the lowest diastolic blood pressure,19-22,60,61 This was 
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supported by our finding of a J~shaped association between a substantial 
decrease or increase in diastolic blood pressure and the risk for white 
matter lesions. This J-curve could be largely attributed to the subjects 
with a myocardial infarction. These findings are consistent with studies 
that reported a J~shaped association between diastolic blood pressure 
and the risk of cardiovascular disease among subjects with preexisting 
heart disease19-22 The clinical relevance of these findings may be that hy-
pertension should as a rule be treated in an elderly population, but low-
ering of the diastolic blood pressure to 'normal' values should be avoided 
in the high-risk group of elderly subjects with prevalent cardiovascular 
disease. 
Considering the high prevalence of both types of white matter lesions 
in the elderly and the serious clinical implications, it would be useful to 
identify individuals at risk for white matter lesions relatively early in life. 12 
We tried to investigate this by relating baseline data on atherosclerosis 
from the Zoetermeer Study (1975-1978) to the presence of cerebral white 
matter lesions later in life. We found that presence of aortic atherosclero~ 
sis during mid~life predicts white matter lesions in later life. This may in~ 
dicate that there is a long interval between the presence of aortic athero~ 
sclerosis and the emergence of white matter lesions. Any preventive inter-
vention should therefore preferably take place in the early stages of ath-
erosclerosis. 
Treatment 
The relation between hypertension or other vascular factors and white 
matter lesions is well established,2-4 as is the association between cogni-
tive impairment and white matter lesions. In addition, our study provides 
evidence for a relation between atrial fibrillation and white matter lesions. 
There arc clues that hypertension and atrial fibrillation are related to cog-
nitive impairment and dementia. 7 ,62-65 Our study and findings of the Car-
diovascular Health Study are consistent with the view that effective 
treatment of hypertension may reduce the risk for white matter Icsions. 3 
We could not investigate the effect of treatment of atrial fibrillation on the 
presence of white matter lesions in our study. 
Despite these observations, experimental research is the only method 
to establish a firm causal relationship between a certain determinant and 
its outcome. For some risk factors described in this thesis experimental 
research would be premature, but hypertension and atrial fibrillation may 
be good candidates for experimental research on their role in the devel~ 
opment of white matter lesions. Theoretically, a double blind randomized 
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trial on the effects of treatment of these particular risk factors would be 
the best design to study the causal links between hypertension or atrial 
fibrillation and the occurrence of white matter lesions. This design mini-
mizes the occurrence of bias (unknown confounders, confounding by in-
dication, blind assessment of outcome). However, such a trial would only 
be clinically acceptable and relevant if not merely the degree of white 
matter lesions was the measure of outcome, but rather cognitive perform-
ance. If any treatment would only reduce the risk of white matter lesions 
-without improving cognitive function, or prevent further impairment, 
treatment would not be a vvise thing to undertake. The notion of treat-
ment is supported by recent findings of the Syst-Eur investigators who 
found that treatment of isolated systolic hypertension reduced the inci-
dence of dementia.66 Although they did not provide any data On white 
matter lesions or other brain features, their findings make a randomized 
trial on the effect of anti-hypertensive treatment on white matter lesions 
superfluous and unethical, even apart from the beneficial effect on other 
organ system. An option to improve our knowledge on the understanding 
of the development of white matter lesions may be the inclusion of neuro-
imaging in new trials that study the effects of antihypertensive medication 
on vascular events in general. 
The same argument applies to atrial fibrillation. There are many 
studies on atrial fibrillation, its treatment and stroke.67 In those studies 
inclusion of a neuropsychological test battery and neuroimaging may pro-
vide more information about the nature of the relation between atrial fib-
rillation and cognitive impairment and dementia. 
Future research 
White matter lesions in the brain are a major challenge for medicine, 
since the prevalence of these lesions is very high among the elderly, and 
even severe white matter lesions are present in a considerable proportion 
of 'healthy' elderly subjects. It is getting more and more clear that these 
lesions are important in the development of cognitive decline and depres-
sion with a late-life onset. 12 Dementia represents the end stage of cogni-
tive impairment, occurring in relatively few people, whereas lesser degrees 
of intellectual handicaps are much more common. Yet these 'minor' cog-
nitive defects may seriously affect the quality of life. 
Since it is suggested that especially the more severe white matter le-
SIOns are related to cognitive impairmentll, 12 or depression 12, 13 it is of 
great importance to study risk factors that are associated with an in-
crease of severity of preexisting white matter lesions. Future prospective 
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studies should address these questions. Due to the cross-sectional design 
in the studies on white matter lesions thus far, risk factors of changes in 
the severity of white matter lesions have not been identified yet. 
As discussed before our study indicated the potential role of cerebral 
hypoperfusion in the pathogenesis of white matter lesions. Since in our 
study a relatively indirect indicator of cerebral perfusion, the vasomotor 
reactivity, was measured in only a small subset of 80 persons, the objec-
tive of a future study may be to assess the role of cerebral blood flow in 
the development of white matter lesions. In my opinion those measure~ 
ments should be carried out in a prospective way, whereas cross-sectional 
analyses seem of less value, because a reduction of cerebral blood flow in 
areas of white matter lesions are not surprising. Possible techniques 
would be the measurement of (regional) cerebral blood flow by means of 
perfusion measured with MRI techniques, single photon emission com-
puted tomography (SPECT), or positron emission tomography (PET). Our 
results suggested a sex difference in the frequency distribution of those 
lesions, and we suggested that a reduction of cerebral blood flow, possible 
by means of a reduction of estrogen levels in post-menopausal women, 
might underlie this association. This warrants further investigation. 
Our study has provided further knowledge on the risk factors for 
white matter lesions. Some risk factors we addressed can be modified, as 
suggested by our finding that effective treatment of hypertension can re-
duce the risk of white matter lesions, As discussed before it is particularly 
important to design a randomized clinical trial to properly investigate 
these questions. 
A common observation in our studies was that the associations were 
strongest in the age category from 60-70 years, especially if the risk factor 
under study was assessed 20 years ago (The Zoetermeer SUb-population). 
This is probably explained by selective mortality and a reduced discrimi-
native power of a risk factor at higher ages, as discussed before in this 
chapter. Future studies therefore should try to include people early in 
mid-life (30-40 years), or if that is not possible, collect data on risk factors 
on that period. This might be an effective strategy to detect people at risk 
for white matter lesions (and possibly for cognitive decline) relatively carly 
in life, thus opening the way for prevention or reduction of severity. A 
major drawback of this option is that it will take a long time before the 
outcome under study occurs. 
In addition, future studies should be large enough to identify specific 
sub-groups that may be at an increased risk for white matter lesions. Our 
study showed that subjects who had a decrease or increase of over 10 mm 
Hg in diastolic blood pressure had an increased risk for white matter le-
sions. It has been suggested that prevalent cardiovascular disease, or hy-
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pertension and its treatment play an important role in this J-curve. 
However, because of the small numbers in these particular subgroups we 
were not able to further address this topic. The same was true for sub-
jects with atrial fibrillation and left ventricular hypertrophy. They ap-
peared to have a greatly increased risk for white matter lesions, but the 
small numbers (n~7 among 1084 participants) did not allow further ex-
ploration of this association. 
Since the determinants for white matter lesions as hypertension and 
atherosclerosis interact in an intricate temporal framework a follow-up 
study is essential to disentangle the causal role of the risk factors we 
studied or to establish that they in turn are consequences of preceding 
factors. 
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Summary I 
This thesis describes the frequency distribution and the risk factors of cerebral white matter lesions. There is increasing evidence that these 
lesions playa role in the development of cognitive decline and dementia. 
These mental illnesses have an enormous impact on health care systems 
as a whole and for the individual affected, induding his or her relatives, 
especially in our aging societies. However, these lesions also frequently 
occur in healthy, non demented subjects, but to what extent is yet not 
clear. Early detection of persons at risk for these illnesses offers potential 
for early intervention and possible treatment of these disorders. Therefore 
the aim of this thesis was to investigate the frequency distribution and 
risk factors for white matter lesions in a healthy population of non-de-
mented elderly. The study was performed in the Rotterdam Scan Study. 
The Rotterdam Scan Study was designed to study determinants and 
consequences of age related brain abnormalities in the elderly. In 1995-
1996, 1904 subjects aged between 60-90 years were randomly selected in 
strata of age (5 years) and sex from two large ongoing prospective follow-
up cohort studies, the Zoetermeer Study and the Rotterdam Study. From 
1724 eligible subjects 1084 participated (response rate 63%). The Zoeter-
meer Study is a prospective population-based study among 10361 sub-
jects, aged between 5-91 years at baseline, which originally addressed 
determinants of chronic diseases. It had its baseline data-collection from 
1975-1978; the mean follow up period was 19.6 years. Due to its long-
follow up data from this study enables us to investigate the relation be-
tween a certain risk factor present already relatively early in life and the 
presence of white matter lesions later in life. The Rotterdam Study had 
the baseline data collection from 1990-1993; mean follow up period was 
4.8 years. The Rotterdam Study is a population-based prospective cohort 
study, among 7983 elderly subjects aged 55 years and over, investigating 
determinants of neurological, cardiovascular, locomotor and ophthalmo-
logic diseases in the elderly. This led us to investigate the relation be-
tween risk factors late in life and the presence of white matter lesions only 
a few years later. 
For the Rotterdam Scan Study a white matter lesions rating scale 
was designed which distinguished lesions in the subcortical and periven-
tricular region. Lesions were rated per size and location in those two re-
gions. 
Chapter 2.1. presents a review on the frequency and risk factors of 
cerebral white matter lesions, based on literature data, while chapter 2.2. 
presents the age and sex specific frequency distribution of white matter 
lesions in the Rotterdam Scan Study. We found a significant association 
between age and presence of white matter lesions. Women had signifi-
cantly more (severe) white matter lesions, especially in the frontal region. 
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Chapter 3 deals with the relation between blood pressure and white 
matter lesions. It is suggested that a change of diastolic blood pressure 
may be a better predictor of cardiovascular disease than the actual level 
of blood pressure, since the latter is the resultant of life-long exposure to 
factors that have influenced the blood pressure, but does not provide in-
formation on the previous blood pressure level. In accordance with that 
observation, other studies among elderly subjects suggested that both a 
low and high diastolic blood pressure are associated with increased risk of 
cardiovascular disease, in particular among subjects with preexisting 
heart disease. Therefore in chapter 3.1. the association between a de-
crease or an increase of blood pressure over a 20 years period and white 
matter lesions is described. We found about a doubled risk for both types 
of white matter lesions in subjects with a decrease or increase in diastolic 
blood pressure of 10 mm Hg or more, over a 20 years period. There was 
no such relation for systolic blood pressure. This J-shaped association 
was also present between diastolic blood pressure and both types of white 
matter lesions in subjects with a history of myocardial infarction, whereas 
this relation was linear in subjects without a history of myocardial infarc-
tion. There was a linear relation between systolic blood pressure and 
white matter lesions in subjects with or without a history of myocardial 
infarction. Chapter 3.2. describes the relation between duration of hy-
pertension and its treatment and white matter lesions. When studying a 
risk factor that is related to mortality selective survival may affect the re-
lation between a risk factor and an outcome. We showed that the most 
unbiased risk estimates are in the 60-70 years age category. In this age 
group we found a 16- to 20-fold increased risk for periventricular and 
subcortical white matter lesions respectively, for individuals who had hy-
pertension for more than 20 years. In addition we showed that effective 
treatment of hypertension reduced the risk for white matter lesions. 
Chapter 4 describes the relation between atherosclerosis and athero-
sclerosis related disorders. In chapter 4.1. we present the association 
between mid-life and late-life aortic atherosclerosis and white matter le-
sions. Individuals who had already signs of aortic atherosclerosis during 
mid-life had a two and a half fold increased risk for periventricular white 
matter lesions, whereas there was no relation with subcortical lesions. We 
found that mid-life aortic atherosclerosis predicts peri ventricular white 
matter lesions later in life in a dose dependent fashion. There was no re-
lation between late-life aortic atherosclerosis and white matter lesions. In 
chapter 4.2. we report an association between indicators of carotid ath-
erosclerosis and periventricular white matter lesions, whereas this rela-
tion was less clear for subcortical white matter lesions. People with pe-
ripheral arterial disease had only a slight increased volume of subcortical 
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white matter lesions compared to those without, whereas for periven-
tricular white matter lesions there was no difference (chapter 4.2.). 
Chapter 4.3. reports on the association between atrial fibrillation and 
white matter lesions. Subjects with atrial fibrillation had more than twice 
as often severe periventricular white matter lesions but not subcortical 
white matter lesions. A high risk subgroup with atrial fibrillation com-
bined with left ventricular hypertrophy had a seven-fold increased risk for 
periventricular white matter lesions and not for subcortical white matter 
lesions. OUT results suggested that cerebral hypoperfusion was the most 
likely mechanism for the presence of white matter lesions, instead of 
atrial fibrillation induced emboli. This association might underlie the as-
sociation between atrial fibrillation and dementia. 
Vasomotor reactivity reflects the ability of small cerebral arteries to 
dilate under the influence of certain stimuli, like carbon dioxide, in order 
to increase cerebral blood flow in case of increased demands. Atheroscle-
rosis may disturb the integrity and function of the arterial wall and 
thereby its capacity to dilate on these stimuli. For that reason we investi-
gated the role of vasomotor reactivity in white matter lesions (Chapter 
4.4.). We found a 30-50% reduced risk per 10% increase in vasomotor 
reactivity for the presence of peri ventricular and subcortical white matter 
lesions, respectively. 
Finally, we examined the relation between the Apolipoprotein E geno-
type and white matter lesions (Chapter 5). Only a few studies investigated 
the relation between white matter lesions and the apolipoprotein E geno-
type, Previous studies found an association between the APOE*4 genotype 
and dementia. It has been suggested that white matter lesions might 
underlie this relation, We found an about seven-fold or a two-fold in-
creased risk for carriers of the APOE2E4 allele for peri ventricular lesions 
and subcortical white matter lesions compared to APOE3E3 carriers 
respectively. When we did the analysis on all individuals with an APOE*4 
allele compared to those with the APOE3E3 genotype APOE*4 carriers had 
a borderline significantly increased risk of 50% for both types of lesions. 
In Chapter 6 the results of our study are discussed. We conclude 
that the prevalence of white matter lesions is high in the elderly, but that 
especially severe white matter lesions appear to be of importance for cog-
nitive consequences. We found an association between classical cardio-
vascular risk factors and white matter lesions. Our results indicate the 
importance of detection of the risk factors already early in life because 
those are the people at the highest risk for white matter lesions, with 
probably the best chances for therapeutic intervention. On the basis of 
our results we hypothesized that white matter lesions are caused by long-
lasting presence of cardiovascular risk factors, leading to atherosclerosis. 
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Atherosclerosis of the small arteries in the white matter may be responsi-
ble for an inadequate reaction on increased demands for blood supply J 
leading to hypoperfusion of the white matter, There is now convincing evi-
dence of a relation between white matter lesions and cognitive impair-
ment. Possible treatable vascular risk factors have been identified as im-
portant risk factors for these lesions. Results from our study suggest that 
treatment of hypertension reduces the risk for white matter lesions. An-
other risk factor for which potentially adequate treatment is available is 
atrial fibrillation. This would make hypertension and atrial fibrillation a 
good candidate for a randomized clinical trial on the effects of treatment 
of these risk factors on white matter lesions and cognition. Because of 
ethical reasons and for reasons of efficacy such a trial should preferably 
be executed within the framework of an ongoing trial on for example 
treatment of hypertension, or atrial fibrillation, and the incidence of car-
diovascular disease. 
1
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Samenvatting I 
D it proefschrift richt zich op de factoren die ten grondslag liggen aan witte stofafwijkingen in de hersenen. Dergelijke witte stofafwijkingen 
komen vaak voar bij Qucleren, oak zander dementie. Tach zijn er in toenc-
mendc mate aanwijzingen dat deze afwijkingen cen rol spelen bij 
cognitieve achteruitgang, tot aan dementie toc. Intellectue1e achteruitgang 
bij ouderen komt vaak voar en heeft daardoor enorme gevolgen voar de 
gezondheidszorg in zijn algemeen, vooral in cen vergrijzende samenleving 
als de aDze, en vear de patient en zijn of haar familie in het bijzonder. 
Vroege detectie van mensen die cen verhoogd risko hebben voar cogni-
tieve achteruitgang of de men tie zou mogebjkheden kunnen bieden voar 
vroege intcrventie en rnogelijke bchandeling van deze ziekten. De vraag-
stelling van dit proefschrift was een nadere bestudering van de risico-
factoren v~~r witte stofafwijkingen, met nadruk op de tijdsfactor, binnen 
een gezonde, niet demente, populatie ouderen. Dit onderzoek werd 
uitgevoerd binnen de Rotterdam Scan Study. 
De Rotterdam Scan Study bestudeert determinanten en gevolgen van 
hersenveranderingen bij ouderen. Van 1995 tot 1996 werden 1904 
Inensen tussen de 60 en de 90 jaar uitgenodigd. Deze mensen werden 
geworven uit de iwee verschillende prospectieve bevolkingsonderzoeken, 
namelijk de Rotterdam Study (in het Nederlands: het Erasmus Rotterdam 
Gezondheid en Ouderen (ERGO) onderzoek) en het Epidemiologisch 
Preventief Onderzock Zoetermeer (EPOZ). Van de 1904 mensen bestonden 
er bij 1724 geen contra-indicaties voor het MRI-onderzoek van de 
hersenenen; 1084 mensen deden dat ook daadwerkelijk (respons 63%). 
De EPOZ studie is reeds begonnen tussen 1975 en 1978, onder 10361 
mensen tussen de 5 en de 91 jaar, met als doe1 het bestuderen van deter-
minanten van chronische ziekten. Door deze lange follow-up (ongeveer 20 
jaar) kunnen we het verband in de tijd bestuderen tussen een risicofacior 
die al relatief vroeg in het leven aanwezig was, en witte stofafwijkingen 
later in het leven. Het ERGO onderzoek (start 1990-1993) omvat 7983 
ouderen van 55 jaar en ouder en onderzoekt risicofactoren voor neuro-
logische, oogheelkundige, cardiovasculaire ziekten en voor ziekten van het 
bewegingsapparaat. Dit stelt ons in staat om het verband na te gaan 
tussen risicofactoren relatief laat in het lev en en de aanwezigheid van 
witte stofafwijkingen enkele jaren later (ongeveer 5 jaar). 
Voor de Rotterdam Scan Study werd een speciale beoordelings-
methode voor witte stofafwijkingen ontworpen, waarbij onderscheid werd 
gemaakt tussen afwijkingen in de subcorticale witte stof, en de pen-
ventriculaire (rond de ventrikels) witte stof. 
Hoofdstuk 2.1 geeft een overzicht van de literatuur over de 
risicofactoren voor witte stofafwijkingen en hun frequentie, terwijl hoofd-
stuk 2,2 de geslachts -en leeftijdsspecifieke frequentieverdelinf van witte 
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stofafwijkingen in de Rotterdam Scan Study beschrijft. Er was een 
significante relatie tussen leeftijd en de aanwezigheid van witte stofafwij-
kingen. Wij vonden tevens dat vrouwen vaker en meer witte stofafwijkin-
gen hadden dan mannen, met name in het frontale deel van de hersenen. 
Hoofdstuk 3 beschrijft het verband tussen bloeddruk en witte 
stofafwijkingen. Er zijn aanwijzingen dat een verandering van de 
bloeddruk een bet ere voorspeller is v~~r hart -en vaatziekten dan de 
absolute waarde van de bloeddruk. In overeenstemming hiermee zijn 
bevindingen in sommige andere studies bij ouderen, die Iaten zien dat 
zowel een lage als een hoge bloeddruk het risko voor cardiovasculaire 
aandoeningen verhoogt. Hoofdstuk 3.1 beschrijft de relatie tussen 
bloeddruk, bloeddruk veranderingen en witte stofafwijkingen. Mensen bij 
wie zich in 20 jaar een aanzienlijke afname of stijging van hun 
diastolische bloeddruk had had voorgedaan, hadden een ongeveer twee 
maal zo hoog risico voor zowel sucorticale als periventriculaire witte 
stofafwijkingen. Dit zogenaamde J-vormige verband vonden we ook in de 
relatie tussen diastolische bloeddruk en witte stofafwijkingen bij mensen 
die al eens een hartinfarct hadden doorgemaakt. Voor systolische bloed-
druk was het verband tussen vroegere bloeddruk en huidige afwijkingen 
van de witte stof lineair, zowel bij mensen met als zonder een doorge-
maakt hartinfarct. In hoofdstuk 3.2 wordt het verb and tussen hyper-
tensie en witte stofafwijkingen beschreven. De relatie tussen een risico-
factor die eveneens geassocieerd is met een verhoogd risko op overlijden 
en bijvoorbeeld witte stofafwijkingen kan worden vertekent door selectieve 
overleving van mensen zonder de risicofactor. Wij vonden dat dit mogelijk 
ook in ons onderzoek van invloed was en vonden dat dit het minst van 
belang was bij deelnemers die tijdens ons onderzoek tussen de 60 en de 
70 jaar waren. In deze leeftijdsgroep vonden we een zestien tot twintig 
keer verhoogd risko voor periventriculaire of subcorticale witte stofafwij-
kingen bij diegenen met ruim 20 jaar hypertensie. Tevens maakten we 
aannemelijk dat effectieve behandeling van hypertensie het risko op witte 
stofafwijkingen verlaagt. 
Hoofdstuk 4 is gewijd aan het verband tussen atherosclerose en 
witte stofafwijkingen. Hoofdstuk 4.1 gaat over de relatie tussen athero-
sclerose in de abdominale aorta en witte stofafwijkingen. Mensen die al 
atherosclerose in de aorta hadden gedurende middelbare leeftijd hadden 
een tweeenhalf maal verhoogd risko op periventriculaire witte stofafwij-
kingen 20 jaar later, terwijl er geen verband was met subcorticale witte 
stofafwijkingen. Er was daarentegen geen relatie tussen at hero sclerose 
van de aorta gemeten laat in het leven en witte stofafwijkingen. 
Hoofdstuk 4.2 beschrijft een gevonden verband tussen atherosc1erose in 
de halsslagader en periventriculaire witte stofafwijkingen, terwiji dit niet 
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gevonden voor subcorticale witte stofafwijkingen. Mensen met perifeer 
vaatlijden hadden een lieht verhoogd volume aan subcorticale witte stof-
afwijkingen, terwijl er voor de periventriculaire afwijkingen geen verschil 
was. Hoofdstuk 4.3 beschrijft het verband tussen atriumfibrilleren en 
witte stofafwijkingen. Mensen met atriumfibrilleren hadden een tweemaal 
verhoogd risico voor periventriculaire witte stofafwijkingen, terwijl er geen 
relatie was voor subcoriieale witte stofafwijkingen. Er bleek een kleine 
groep mensen te zijn met atriumfibrillieren en linker ventrikel hypertrofie, 
die een zeven maal verhoogd risico hadden voor periventriculaire witte 
stofafwijkingen (en niet voor subcorticale afwijkingen). Op grand van deze 
resultaten kan men veronderstellen dat cerebrale hypoperfusie de meest 
waarschijnlijke intermediaire factor was bij het ontstaan van de witte 
stofafwijkingen, en niet eventuele, door atriumfibrilleren gevormde, 
thromboembolieen. Deze associatie kan mogelijk het door anderen 
gevonden vcrband tussen atriumfibrilleren en dementie verklaren. Onder 
normale omstandigheden kunnen arteriolae in de hersenen verwij den 
onder invloed van stimuli als kooldioxide of een daling van de bloeddruk 
(chemoregulatie resp. autoregulatie), om een zo contstant mogelijke cere-
brale doorbloeding te bewerkstelligen. Atherosclerose kan deze functie van 
de wand van de arteriolae aantasten en zo lei den tot een verminderde 
cerebrale perfusie. Inderdaad vonden wij bij mensen met een goede 
vasomotoire reserve capaciteit (na toediening van kooldioxide) een signi-
ficant verlaagd risico voor periventriculaire en subcorticale witte stof-
afwijkingen (hoofdstuk 4.4). 
Ten slotte onderzochten we in hoofdstuk 5 het verband tussen het 
apolipoproteine E genotype (APOE) en witte stofafwijkingen. Eerdere 
onderzoekingen heten een verband zien tussen het APOE*4 genotype en 
dementie. Er wordt weI verandersteld dat witte stofafwijkingen de 
intermediaire factor vormen. Wij vonden een zevenmaal resp. tweemaal 
verhoogd risico voor periventriculaire of subcorticale witte stofafwijkingen 
bij dragers van het APOE2E4 genotype, vergeleken met dragers van het 
APOE3E3 genotype. Mensen met het APOE*4 genotype hadden een, bijna 
significant, anderhalf keer verhoogd risico voor beide typen witte stof-
afwijkingen. 
In hoofdstuk 6 worden de bevindingen van ons onderzoek bezien in 
samenhang met andere studies. Tevens wordt een verklaring voorgesteld 
voor het ontstaan van witte stofafwijkingen. Wij vonden dat de prevalentie 
van witte siofafwijkingen hoog was en dat er een sterk verband bestond 
met de klassieke cardiovasculaire risicofactoren zoals hypertensie en 
atherosclerose. Onze resultaten laten zien dat het mogelijk en belangrijk 
is am mensen met een verhoogd risico reeds vroeg in het leven op te 
sporen, zodat preventie en eventueel behandeling nag goed mogelijk zijn. 
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Onze veronderstelling over de ontstaanswijze van witte stofafwijkingen is 
als voIgt: langdurige hypertensie leidt tot atherosclerotische veranderin-
gen in de kleine cerebrale arteriolen. Deze vaatwandveranderingen 
verhinderen mogelijk een doeltreffende reactie op een afnemende 
cerebrale doorbloeding, hetgeen leidt tot chronische ischemie. De 
ischemische veranderingen van de witte stof leiden waarschijnlijk tot het 
typische MRI-beeld van witte stofafwijkingen. 
Er zijn nu meeT en meeT aanwijzingen voar een verband tussen witte 
stofafwijkingen enerzijds en cognitieve achteruitgang en dementie en 
depressie anderzijds op oudere leeftijd. Uit onze bevindingen blijkt dat te 
belDvloeden vasculaire factoren de kans op witte stofafwijkingen sterk 
verhagen. In een gerandomiseerde klinische trial zou het effect kunnen 
worden onderzocht van behandeling van hypertensie en atriumfibrilleren 
op witte stofafwijkingen en de daarmee gepaard gaande cognitieve 
stoornissen, Vanuit het oogpunt van efficiency en vanwege ethische 
bezwaren zou een dergelijke trial bij voorkeur moeten worden uitgevoerd 
binnen het kader van een trial die is gericht op de meest ernstige 
complicaties van bovengenoemde risicofactoren (hartinfarcten en 
beroertes) . 
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Na zeventigduizend MRI-beclden te hebben beoordeeld, duizenden 
analyses te hebben gedaan en honderden mensen te hebben onderzocht, 
is er dan eindeUjk na ruim drie jaar cen proefschrift. Deze grate 
hoeveelheid werk te kunnen samenvatten in een zin suggereert dat heel 
veel werk door anderen gedaan is en die personen wil ik dan oak hier 
bedanken. Allereerst mijn promotor Prof. dr A. Hofman, Bert door jouw 
epidemiologische kennis kon jij goed de yinger op de zwakke plek leggen. 
Tevens gaf je aan hoe belangrijk presentatie van onderzoek is, zowe1 in 
waard als geschrift. Ook mijn tweede promotor Prof. dr J. van Gijn wil ik 
bedanken voar de altijd zeer snelle stilistische en taalkundige adviczen die 
de kwaliteit van aIle manuscripten zeer deden verbeteren en voor de (voar 
mij) onverwachte invalshoeken vanuit de klinische neurologic. Ondanks 
de afstand verliep de communicatie altijd erg soepeJtjes en erg snel (Fleur 
en Stephanie bedankt!). 
Ook cen waard van dank voor aIle begeleiding van co-promotor Dr 
Monique Bretelcr. Dankzij jouw gcvoel voor stijl en struetuur zijn aIle 
manuscripten tot vlot leesbare papers geworden. 
Een speciaal woord van dank wil ik riehten tot 'mijn' eo-promovendus 
Jan Cees de Groot. Beste Jan Cees, dankzij jouw enorme hoeveelheid 
voorwerk kon ik op een rijdende trein springen. Ook na de data-
verzameling, tijdens ons verblijf op de 21 stc , was het een gezellige tijd en 
kon je Inet je humoristische statements de zaken altijd goed relativeren. 
Ik ben blij dat je nu paranimf wilt zijn. Jammer dat je nu naar Leiden 
'moet' ....... . 
Een groat dierenliefhebber ben ik door mijn lidmaatschap van de 
vetcrinaire epidemiologie nooit geworden, maar met drie zulke lotgenoten 
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(JeCe, Casper en Arjen) op een kamer te worden gezet, als cootje nog weI, 
zal ik nooit vergeten. He1aas moest er al snel een deel in permanente 
ballingschap op de 22'" verdieping. Arjen, ik vind het erg leuk dat we 
sarnen in Utrecht worden opgeleid tot neuroloog. Om maar eens een 
geveugelde afdelingsuitdrukking te gebruiken: 'Jongens het ga jullie goed'. 
Gelukkig werden ze waardig opgevolgd door achtereenvolgens Sanjay, 
Tommie (de 'briljante' koffiezetter) en Sarah. Veel promotieperikelen 
konden te uit en te na worden besproken met cen bijna niet op te noernen 
aantal mede-promovendi (en dat zal ik dan ook niet doen). 
Het maken van zoveel MRI -scans zou niet mogelijk zijn geweest 
zonder Matthijs Oudkerk en zijn afdeling Radiologie van de Daniel den 
Hoed Kliniek en de afdeling Radiologie van het Academisch Ziekenhuis 
Utrecht (Prof. dr W.P.T.M. Mali en Drs L.M.P. Ramos). Het daadwerkelijk 
maken van de MRI-scans zou onmogelijk zijn geweest zander Bart Schraa 
en Deni Kraus en de laboranten van de afdeling radiologie van het AZU, 
die bij toerbeurten de avond-MRI-sessies op de Daniel, respectievelijk de 
zaterdagsessies op het AZU verzorgden. 
Dankzij de kennis en ervaring van dr Philip Scheltens, dr Eric Achten 
en drs R. Heijboer konden we een 'rating scale' voor 'age related brain 
changes' ontwerpen die goed toepasbaar en reproduceerbaar bleek. 
Het uitnodigen en onderzoeken van aIle deelnemers aan het ERGO-
en het EPOZ-onderoek zou natuurlijk niet mogelijk zijn zonder alle 
deelnemers, maar zou zeker niet zijn gelukt zonder de onvermoeibare 
inzet van een groot deel van het ERGO-team. Ada Hooghart, Agnes van 
der Voorn, Anneke Korving, Corina Brussee, Dick Slof, Hanneke van 
Meurs, lnge Haumersen, Joke Janssen, Margriet van Rees, Micheline de 
Haes, Ria Rijneveldshoek en Toos Stehman wil ik hiervoor, in alfabetische 
volgorde, met name bedanken. Jullie waren er altijd en zorgen altijd voor 
de juiste ambiance op het ERGO- c.q. EPOZ-centrum. 
Het selecteren van deelnemers en het maken van 'even' een 'sav-
filetje' of het installeren van een programmaatje werd altijd perfect 
geregeld door de automatiseringssectie van Eric Neeleman; Marcel 
Eijgermans, Rene Vermeeren en Nano Suwarno, bedankt. Bij de dames en 
hcren van de Biostatistiek stond de deur altijd open om de te lang geleden 
statistiek cursussen weer op te frissen. 
Mijn nieuwe collega' s op de afdeling Neurologie bedank ik voor de 
tijd die ze me gaven om de laatste hand aan het 'boekje' te leggen. 
Mijn ouders wil ik bedanken voor alle hulp die ze altijd bieden; dat 
heeft mede bijgedragen aan het op tijd afkomen van het boekje. Ernst-Jan 
bedank ik voor het feit paranimf te willen zijn. 
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Lieve Amanda, dat je drie kwartier geen paranimf bent, dat gaat nag 
net; maar ik ben blij te weten dat het maar zo kart duurt. Ik wil jall en 
Lodewijk bedanken voar het leven naast de wetenschap. 
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